Days At A Glance Speakers Session Type Search
Type

    07:00 - 20:00 
    Registration
    07:30 - 08:00 
    Breakfast for Working Group Attendees
    Pacific Foyer, King Willem Alexander on 1st Floor, First Floor Lobby, Amazon Foyeer
    08:00 - 09:30 
    ESPE Working Group on Disorders of Sex Development
    Atlantic
    Chair: Tülay Güran (Istanbul, Turkey)
    Thu 21 08:00
    ESPE Working Group on Disorders of Sex Development
    Introduction
    Turkey, Istanbul
    Thu 21 08:05
    ESPE Working Group on Disorders of Sex Development
    Case Presentation
    Istanbul, Turkey
    Thu 21 08:15
    ESPE Working Group on Disorders of Sex Development
    Case presentation
    Zagreb, Croatia
    Thu 21 08:25
    ESPE Working Group on Disorders of Sex Development
    Androgen insensitivity syndrome Type 1
    Cambridge, UK
    Thu 21 08:50
    ESPE Working Group on Disorders of Sex Development
    Androgen insensitivity syndrome Type 2
    Kiel, Germany
    Thu 21 09:15
    ESPE Working Group on Disorders of Sex Development
    Discussion with attendees
    Thu 21 09:25
    ESPE Working Group on Disorders of Sex Development
    Concluding Remarks
    Belgrade, Serbia
    Turkey, Istanbul
    08:00 - 09:30 
    ESPE Working Group on Obesity
    Pacific
    Chair: Erica van den Akker (Rotterdam, The Netherlands)
    Thu 21 08:00
    ESPE Working Group on Obesity
    The ESPE Obesity Working Group
    Rotterdam, The Netherlands
    Thu 21 08:20
    ESPE Working Group on Obesity
    Environmental contributions to obesity development
    Copenhagen, Denmark
    Thu 21 08:40
    ESPE Working Group on Obesity
    New treatment in children and adolescents with obesity
    Paracelsus Medical School, Salzburg, Austria
    Thu 21 09:00
    ESPE Working Group on Obesity
    Overweight and obesity in European Young Children: ToyBox-study lessons
    Thu 21 09:20
    ESPE Working Group on Obesity
    Q&A
    08:00 - 09:30 
    ESPE Bone and Growth Plate Working Group
    Yangtze 1&2
    Chair: Evelien Gevers (London, UK)
    Thu 21 08:00
    ESPE Bone and Growth Plate Working Group
    Radiology of rare and less rare skeletal dysplasia
    London, UK
    Thu 21 08:30
    ESPE Bone and Growth Plate Working Group
    Genetics of rare skeletal dysplasia
    Stockholm, Sweden
    Thu 21 09:00
    ESPE Bone and Growth Plate Working Group
    2x clinical case from working group members
    08:00 - 09:30 
    ESPE Working Group on Diabetes Technology
    Mississippi
    Chair: Moshe Phillip (Petah Tikva, Israel)
    Thu 21 08:00
    ESPE Working Group on Diabetes Technology
    Introduction
    Petah Tikva, Israel
    Thu 21 08:05
    ESPE Working Group on Diabetes Technology
    Stage 1/Stage 2 T1DM – how do we monitor outside of clinical studies?
    Petah Tikva, Israel
    Thu 21 08:25
    ESPE Working Group on Diabetes Technology
    CGM use in Stage 2 T1DM
    Ljubljana, Slovenia
    Thu 21 08:45
    ESPE Working Group on Diabetes Technology
    Immune intervention of newly diagnosed of T1DM – where are we today?
    Oulu, Finland
    Thu 21 09:05
    ESPE Working Group on Diabetes Technology
    Discussion - Round Table
    08:00 - 09:30 
    ESPE Working Group on Paediatric and Adolescent Gynaecology
    King Willem Alexander Auditorium
    Chair: Lourdes Ibanez Toda (Barcelona, Spain)
    Thu 21 08:00
    ESPE Working Group on Paediatric and Adolescent Gynaecology
    Early puberty: connecting nutritional status and pubertal activation
    Córdoba, Spain
    Thu 21 08:25
    ESPE Working Group on Paediatric and Adolescent Gynaecology
    Environmental programming of early pubertal onset
    Rome, Italy
    Thu 21 08:50
    ESPE Working Group on Paediatric and Adolescent Gynaecology
    Management of early puberty : adaptation or overmedicalization?
    Paris, France
    France
    08:00 - 09:30 
    ESPE Working Group on Gender Incongruence
    Amazon
    Chair: Sabine Hannema (Amsterdam, The Netherlands)
    Thu 21 08:00
    ESPE Working Group on Gender Incongruence
    Gender dysphoria and autism, implications for diagnosis and decision making
    Amsterdam, The Netherlands
    Thu 21 08:30
    ESPE Working Group on Gender Incongruence
    Animal models of transgender care, advantages and drawbacks
    Georgetown, USA
    Thu 21 09:00
    ESPE Working Group on Gender Incongruence
    Moral dilemmas surrounding puberty suppression in transgender adolescents’
    Leiden, The Netherlands
    08:00 - 09:30 
    ESPE Working Group on Turner Syndrome
    Everest 1&2
    Chair: Janielle van der Velden (Nijmegen, The Netherlands)
    Thu 21 08:00
    ESPE Working Group on Turner Syndrome
    Challenges and opportunities in prenatal and postnatal diagnosis of Turner Syndrome & Parents’ Testimony
    Nijmegen, Netherlands
    Hoeselt, Belgium
    Thu 21 08:10
    ESPE Working Group on Turner Syndrome
    Medical aspects
    The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom
    Thu 21 08:25
    ESPE Working Group on Turner Syndrome
    Psychological aspects
    Bristol, UK
    Thu 21 08:35
    ESPE Working Group on Turner Syndrome
    Ethical considerations
    Leiden, The Netherlands
    Thu 21 08:45
    ESPE Working Group on Turner Syndrome
    Panel discussion (interactive)
    Thu 21 09:15
    ESPE Working Group on Turner Syndrome
    I-TS & pubertal induction study
    Glasgow, UK
    Thu 21 09:25
    ESPE Working Group on Turner Syndrome
    Update form TSWG and Disclosure
    Nijmegen, Netherlands
    09:30 - 10:00 
    Refreshment Break, Posters and Exhibition
    Exhibition Hall
    10:00 - 10:15 
    Opening Ceremony
    King Willem Alexander Auditorium
    10:15 - 10:45 
    Plenary 1: Sex Differences in the Brain: Intersection of the Endocrine, Immune and Nervous Systems
    King Willem Alexander Auditorium
    Chairs: Anita Hokken-Koelega (Rotterdam, The Netherlands) & Sabine Hannema (Amsterdam, The Netherlands)
    Thu 21 10:15
    PL1
    Plenary 1: Sex Differences in the Brain: Intersection of the Endocrine, Immune and Nervous Systems
    Sex Differences in the Brain: Intersection of the Endocrine, Immune and Nervous Systems
    Baltimore, USA
    10:45 - 11:15 
    Awards 1 - Henning Andersen Prizes
    King Willem Alexander Auditorium
    Chair: Nils Krone (Sheffield, UK)
    Thu 21 10:45
    Awards 1 - Henning Andersen Prizes
    Awards 1 - Henning Andersen Prizes
    11:25 - 12:55 
    Symposium 1 - Disorders of Sex Development
    Atlantic
    Chairs: Angela Lucas Herald (Glasgow, UK) & David Zangen (Jerusalem, Israel)
    Thu 21 11:25
    S1.1
    Symposium 1 - Disorders of Sex Development
    Life-long care for people with 46,XY DSD
    Lübeck, Germany
    Thu 21 11:55
    S1.2
    Symposium 1 - Disorders of Sex Development
    Regulation of germ cell fate during sex determination
    Geneva, Switzerland
    Thu 21 12:25
    S1.3
    Symposium 1 - Disorders of Sex Development
    Pathogenesis of testicular dysfunction in Klinefelter syndrome
    Copenhagen, Denmark
    11:25 - 12:55 
    Symposium 2 - Hypothalamo-pituitary disorders
    Pacific
    Chairs: Mariacarolina Salerno (Naples, Italy) & Roland Pfaffle (Leipzig, Germany)
    Thu 21 11:25
    S2.1
    Symposium 2 - Hypothalamo-pituitary disorders
    Novel imaging techniques in pituitary tumours
    University of Cambridge, Cambridge, UK
    Thu 21 11:55
    S2.2
    Symposium 2 - Hypothalamo-pituitary disorders
    Stem cells in the pituitary
    London, UK
    Thu 21 12:25
    S2.3
    Symposium 2 - Hypothalamo-pituitary disorders
    Pioneer transcription factors
    Montreal, Canada
    11:25 - 12:55 
    Symposium 3 - Endocrine effects of cancer treatment
    Mississippi
    Chairs: Hoong-wei Gan (London, UK) & Hanneke van Santen (Utrecht, The Netherlands)
    Thu 21 11:25
    S3.1
    Symposium 3 - Endocrine effects of cancer treatment
    Safety of GH treatment in cancer survivors
    Stockholm, Sweden
    Thu 21 11:55
    S3.2
    Symposium 3 - Endocrine effects of cancer treatment
    Surveillance for endocrine disease in Childhood Cancer Survivors
    Pittsburgh, USA
    Thu 21 12:25
    S3.3
    Symposium 3 - Endocrine effects of cancer treatment
    Fertility preservation in children with cancer
    Edinburgh, UK
    11:25 - 12:55 
    Symposium 4 - Novel insights and innovations in diabetes
    Yangtze 1&2
    Chairs: Jacques Beltrand (Paris, France) & May Ng (Liverpool, UK)
    Thu 21 11:25
    S4.1
    Symposium 4 - Novel insights and innovations in diabetes
    Role of alpha cells in islet function
    Uppsala, Sweden
    Thu 21 11:55
    S4.2
    Symposium 4 - Novel insights and innovations in diabetes
    Delaying the development of T1DM
    New Haven, USA
    Thu 21 12:25
    S4.3
    Symposium 4 - Novel insights and innovations in diabetes
    Physical interaction between beta and delta cells
    Oxford, UK
    11:25 - 12:25 
    Yearbook 1
    Amazon
    Chair: Christa Flück (Bern, Switzerland)
    Thu 21 11:25
    YB1.1
    Yearbook 1
    Global Health for the Paediatric Endocrinologist
    Vancouver, Canada
    Thu 21 11:37
    YB1.2
    Yearbook 1
    Type 2 Diabetes, Metabolic Syndrome and Lipids
    Tel Aviv, Israel
    Thu 21 11:49
    YB1.3
    Yearbook 1
    Obesity and Weight Regulation
    University of Ulm, Germany
    Thu 21 12:01
    YB1.4
    Yearbook 1
    Adrenal
    Athens, Greece
    Thu 21 12:13
    YB1.5
    Yearbook 1
    The Year in Science & Medicine
    Bern, Switzerland
    12:55 - 14:25 
    Lunch, posters and exhibition
    Exhibition Hall
    13:15 - 14:15 
    Satellite Symposium 1
    For more information please see satellite programme
    13:15 - 14:15 
    Satellite Symposium 2
    For more information please see satellite programme
    14:25 - 15:55 
    How do I…? 1
    King Willem Alexander Auditorium
    Chairs: Naomi Weintrob (Tel Aviv, Israel) & Johnny Deladoëy (Montréal, Canada)
    Thu 21 14:25
    HDI1.1
    How do I…? 1
    How do I manage abnormal thyroid function tests in the newborn?
    London, UK
    Thu 21 14:55
    HDI1.2
    How do I…? 1
    How do I use AMH in paediatric practice?
    Buenos Aires, Argentina
    Thu 21 15:25
    HDI1.3
    How do I…? 1
    How do I manage a child with hypercalcemia?
    Bochum, Germany
    14:25 - 14:55 
    Rapid Free Communications 1: Adrenals and HPA Axis
    Pacific
    Chairs: Christa Flück (Bern, Switzerland) & Li Chan (London, UK)
    Thu 21 14:25
    RFC1.4
    Rapid Free Communications 1: Adrenals and HPA Axis
    Unfavorable Body Composition in Children with Premature Adrenarche: Implications for Metabolic Health
    Tel Aviv, Israel
    Tel Aviv, Israel
    Thu 21 14:30
    RFC1.3
    Rapid Free Communications 1: Adrenals and HPA Axis
    The chimeric CYP21A1P/CYP21A2 and TNXA/TNXB gene deficiencies in patients with Congenital Adrenal Hyperplasia
    Nicosia, Cyprus
    Thu 21 14:35
    RFC1.5
    Rapid Free Communications 1: Adrenals and HPA Axis
    The effect of storage and temperature on the stability of steroid hormones in dried blood spots
    Amsterdam, The Netherlands
    Thu 21 14:40
    RFC1.1
    Rapid Free Communications 1: Adrenals and HPA Axis
    Lack of NAD(P)+ transhydrogenase activity in patients with primary adrenal insufficiency due to NNT mutations
    Istanbul, Turkey
    Thu 21 14:45
    Rapid Free Communications 1: Adrenals and HPA Axis
    Clinical and genetic characteristics of 42 Chinese paediatric patients with X-Linked Adrenal Hypoplasia Congenita
    Shanghai, China
    Thu 21 14:50
    RFC1.2
    Rapid Free Communications 1: Adrenals and HPA Axis
    Interlaboratory comparison of LC-MS/MS measurements of 11 relevant steroid hormones in 27 DSD patients
    Kiel, Germany
    14:25 - 14:55 
    Rapid Free Communications 2: Bone, growth plate and mineral metabolism
    Mississippi
    Chairs: Evelien Gevers (London, UK) & Wolfgang Högler (Linz, Austria)
    Thu 21 14:25
    RFC2.1
    Rapid Free Communications 2: Bone, growth plate and mineral metabolism
    Identification of novel genes including NAV2 associated with isolated tall stature
    Heidelberg, Germany
    Thu 21 14:30
    RFC2.2
    Rapid Free Communications 2: Bone, growth plate and mineral metabolism
    Familial pseudohypoparathyroidism type IB associated with an SVA retrotransposon insertion in the GNAS locus.
    Tokyo, Japan
    Thu 21 14:35
    RFC2.3
    Rapid Free Communications 2: Bone, growth plate and mineral metabolism
    High incidence of Chiari type I anomalies on MRI in young patients with X-linked hypophosphatemic rickets (XLHR)
    Paris, France
    Thu 21 14:40
    RFC2.4
    Rapid Free Communications 2: Bone, growth plate and mineral metabolism
    Documentation of inactivating PTH/PTHrP Signaling Disorders (Pseudohypoparathyroidism) cases in EuRRECa / EuRR-Bone: a challenging, but worthwhile journey
    Le Kremlin-Bicêtre, France
    Thu 21 14:45
    RFC2.5
    Rapid Free Communications 2: Bone, growth plate and mineral metabolism
    Growth in young children with X-linked hypophosphatemia treated with burosumab
    Le Kremlin-Bicêtre, France
    Thu 21 14:50
    RFC2.6
    Rapid Free Communications 2: Bone, growth plate and mineral metabolism
    Short term side effects of first bisphosphonate infusion in children with different underlying bone pathologies.
    Vienna, Austria
    14:25 - 14:55 
    Rapid Free Communications 3: Fat, metabolism and obesity 1
    Yangtze 1&2
    Chairs: Francesco Chiarelli (Chieti, Italy) & Senthil Senniappan (Liverpool, UK)
    Thu 21 14:25
    RFC3.1
    Rapid Free Communications 3: Fat, metabolism and obesity 1
    Fasting and meal-related zonulin serum levels in a large cohort of obese children and adolescents: a cross sectional study
    Messina, Italy
    Thu 21 14:30
    RFC3.2
    Rapid Free Communications 3: Fat, metabolism and obesity 1
    Reduced central sensitivity to thyroid hormones in children and adolescents with overweight or obesity and impaired glucose tolerance.
    Messina, Italy
    Thu 21 14:35
    RFC3.3
    Rapid Free Communications 3: Fat, metabolism and obesity 1
    Early Corneal Nerve Loss in Children with Melanocortin 4 Receptor (MC4R) Gene Mutation Related Obesity
    Doha, Qatar
    Thu 21 14:40
    RFC3.4
    Rapid Free Communications 3: Fat, metabolism and obesity 1
    Effect of maternal diet and breastfeeding on growth and distribution of adiposity from birth up to 12 months: data from the European LIFE-MILCH project
    Parma, Italy
    Thu 21 14:45
    RFC3.5
    Rapid Free Communications 3: Fat, metabolism and obesity 1
    Multi-omics Reveals molecule target Underlying Adolescent obesity with metabolic syndrome
    Nanchang, China
    Thu 21 14:50
    RFC3.6
    Rapid Free Communications 3: Fat, metabolism and obesity 1
    Glucocorticoid-mediated leptin secretion from human adipocytes is dependent on glucose availability
    Ulm, Germany
    14:25 - 14:55 
    Rapid Free Communications 4: Growth and syndromes (to include Turner syndrome)
    Atlantic
    Chairs: Cheri Deal (Montréal, Canada) & Janielle van der velden (Nijmegen, The Netherlands)
    Thu 21 14:25
    RFC4.1
    Rapid Free Communications 4: Growth and syndromes (to include Turner syndrome)
    Functional networks reveal pathways linking early growth to childhood blood pressure in the Manchester BabyGRO Study
    Manchester, UK
    Thu 21 14:30
    RFC4.2
    Rapid Free Communications 4: Growth and syndromes (to include Turner syndrome)
    Molecular genetic diagnosis in children with Idiopathic Short Stature: Single Center Experience
    Izmir, Turkey
    Thu 21 14:35
    RFC4.3
    Rapid Free Communications 4: Growth and syndromes (to include Turner syndrome)
    Aromatase inhibitors: an effective and safe option for height increment in boys with growth hormone deficiency?
    Izmir, Turkey
    Thu 21 14:40
    RFC4.4
    Rapid Free Communications 4: Growth and syndromes (to include Turner syndrome)
    Genetic findings in short Turkish children born to consanguineous parents
    Leiden, The Netherlands
    Thu 21 14:45
    RFC4.5
    Rapid Free Communications 4: Growth and syndromes (to include Turner syndrome)
    Real-world safety and effectiveness of vosoritide: Results from an early access program in France
    Paris, France
    Thu 21 14:50
    RFC4.6
    Rapid Free Communications 4: Growth and syndromes (to include Turner syndrome)
    Results from the PROPEL 2 dose-finding study: oral infigratinib leads to significant increases in height velocity with good tolerability in children with achondroplasia
    Melbourne, Australia
    14:25 - 14:55 
    Rapid Free Communications 5: Diabetes and insulin 1
    Amazon
    Chairs: Paul Voorhoeve (Nijmegen, The Netherlands) & Marianna Rachmiel (Zerifin, Israel)
    Thu 21 14:25
    RFC5.1
    Rapid Free Communications 5: Diabetes and insulin 1
    Tear proteomics profile in children and adolescents with type 1 diabetes mellitus
    Athens, Greece
    Thu 21 14:30
    RFC5.2
    Rapid Free Communications 5: Diabetes and insulin 1
    Comparison of Optical Coherence Tomography Angiography Findings in Children with Type 1 Diabetes Mellitus and Autoimmune Thyroiditis with Healthy Children
    Izmir, Turkey
    Thu 21 14:35
    RFC5.3
    Rapid Free Communications 5: Diabetes and insulin 1
    3 Screen ICA ELISA–A new tool to identify pre-clinical diabetes in first-degree relatives of patients with type 1 diabetes (pre-d1abetes study)
    Białystok, Poland
    Thu 21 14:40
    RFC5.4
    Rapid Free Communications 5: Diabetes and insulin 1
    Effect of probiotic on glycemic control in children with type 1 diabetes : A randomized controlled trial
    Mansoura, Egypt
    Thu 21 14:45
    RFC5.5
    Rapid Free Communications 5: Diabetes and insulin 1
    Syndrome of hypoglycemia unawareness in children with type 1 diabetes: clinical contribution of Clark and Gold questionnaire
    Prague, Czech Republic
    Thu 21 14:50
    RFC5.6
    Rapid Free Communications 5: Diabetes and insulin 1
    Do females with Type 1 Diabetes have puberty earlier?
    Cáceres, Spain
    14:55 - 15:55 
    Free Communications 1: Adrenals and HPA Axis
    Pacific
    Chairs: Christa Flück (Bern, Switzerland) & Li Chan (London, UK)
    Thu 21 14:55
    FC1.1
    Free Communications 1: Adrenals and HPA Axis
    Investigating intergenerational effects of glucocorticoids
    Cambridge, UK
    Thu 21 15:05
    FC1.2
    Free Communications 1: Adrenals and HPA Axis
    The pathophysiologic response of central nervous system due to differently impaired steroidogenesis
    Sheffield, UK
    Thu 21 15:15
    FC1.4
    Free Communications 1: Adrenals and HPA Axis
    Response to Crinecerfont Treatment in Adolescents with Classic Congenital Adrenal Hyperplasia Is Correlated with Elevated Baseline Hormone Concentrations but Not Glucocorticoid Dose
    Minneapolis, USA
    Thu 21 15:25
    FC1.3
    Free Communications 1: Adrenals and HPA Axis
    Generation and Characterization of a novel Humanized CYP21A2 Knock-in Mouse Model for Congenital Adrenal Hyperplasia
    Dresden, Germany
    Thu 21 15:35
    FC1.5
    Free Communications 1: Adrenals and HPA Axis
    Management of congenital adrenal hyperplasia in the first 90 days of life: a multi-centre I-CAH analysis of contemporary practice
    Southampton, UK
    Thu 21 15:45
    FC1.6
    Free Communications 1: Adrenals and HPA Axis
    Cardiovascular risk profile in adult patients with congenital adrenal hyperplasia: a cross-sectional study
    Nijmegen, The Netherlands
    14:55 - 15:55 
    Free Communications 2: Bone, growth plate and mineral metabolism
    Mississippi
    Chairs: Evelien Gevers (London, UK) & Wolfgang Högler (Linz, Austria)
    Thu 21 14:55
    FC2.1
    Free Communications 2: Bone, growth plate and mineral metabolism
    Hearing loss in pseudohypoparathyroidism (inactivating PTH/PTHRP Signaling Disorder): a prospective study to assess prevalence and predictive factors of hearing loss in 44 patients affected with iPPSD/PHP
    Le Kremlin-Bicêtre, France
    Thu 21 15:05
    FC2.2
    Free Communications 2: Bone, growth plate and mineral metabolism
    First Results of the Global ALPL Gene Variant Classification Project
    Linz, Austria
    Thu 21 15:15
    FC2.3
    Free Communications 2: Bone, growth plate and mineral metabolism
    Hyperparathyroidism after three years of burosumab in children affected with x-linked hypophosphatemia
    Le Kremlin-Bicêtre, France
    Thu 21 15:25
    FC2.4
    Free Communications 2: Bone, growth plate and mineral metabolism
    A real-world study in Germany and Switzerland regarding renal health in children with X-linked hypophosphatemia
    Hannover, Germany
    Thu 21 15:35
    FC2.5
    Free Communications 2: Bone, growth plate and mineral metabolism
    Generation of novel genetic zebrafish models and using RNA-seq analysis to explore the role of ankrd11 gene on bone growth
    Thu 21 15:45
    FC2.6
    Free Communications 2: Bone, growth plate and mineral metabolism
    Human breast milk-derived exosomes promote growth plate cell lines in vitro
    Istanbul, Turkey
    14:55 - 15:55 
    Free Communications 3: Fat, metabolism and obesity 1
    Yangtze 1&2
    Chairs: Francesco Chiarelli (Chieti, Italy) & Senthil Senniappan (Liverpool, UK)
    Thu 21 14:55
    FC3.1
    Free Communications 3: Fat, metabolism and obesity 1
    Early childhood height and weight development in children with monogenic obesity: A European multicenter cohort study
    Ulm, Germany
    Thu 21 15:05
    FC3.2
    Free Communications 3: Fat, metabolism and obesity 1
    Analysis of ligand- and mutation-dependent signaling of the melanocortin 4 receptor (MC4R): an example of the relevance of differential signaling (bias signaling)
    Berlin, Germany
    Thu 21 15:15
    FC3.3
    Free Communications 3: Fat, metabolism and obesity 1
    Frequency of Obesity-Related Gene Variants in a European Population With Early-Onset, Severe Obesity
    Madrid, Spain
    Thu 21 15:25
    FC3.4
    Free Communications 3: Fat, metabolism and obesity 1
    A Novel Mutation in DYRK1B Associated With Abdominal Obesity Metabolic Syndrome 3 (AOMS3)
    Doha, Qatar
    Thu 21 15:35
    FC3.5
    Free Communications 3: Fat, metabolism and obesity 1
    Early corneal nerve loss in children with obesity and type 2 diabetes
    Doha, Qatar
    Thu 21 15:45
    FC3.6
    Free Communications 3: Fat, metabolism and obesity 1
    Impact of Setmelanotide on Future Metabolic Syndrome Risk in Pediatric Patients With Bardet-Biedl Syndrome
    Madrid, Spain
    14:55 - 15:55 
    Free Communications 4: Growth and syndromes (to include Turner syndrome)
    Atlantic
    Chairs: Cheri Deal (Montréal, Canada) & Janielle van der velden (Nijmegen, The Netherlands)
    Thu 21 14:55
    FC4.1
    Free Communications 4: Growth and syndromes (to include Turner syndrome)
    Heterozygous Null Mutations in FLNB as a Cause of apparent isolated Short Stature in Chinese Children
    Suzhou, China
    Thu 21 15:05
    FC4.2
    Free Communications 4: Growth and syndromes (to include Turner syndrome)
    Genetic and phenotypic features of children with familial tall stature
    Prague, Czech Republic
    Thu 21 15:15
    Free Communications 4: Growth and syndromes (to include Turner syndrome)
    Pathogenic variants in GHSR cause short stature and growth hormone neurosecretory dysfunction; results from a large case series
    Leiden, The Netherlands
    Thu 21 15:25
    Free Communications 4: Growth and syndromes (to include Turner syndrome)
    Growth failure in aggrecan haploinsufficiency is due to a decrease in growth plate matrix volume and hypertrophic cell size
    Stockholm, Sweden
    Thu 21 15:35
    Free Communications 4: Growth and syndromes (to include Turner syndrome)
    From thalidomide embryopathy to genetic defects of the upper limb, internal organs, cerebral midline, and pituitary: The phenotypic spectrum of SALL4
    Prague, Czech Republic
    Thu 21 15:45
    Free Communications 4: Growth and syndromes (to include Turner syndrome)
    Persistence of Growth Promoting Effects in Infants and Toddlers with Achondroplasia: Results in Children Aged Over 2 Years Old from a Phase II Extension Study with Vosoritide
    London, UK
    14:55 - 15:55 
    Free Communications 5: Diabetes and insulin 1
    Amazon
    Chairs: Paul Voorhoeve (Nijmegen, The Netherlands) & Marianna Rachmiel (Zerifin, Israel)
    Thu 21 14:55
    FC5.1
    Free Communications 5: Diabetes and insulin 1
    Diabetes mellitus and gender incongruence: Worse metabolic control in type 1 and higher mental health issue rates in type 1 and 2 diabetes – a DPV registry study
    Bern, Switzerland
    Thu 21 15:05
    FC5.2
    Free Communications 5: Diabetes and insulin 1
    Nailfold capillaroscopy: An alternative non-invasive tool for evaluating microvascular involvement in children with type 1 diabetes
    Istanbul, Turkey
    Thu 21 15:15
    FC5.3
    Free Communications 5: Diabetes and insulin 1
    How feasible is it to meet the Time in Tight Range (TITR) target with Automatic Insulin Delivery (AID)?: 2128-day real-world data from a single center
    Istanbul, Turkey
    Thu 21 15:25
    FC5.4
    Free Communications 5: Diabetes and insulin 1
    Changes of intestinal flora in children with type 1 diabetes mellitus and its related immune mechanism
    Nanchang, China
    Thu 21 15:35
    FC5.5
    Free Communications 5: Diabetes and insulin 1
    Sleep Characteristics, Glycemic Control, and Endothelial Function in Adolescents and Young Adults with Type 1 Diabetes
    Bangkok, Thailand
    Thu 21 15:45
    FC5.6
    Free Communications 5: Diabetes and insulin 1
    Post-Hypoglycemic Hyperglycemia Are Highly Relevant Markers For Stratification Of Glycemic Variability and Remission Status Of Pediatric Patients With New-Onset Type 1 Diabetes.
    Bruxelles, Belgium
    15:55 - 16:15 
    Refreshment Break, Posters and Exhibition
    Exhibition Hall
    16:15 - 16:45 
    Plenary 2
    King Willem Alexander Auditorium
    Chairs: Stefano Cianfarani (Rome, Italy) & Erica van den Akker (Rotterdam, The Netherlands)
    Thu 21 16:15
    PL2
    Plenary 2
    The food environment and the global childhood obesity epidemic: The role of ultra-processed food
    Boston, USA
    16:55 - 17:40 
    Meet the Expert 1.1
    Mississippi
    Thu 21 16:55
    Meet the Expert 1.1
    Management of MEN1 in children and adolescents
    Utrecht, The Netherlands
    16:55 - 17:40 
    Meet the Expert 2.1
    Atlantic
    Thu 21 16:55
    Meet the Expert 2.1
    Informing children about their DSD – when and how?
    Oklahoma, USA
    16:55 - 17:40 
    Meet the Expert 3.1
    Yangtze 1&2
    Thu 21 16:55
    Meet the Expert 3.1
    Uncertainties around diagnosing growth hormone deficiency
    Leiden, The Netherlands
    16:55 - 17:40 
    Meet the Expert 4.1
    Amazon
    Thu 21 16:55
    Meet the Expert 4.1
    Clinical Management of Prader-Willi Syndrome in infants, children and adolescents
    Toulouse, France
    16:55 - 17:55 
    Ethics in Endocrinology
    King Willem Alexander Auditorium
    Chairs: Theo Sas (Rotterdam, The Netherlands) & Marek Niedziela (Poznan, Poland)
    Thu 21 16:55
    EE1.1
    Ethics in Endocrinology
    Ethics of expensive treatments
    Utrecht, The Netherlands
    Thu 21 17:25
    EE1.2
    Ethics in Endocrinology
    Should we strive for normality?
    Leiden, The Netherlands
    17:50 - 19:20 
    Satellite Symposium 3
    For more information please see satellite programme
    17:50 - 19:20 
    Satellite Symposium 4
    For more information please see satellite programme
    17:50 - 19:20 
    Satellite Symposium 5
    For more information please see satellite programme

    07:15 - 19:30 
    Registration
    08:00 - 08:30 
    Plenary 3
    King Willem Alexander Auditorium
    Chairs: Agnès Linglart (Paris, France) & Paul van Trotsenburg (Amsterdam, The Netherlands)
    Fri 22 08:00
    PL3
    Plenary 3
    Structural and functional development of the adolescent brain
    Leiden, Netherlands
    08:15 - 08:45 
    Industry Expert Forum 1
    For more information please see Industry Expert programme
    08:30 - 09:30 
    Controversy 1
    King Willem Alexander Auditorium
    Chairs: Peter Clayton (Manchester, UK) & Philippe Backeljauw (Cincinnati, USA)
    Fri 22 08:30
    Controversy 1
    Pharmacological manipulation of bone maturation should be used to preserve final height in short children (FOR)
    Santiago, Chile
    Fri 22 08:30
    Controversy 1
    Pharmacological manipulation of bone maturation should NOT be used to preserve final height in short children (AGAINST)."
    Helsinki, Finland
    08:35 - 09:20 
    Meet the Expert 5.1
    Yangtze 1&2
    Fri 22 08:35
    Meet the Expert 5.1
    Management of Pituitary adenomas in Children
    Brussels, Belgium
    08:35 - 09:20 
    Meet the Expert 6.1
    Atlantic
    Fri 22 08:35
    Meet the Expert 6.1
    Approach to Thyroid cancer in Children
    Poznan, Poland
    08:35 - 09:20 
    Meet the Expert 7.1
    Amazon
    Fri 22 08:35
    Meet the Expert 7.1
    Management of hyperinsulism beyond the acute phase
    Texas, USA
    08:35 - 09:20 
    Meet the Expert 8.1
    Mississippi
    Fri 22 08:35
    Meet the Expert 8.1
    Puberty induction in hypogonadism
    Imperial College London, London, UK
    08:35 - 09:20 
    Meet the Expert 1.2
    Pacific
    Fri 22 08:35
    Meet the Expert 1.2
    Management of MEN1 in children and adolescents
    Utrecht, The Netherlands
    09:00 - 09:30 
    Industry Expert Fora 2&3
    For more information please see Industry Expert programme
    09:30 - 11:00 
    Endo-ERN Symposium
    Oceania
    Chairs: Olaf Hiort (Lübeck, Germany) & Luca Persani (Milan, Italy)
    Fri 22 09:30
    Endo-ERN Symposium
    Perspective of Endo-ERN for the next five years
    Lübeck, Germany
    Fri 22 09:40
    Endo-ERN Symposium
    European medicine shortages: How can we avoid a disaster for patients with rare conditions?
    Nijkerk, The Netherlands
    Fri 22 10:05
    Endo-ERN Symposium
    It matters - set up of clinical trials in rare diseases
    Berlin, Germany
    Fri 22 10:35
    Endo-ERN Symposium
    ERNs and clinical trials; the ERICA and Rare Disease Partnership perspective
    Amsterdam, The Netherlands
    09:30 - 10:00 
    Rapid Free Communications 6: Pituitary, neuroendocrinology and puberty 1
    Pacific
    Chairs: Nitash Zwaveling-Soonawala (Amsterdam, The Netherlands) & Paul Dimitri (Sheffield, UK)
    Fri 22 09:30
    RFC6.1
    Rapid Free Communications 6: Pituitary, neuroendocrinology and puberty 1
    Clinical application of LH cut-off value in the diagnosis of CPP according to the international consensus
    Zhengzhou, China
    Fri 22 09:35
    RFC6.2
    Rapid Free Communications 6: Pituitary, neuroendocrinology and puberty 1
    Psychosocial Evaluation of Girls with Rapidly Progressive Puberty Presenting with Early Menarche
    Izmir, Turkey
    Fri 22 09:40
    RFC6.3
    Rapid Free Communications 6: Pituitary, neuroendocrinology and puberty 1
    Exposure to Per- and Polyfluoroalkyl Substances and Pubertal Assessment by Ultrasound in Norwegian Boys and Girls: Data from the Bergen Growth Study 2
    Norway
    Fri 22 09:45
    RFC6.4
    Rapid Free Communications 6: Pituitary, neuroendocrinology and puberty 1
    Earlier Occurrence of Puberty and Pubertal Hair Development in Boys and Girls - Insights from the DPV Initiative Data
    Germany
    Fri 22 09:50
    RFC6.5
    Rapid Free Communications 6: Pituitary, neuroendocrinology and puberty 1
    EFFICACY AND SECURITY OF GONADOTROPIN TREATMENT IN ADOLESCENTS WITH CONGENITAL HYPOGONADOTROPIC HYPOGONADISM
    Spain
    Fri 22 09:55
    RFC6.6
    Rapid Free Communications 6: Pituitary, neuroendocrinology and puberty 1
    Evaluation of Serum MKRN3 and DLK1 Concentrations for Predicting Variant Detection in MKRN3 and DLK1Genes in Patients with Central Precocious Puberty
    Turkey
    09:30 - 10:00 
    Rapid Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
    Atlantic
    Chairs: Hedi Claahsen (Nijmegen, The Netherlands) & Anna Nordenström (Stockholm, Sweden)
    Fri 22 09:30
    RFC7.1
    Rapid Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
    Penile width increases more clearly than penile length during minipuberty: a longitudinal study of 136 healthy infant boys
    Copenhagen, Denmark
    Fri 22 09:35
    RFC7.2
    Rapid Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
    International Evidence-Based Guidelines for PCOS 2023: Recommendations in Adolescent Girls
    Pittsburgh, USA
    Fri 22 09:40
    RFC7.3
    Rapid Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
    Histone code, cryptorchidism,infertility
    Liestal, Switzerland
    Fri 22 09:45
    RFC7.4
    Rapid Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
    Serum steroid metabolome dynamics during infancy: a prospective, longitudinal cohort of healthy boys
    Copenhagen, Denmark
    Fri 22 09:50
    RFC7.5
    Rapid Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
    Sex differences in endocrine mechanisms during early human fetal brain development
    London, UK
    Fri 22 09:55
    RFC7.6
    Rapid Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
    Prenatal AnoGenital Distance (AGD) by ultrasonography in 571 fetuses and correlation to postnatal AGD: A longitudinal cohort study of healthy males and females
    Copenhagen, Denmark
    09:30 - 10:00 
    Rapid Free Communications 8: Fat, metabolism and obesity 2
    Yangtze 1&2
    Chairs: Cosimo Giannini (Chieti, Italy) & Thomas Reinehr (Datteln, Germany)
    Fri 22 09:30
    RFC8.1
    Rapid Free Communications 8: Fat, metabolism and obesity 2
    A novel heterozygous likely pathogenic variant in GNB1 causing hyperphagia, severe early onset obesity and neurodevelopmental disorder
    Athens, Greece
    Fri 22 09:35
    RFC8.2
    Rapid Free Communications 8: Fat, metabolism and obesity 2
    Acute rise of leptin after five days of dexamethasone and its association with hunger, fat mass, sleep and fatigue, in children with acute lymphoblastic leukemia
    Utrecht, The Netherlands
    Fri 22 09:40
    RFC8.3
    Rapid Free Communications 8: Fat, metabolism and obesity 2
    Higher levels of serum α-Klotho are longitudinally associated with less visceral fat accumulation in apparently healthy girls experiencing weight gain
    Utrecht, The Netherlands
    Fri 22 09:45
    RFC8.4
    Rapid Free Communications 8: Fat, metabolism and obesity 2
    Understanding the genetics of early onset obesity in a cohort of children from Qatar
    Doha, Qatar
    Fri 22 09:50
    RFC8.5
    Rapid Free Communications 8: Fat, metabolism and obesity 2
    Effects of leptin knockdown on a human preadipocyte model
    Leipzig, Germany
    Fri 22 09:55
    RFC8.6
    Rapid Free Communications 8: Fat, metabolism and obesity 2
    Leukocytes and Neutrophil–Lymphocyte Ratio as Indicators of decreased insulin sensitivity in NGT Overweight and Obese Children with high 1-hour post-load plasma glucose levels
    Chieti, Italy
    09:30 - 10:00 
    Rapid Free Communications 9: Diabetes and insulin 2
    Mississippi
    Chairs: Kanetee Busiah (Vaud, Switzerland) & Mieke Houdijk (Leiden, The Netherlands)
    Fri 22 09:30
    RFC9.1
    Rapid Free Communications 9: Diabetes and insulin 2
    The association of dietary glycemic index and load with insulin sensitivity and secretion from early childhood to late adolescence: the QUALITY cohort
    Montréal, Canada
    Fri 22 09:35
    RFC9.2
    Rapid Free Communications 9: Diabetes and insulin 2
    Two new candidate genes,OGDH and FGFR1 discovered in an insulinoma from a fifteen-year-old male
    Odense, Denmark
    Fri 22 09:40
    RFC9.3
    Rapid Free Communications 9: Diabetes and insulin 2
    Impaired Insulin Secretion as a Pathophysiology Underlying Abnormal Glucose Metabolism in Pediatric Acute Lymphoblastic Leukemia (ALL) Survivors: A Study Comparing Glucose Metabolism between ALL Survivors and Simple Obese Children
    Bangkok, Thailand
    Fri 22 09:45
    RFC9.4
    Rapid Free Communications 9: Diabetes and insulin 2
    Clinical and genetic characteristics of patients suspected to have Maturity-Onset Diabetes of the Young in the Czech Republic
    Prague, Czech Republic
    Fri 22 09:50
    RFC9.5
    Rapid Free Communications 9: Diabetes and insulin 2
    Insulin secretion defect in children and adolescents with obesity: Clinical and molecular genetic characterization
    Berlin, Germany
    Fri 22 09:55
    RFC9.6
    Rapid Free Communications 9: Diabetes and insulin 2
    Wharton jelly derived mesenchymal stem cells exosomes protect pancreatic beta cells from inflamation
    Istanbul, Turkey
    09:30 - 10:00 
    Rapid Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
    Amazon
    Chairs: Rasa Verkauskiene (Kaunas, Lithuania) & Martijn Finken (Amsterdam, The Netherlands)
    Fri 22 09:30
    RFC10.1
    Rapid Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
    A novel maternally inherited GNAS variant in a family with hyperphagia and obesity.
    London, UK
    London, UK
    Fri 22 09:35
    RFC10.2
    Rapid Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
    Utility of Continuous Glucose Monitoring (CGM) during pancreatic surgery in patients with Congenital Hyperinsulinism
    Manchester, UK
    Manchester, UK
    Fri 22 09:40
    RFC10.3
    Rapid Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
    Non-coding Variants in HK1 Account for 5% of Cases of Congenital Hyperinsulinism Without an Identified Genetic Cause
    Philadelphia, USA
    Fri 22 09:45
    RFC10.4
    Rapid Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
    Clinical phenotypes of a multicentric cohort of ROHHAD patients
    Genoa, Italy
    Fri 22 09:50
    RFC10.5
    Rapid Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
    Insulinoma in childhood: A multicenter retrospective study of 28 patients
    Moscow, Russian Federation
    Fri 22 09:55
    RFC10.6
    Rapid Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
    Two novel mutations in the DCAF17 gene in two Palestinian families with primary amenorrhea revealing molecular genetics in Woodhouse-Sakati syndrome & unique presentation
    Jerusalem, Israel
    10:00 - 11:00 
    Free Communications 6: Pituitary, neuroendocrinology and puberty 1
    Pacific
    Chairs: Nitash Zwaveling-Soonawala (Amsterdam, The Netherlands) & Paul Dimitri (Sheffield, UK)
    Fri 22 10:00
    FC6.1
    Free Communications 6: Pituitary, neuroendocrinology and puberty 1
    Methylome analysis in idiopathic central precocious puberty girls
    Fri 22 10:10
    FC6.2
    Free Communications 6: Pituitary, neuroendocrinology and puberty 1
    The role of body composition and appetite-regulating hormones in idiopathic central precocious puberty and their changes during GnRH analogue therapy.
    Istanbul, Turkey
    Fri 22 10:20
    FC6.3
    Free Communications 6: Pituitary, neuroendocrinology and puberty 1
    Is the 24-hour urinary gonadotropin assay an effective diagnostic tool in central precocious puberty? A retrospective study of threshold setting and validation in two cohorts.
    Lyon, France
    Fri 22 10:30
    FC6.4
    Free Communications 6: Pituitary, neuroendocrinology and puberty 1
    Sleeptime-excreted total urinary luteinizing hormone concentrations reveal that the onset of central puberty occurs at around the same time in boys and girls: a longitudinal study
    Helsinki, Finland
    Fri 22 10:40
    FC6.5
    Free Communications 6: Pituitary, neuroendocrinology and puberty 1
    Clinical characteristics of 213 children with early pubertal development complicated with pineal cyst
    Zhengzhou, China
    Fri 22 10:50
    FC6.6
    Free Communications 6: Pituitary, neuroendocrinology and puberty 1
    Serum Kisspeptin and DLK1 levels as a tool for diagnosis and monitoring of central precocious puberty treatment in Thai girls
    Bangkok, Thailand
    10:00 - 11:00 
    Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
    Atlantic
    Chairs: Hedi Claahsen (Nijmegen, The Netherlands) & Anna Nordenström (Stockholm, Sweden)
    Fri 22 10:00
    FC7.1
    Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
    Polygenic scores for testosterone and SHBG are associated with hormone levels in male infants
    Copenhagen, Denmark
    Fri 22 10:10
    FC7.2
    Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
    Mapping the transcriptomic landscape of early human fetal ovary development through a clinically-focused lens
    London, United Kingdom
    Fri 22 10:20
    FC7.3
    Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
    ROS scavengers may improve genital skin healing in boys with hypospadias
    Glasgow, UK
    Fri 22 10:30
    FC7.4
    Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
    The effect of common genetic variants in CYP19A1 on serum Estradiol to Testosterone Ratio in healthy Danish children and adolescents
    Copenhagen, Denmark
    Fri 22 10:40
    FC7.5
    Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
    SGPL1 deficiency, a cause of 46XY DSD and adrenal insufficiency, impairs lipid metabolism and steroidogenesis in Leydig cells
    London, UK
    Fri 22 10:50
    FC7.6
    Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
    GnRHa response patterns of testis expressed genes in cryptorchid boys
    Liestal, Switzerland
    10:00 - 11:00 
    Free Communications 8: Fat, metabolism and obesity 2
    Yangtze 1&2
    Chairs: Cosimo Giannini (Chieti, Italy) & Thomas Reinehr (Datteln, Germany)
    Fri 22 10:00
    FC8.1
    Free Communications 8: Fat, metabolism and obesity 2
    Aberrant expression of agouti signaling protein (ASIP) as a new cause of monogenic severe childhood obesity
    Leipzig, Germany
    Fri 22 10:10
    FC8.2
    Free Communications 8: Fat, metabolism and obesity 2
    Frequency of MC4R Pathway Variants in a European Cohort of Individuals With Early-Onset Severe Obesity
    London, UK
    Fri 22 10:20
    FC8.3
    Free Communications 8: Fat, metabolism and obesity 2
    Impact of growth hormone therapy on body mass index in childhood-onset craniopharyngioma: a multicenter Italian study in 117 patients.
    Novara, Italy
    Fri 22 10:30
    FC8.4
    Free Communications 8: Fat, metabolism and obesity 2
    Irs1 expression in peripheral blood associates with obesity and cardiovascular risk parameters in school-age girls
    Salt, Spain
    Fri 22 10:40
    FC8.5
    Free Communications 8: Fat, metabolism and obesity 2
    Impact of Setmelanotide on Metabolic Syndrome Risk in Pediatric Patients With POMC and LEPR Deficiency
    University of Ulm, Germany
    Fri 22 10:50
    FC8.6
    Free Communications 8: Fat, metabolism and obesity 2
    Liraglutide treatment in adolescents with extreme obesity - Effects on weight loss in the first 9 months under real-life conditions
    Ulm, Germany
    10:00 - 11:00 
    Free Communications 9: Diabetes and insulin 2
    Mississippi
    Chairs: Kanetee Busiah (Vaud, Switzerland) & Mieke Houdijk (Leiden, The Netherlands)
    Fri 22 10:00
    FC9.1
    Free Communications 9: Diabetes and insulin 2
    Reference values for the insulin response to glucose challenge enable the early detection of emerging (pre)diabetes in children and young adults with obesity
    Leipzig, Germany
    Fri 22 10:10
    FC9.2
    Free Communications 9: Diabetes and insulin 2
    Characterization of pediatric patients with type 2 diabetes and trends in their pharmaceutical management 2000-2022 in German-speaking countries: Analysis based on the DPV registry
    Luxembourg, Luxembourg
    Berlin, Germany
    Fri 22 10:20
    FC9.3
    Free Communications 9: Diabetes and insulin 2
    A novel case of hypoglycaemia secondary to a pro-insulin processing disorder
    Leeds Teaching Hospital, Leeds, UK
    Fri 22 10:30
    FC9.4
    Free Communications 9: Diabetes and insulin 2
    The high proportion of INS-MODY in Chinese children with MODY
    Shanghai, China
    Shanghai, China
    Fri 22 10:40
    FC9.5
    Free Communications 9: Diabetes and insulin 2
    A case of NARS1 deficiency resulting in diabetes mellitus with liver cirrhosis and pancreatic atrophy
    Osaka, Japan
    Fri 22 10:50
    FC9.6
    Free Communications 9: Diabetes and insulin 2
    Puberty and Gonadal function in Wolfram Syndrome: A retrospective single centre study
    Birmingham, UK
    10:00 - 11:00 
    Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
    Amazon
    Chairs: Rasa Verkauskiene (Kaunas, Lithuania) & Martijn Finken (Amsterdam, The Netherlands)
    Fri 22 10:00
    FC10.1
    Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
    Dasiglucagon safety in paediatric participants with CHI
    Düsseldorf, Germany
    Fri 22 10:10
    FC10.2
    Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
    Immune profile response to rituximab in ROHHAD syndrome
    Bristol, UK
    Fri 22 10:20
    FC10.3
    Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
    ROHHAD syndrome, thrombotic risk and endothelial damage: a single center experience.
    Genoa, Italy
    Fri 22 10:30
    FC10.4
    Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
    A Novel Mutation in RAI1 Gene in a Patient with Clinical Diagnosis of Rapid-Onset Obesity with Hypothalamic Dysregulation, Hypoventilation, and Autonomic Dysregulation (ROHHAD) Syndrome with Overlapping Symptoms of Smith Magenis Syndrome (SMS).
    Orange, USA
    Fri 22 10:40
    FC10.5
    Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
    MCM4 deficiency causing Natural Killer and Glucocorticoid Deficiency with DNA repair defect (AR-NKGCD) - a large cases series from the Irish Traveller Community
    Lodz, Poland
    Fri 22 10:50
    FC10.6
    Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
    PLACENTAL MEST GENE EXPRESSION IS ASSOCIATED WITH POSTNATAL GROWTH AND OBESITY
    Girona, Spain
    11:00 - 11:30 
    Refreshment Break, Posters and Exhibition
    Exhibition Hall
    11:30 - 12:00 
    Awards 2
    ESPE Research Award
    King Willem Alexander Auditorium
    Chair: Agnès Linglart (Paris, France)
    Fri 22 11:30
    Awards 2
    ESPE Research Award
    12:00 - 12:30 
    Plenary 4
    King Willem Alexander Auditorium
    Chairs: Martine Cools (Ghent, Belgium) & Faisal Ahmed (Glasgow, UK)
    Fri 22 12:00
    Plenary 4
    How AI will change medicine
    Amsterdam, The Netherlands
    12:30 - 13:00 
    Awards 3
    King Willem Alexander Auditorium
    Fri 22
    Awards 3
    ESPE International Outstanding Clinician Award
    Madrid, Spain
    Fri 22
    Awards 3
    Outstanding Clinician Award
    Madrid, Spain
    Fri 22
    Awards 3
    ESPE Hormone Research in Paediatrics Prizes
    University of Rome Tor Vergata, Rome, Italy
    Fri 22
    Awards 3
    IFCAH-ESPE Award
    Ghent, Belgium
    13:00 - 14:30 
    Lunch, posters and exhibition
    Exhibition Hall
    13:20 - 14:20 
    Satellite Symposium 5
    For more information please see satellite programme
    14:30 - 15:30 
    Yearbook 2
    Amazon
    Chair: Ken Ong (Cambridge, UK)
    Fri 22 14:30
    YB2.1
    Yearbook 2
    Puberty
    Liège, Belgium
    Fri 22 14:42
    YB2.2
    Yearbook 2
    DSD and gender incongruence
    Turkey, Istanbul
    Fri 22 14:54
    YB2.3
    Yearbook 2
    Oncology and Chronic Disease
    Rome, Italy
    Fri 22 15:06
    YB2.4
    Yearbook 2
    Diabetes Type 1
    Cambridge, UK
    Fri 22 15:18
    YB2.5
    Yearbook 2
    Editors' Choice
    Cambridge, UK
    14:30 - 16:00 
    Symposium 5 - Hypothalamic syndromes
    Mississippi
    Chairs: Herman Müller (Berlin, Germany) & Maithé Tauber (Toulouse, France)
    Fri 22 14:30
    S5.1
    Symposium 5 - Hypothalamic syndromes
    Hypothalamic syndrome in Cancer survivors
    Utrecht, The Netherlands
    Fri 22 15:00
    S5.2
    Symposium 5 - Hypothalamic syndromes
    The evolution of the hypothalamus
    Sheffield, UK
    Fri 22 15:30
    S5.3
    Symposium 5 - Hypothalamic syndromes
    ROHHAD/ROHHADNET syndrome
    Chicago, USA
    13:20 - 14:20 
    Satellite Symposium 6
    For more information please see satellite programme
    13:20 - 14:20 
    Satellite Symposium 7
    For more information please see satellite programme
    14:30 - 16:00 
    Symposium 6 - Neonatal endocrinology
    Yangtze 1&2
    Chairs: Khalid Hussain (Doha, Qatar) & Maria Güemes (Madrid, Spain)
    Fri 22 14:30
    S6.1
    Symposium 6 - Neonatal endocrinology
    Unravelling the role of epigenetics in reproductive adaptations to early-life environment
    Haifa, Israel
    Fri 22 15:00
    S6.2
    Symposium 6 - Neonatal endocrinology
    The role of insulin in prenatal programming of future metabolic disease
    Cambridge, UK
    Fri 22 15:30
    S6.3
    Symposium 6 - Neonatal endocrinology
    The development of the HPA axis of the newborn
    Amsterdam, The Netherlands
    14:30 - 16:00 
    Symposium 7 - Theories of obesity development and their implications on dietary interventions
    Pacific
    Chairs: Violeta Iotova (Varna, Bulgaria) & Ram Weiss (Jerusalem, Israel)
    Fri 22 14:30
    S7.1
    Symposium 7 - Theories of obesity development and their implications on dietary interventions
    Competing Paradigms of Obesity Pathogenesis
    Boston, USA
    Fri 22 15:00
    S7.2
    Symposium 7 - Theories of obesity development and their implications on dietary interventions
    From the social life through the psyche and the brain to the epidemic expansion of the adipose mass
    Copenhagen, Denmark
    Fri 22 15:30
    S7.3
    Symposium 7 - Theories of obesity development and their implications on dietary interventions
    Polygenic risk score
    Copenhagen, Denmark
    14:30 - 16:00 
    Symposium 8 - Adrenals
    Atlantic
    Chairs: Evangelia Charmandari (Athens, Greece) & Uta Neumann (Berlin, Germany)
    Fri 22 14:30
    S8.1
    Symposium 8 - Adrenals
    Understanding the role of 11-oxygenated androgens
    Munich, Germany
    Fri 22 15:00
    S8.2
    Symposium 8 - Adrenals
    Adrenal cortex renewal in health and disease
    Nice, France
    Fri 22 15:30
    S8.3
    Symposium 8 - Adrenals
    Central nervous consequences of CAH and other adrenal disorders
    Stockholm, Sweden
    14:30 - 16:00 
    ESPE Nursing and Allied Health Working Group (PENS)
    Everest 1&2
    Chairs: Camilla Ernstsson (Umeå, Sweden), Clare Simpson (Leeds, UK) & Sandra Greetham (Hull, UK)
    Fri 22 14:30
    ESPE Nursing and Allied Health Working Group (PENS)
    Childhood craniopharyngioma - challenges for the pediatric endocrinologist
    Malmö, Sweden
    Fri 22 15:00
    ESPE Nursing and Allied Health Working Group (PENS)
    The role of a nurse in managing and supporting children and their families with a craniopharyngioma - Roisin Boyle
    Glasgow, UK
    Fri 22 15:30
    ESPE Nursing and Allied Health Working Group (PENS)
    Q&A in Endocrine Nursing
    16:10 - 16:40 
    Plenary 5
    King Willem Alexander Auditorium
    Chairs: Rasha Hamza (Cairo, Egypt) & Mehul Dattani (London, UK)
    Fri 22 16:10
    PL5
    Plenary 5
    Cracking the pituitary stem cell code across life using single-cell transcriptomics and organoid models
    Leuven, Belgium
    16:40 - 17:00 
    Refreshment Break, Posters and Exhibition
    Exhibition Hall
    17:00 - 18:30 
    Satellite Symposium 8
    For more information please see satellite programme
    17:00 - 18:30 
    Satellite Symposium 9
    For more information please see satellite programme
    17:00 - 18:30 
    Satellite Symposium 10
    For more information please see satellite programme
    18:30 - 19:45 
    ESPE Annual Business Meeting
    Pacific

    07:15 - 18:30 
    Registration
    08:00 - 08:45 
    Meet the Expert 3.2
    Yangtze 1&2
    Sat 23 08:00
    Meet the Expert 3.2
    Uncertainties around diagnosing growth hormone deficiency
    Leiden, The Netherlands
    08:00 - 08:45 
    Meet the Expert 4.2
    Pacific
    Sat 23 08:00
    Meet the Expert 4.2
    Clinical Management of Prader-Willi Syndrome in infants, children and adolescents
    Toulouse, France
    08:00 - 08:45 
    Meet the Expert 5.2
    Everest 1&2
    Sat 23 08:00
    Meet the Expert 5.2
    Management of Pituitary adenomas in Children
    Brussels, Belgium
    08:00 - 08:45 
    Meet the Expert 8.2
    Atlantic
    Sat 23 08:00
    Meet the Expert 8.2
    Puberty induction in hypogonadism
    Imperial College London, London, UK
    08:00 - 09:00 
    Yearbook 3
    Amazon
    Chairs: Christa Flück (Bern, Switzerland) & Ken Ong (Cambridge, UK)
    Sat 23 08:00
    YB3.1
    Yearbook 3
    Thyroid
    Basel, Switzerland
    Sat 23 08:15
    YB3.2
    Yearbook 3
    Growth and Growth Factors
    Rome, Italy
    Sat 23 08:30
    YB3.3
    Yearbook 3
    Bone, Growth Plate and Mineral Metabolism
    Stockholm, Sweden
    Sat 23 08:45
    YB3.4
    Yearbook 3
    A tribute to Ze’ev Hochberg’s work
    Bern, Switzerland
    Cambridge, UK
    09:00 - 10:30 
    How do I…? 2
    King Willem Alexander Auditorium
    Chairs: Zdenek Sumnik (Prague, Czech Republic) & Saartje Straetemans (Maastricht, The Netherlands)
    Sat 23 09:00
    HDI2.1
    How do I…? 2
    How to manage long term complications in T2DM in adolescents?
    Tel-Aviv, Israel
    Sat 23 09:30
    HDI2.2
    How do I…? 2
    How Do I initiate and follow patients on a closed-loop system?
    Petah Tikva, Israel
    Sat 23 10:00
    HDI2.3
    How do I…? 2
    Diagnosis and management of hypercholesterolemia
    Modena, Italy
    09:00 - 09:30 
    Rapid Free Communications 11: GH and IGFs
    Pacific
    Chairs: Helen Storr (London, UK) & Christiaan de Bruin (Leiden, The Netherlands)
    Sat 23 09:00
    RFC11.1
    Rapid Free Communications 11: GH and IGFs
    The genetic aetiology of primary multiple pituitary hormone deficiency: a next-generation sequencing analysis of a single-centre cohort.
    Prague, Czech Republic
    Sat 23 09:05
    RFC11.2
    Rapid Free Communications 11: GH and IGFs
    Are pappalysins and stanniocalcins involved in modifying the bioavailability of IGF-I in children with onset of type 1 diabetes mellitus?
    Madrid, Spain
    Sat 23 09:10
    RFC11.3
    Rapid Free Communications 11: GH and IGFs
    Longitudinal assessment of health-related quality of life (HRQoL) & behavior in adults born small for gestational age (SGA) who were treated with growth hormone during childhood
    Rotterdam, The Netherlands
    Sat 23 09:15
    RFC11.4
    Rapid Free Communications 11: GH and IGFs
    Functional analysis of a novel mutation of IGF1R gene in two twins with growth failure. An example of genotype-phenotype heterogeneity.
    Rome, Italy
    Sat 23 09:20
    RFC11.5
    Rapid Free Communications 11: GH and IGFs
    Influence of sirtuin 1 and fibroblast growth factor 21 levels on IGF-1 concentration in children with short stature of different etiology
    Lodz, Poland
    Sat 23 09:25
    RFC11.6
    Rapid Free Communications 11: GH and IGFs
    Evaluation Of The Growth Hormone-Insulin like Growth Factor1 Axis And Serum Fibroblast Growth Factor 21 Levels As Related To Stature In Children And Adolescents With Coeliac Disease Adherent To Gluten Free Diet
    Istanbul, Turkey
    09:00 - 09:30 
    Rapid Free Communications 12: Thyroid
    Mississippi
    Chairs: Athanasia Stoupa (Paris, France) & Joachim Pohlenz (Mainz, Germany)
    Sat 23 09:00
    RFC12.1
    Rapid Free Communications 12: Thyroid
    Macro-TSH IgG complex in a case of Congenital Hypothyroidism (CH).
    Milan, Italy
    Sat 23 09:05
    RFC12.2
    Rapid Free Communications 12: Thyroid
    A novel frameshift mutation in Immunoglobulin Superfamily, Member 1 (IGSF1) causing central hypothyroidism, delayed puberty and GH deficiency
    London, UK
    Sat 23 09:10
    RFC12.3
    Rapid Free Communications 12: Thyroid
    Thyroid disorders in childhood cancer survivors treated with 131 I-MIBG, TKIs or immune checkpoint inhibitors: incidence, mechanisms and clinical management – systematic review
    Leuven, Belgium
    Leuven, Belgium
    Sat 23 09:15
    RFC12.4
    Rapid Free Communications 12: Thyroid
    Polyethylene glycol thyroid stimulating hormone (PEG-TSH) in real-life: a practical tool for solving a biochemical dilemma
    Tel Aviv, Israel
    Tel Aviv, Israel
    Sat 23 09:20
    RFC12.5
    Rapid Free Communications 12: Thyroid
    Application of Shear Wave Elastography (SWE) in the ultrasound evaluation of thyroid nodules in children and adolescents
    Białystok, Poland
    Sat 23 09:25
    RFC12.6
    Rapid Free Communications 12: Thyroid
    Phenylbutyrate treatment of three patients with Monocarboxylate Transporter 8 deficiency
    Rehovot, Israel
    09:00 - 09:30 
    Rapid Free Communications 13: Pituitary, neuroendocrinology and puberty 2
    Atlantic
    Chairs: Cynthia Andoniadou (London, UK) & Anne Rochtus (Leuven, Belgium)
    Sat 23 09:00
    RFC13.1
    Rapid Free Communications 13: Pituitary, neuroendocrinology and puberty 2
    Are Glucagon-like peptide-1 (GLP-1) receptor agonists a new treatment option for hypothalamic obesity in the paediatric population: Preliminary experience from a tertiary paediatric endocrine centre
    Bristol, UK
    Sat 23 09:05
    RFC13.2
    Rapid Free Communications 13: Pituitary, neuroendocrinology and puberty 2
    Arginine-stimulated copeptin is independent of GH secretion status
    Tubingen, Germany
    Sat 23 09:10
    RFC13.3
    Rapid Free Communications 13: Pituitary, neuroendocrinology and puberty 2
    Treatment and outcome of the Dutch Childhood Craniopharyngioma Cohort study; first results after centralization of care
    Utrecht, The Netherlands
    Sat 23 09:15
    RFC13.4
    Rapid Free Communications 13: Pituitary, neuroendocrinology and puberty 2
    Trio analyses of patients with congenital hypopituitarism reveals novel candidate genes
    Lausanne, Switzerland
    Sat 23 09:20
    RFC13.5
    Rapid Free Communications 13: Pituitary, neuroendocrinology and puberty 2
    Growth hormone and TSH deficiency after [177Lu]Lu-DOTATATE therapy for pediatric neuroblastoma; description of a first case.
    Utrecht, The Netherlands
    Sat 23 09:25
    RFC13.6
    Rapid Free Communications 13: Pituitary, neuroendocrinology and puberty 2
    Pituitary size on volumetric MRI predicts the severity of the neuroendocrine phenotype in populations at risk
    London, UK
    09:00 - 09:30 
    Rapid Free Communications 14 - Late Breaking
    Yangtze 1&2
    Chairs: Annemarie Verrijn-Stuart (Utrecht, Netherlands) & Tommaso Aversa (Messina, Italy)
    Sat 23 09:00
    RFC14.1
    Rapid Free Communications 14 - Late Breaking
    Clinical characteristics of patients presented with primary adrenal insufficiency due to a p.R451W mutation in the CYP11A1 gene
    Erzurum, Turkey
    Ankara, Turkey
    Sat 23 09:05
    RFC14.2
    Rapid Free Communications 14 - Late Breaking
    No Relationship Between Thyroid Function and ADHD – Results From a Nationwide Prospective Epidemiological Study and Mendelian Randomization
    Essen, Germany
    Sat 23 09:10
    RFC14.3
    Rapid Free Communications 14 - Late Breaking
    Body composition in a pediatric population with type 1 diabetes mellitus - The importance of planned physical activity
    Vila Nova de Gaia, Portugal
    Sat 23 09:15
    RFC14.4
    Rapid Free Communications 14 - Late Breaking
    Evaluating the Effect of Recombinant Human Growth Hormone Treatment on Sleep-related Breathing Disorders in Toddlers with Prader–Willi Syndrome: a one-year retrospective cohort study.
    Shanghai, China
    Sat 23 09:20
    RFC14.5
    Rapid Free Communications 14 - Late Breaking
    Functional demonstration that variants in the C-terminal of IHH cause short stature and/brachdactyly
    Madrid, Spain
    Sat 23 09:25
    RFC14.6
    Rapid Free Communications 14 - Late Breaking
    Enhanced histones acetylation in children with obesity: relationship with insulin resistance and inflammation
    Tehran, Iran
    09:30 - 10:30 
    Free Communications 11: GH and IGFs
    Pacific
    Chairs: Helen Storr (London, UK) & Christiaan de Bruin (Leiden, The Netherlands)
    Sat 23 09:30
    FC11.1
    Free Communications 11: GH and IGFs
    GH replacement therapy with once-weekly somapacitan in children with GH deficiency is effective and well-tolerated: 2-year results from REAL4
    Minneapolis, USA
    Sat 23 09:40
    FC11.2
    Free Communications 11: GH and IGFs
    Clinical characteristics of heterozygous ACAN gene variants and longer-term response to growth hormone treatment: real-world data
    Rotterdam, The Netherlands
    Sat 23 09:50
    FC11.3
    Free Communications 11: GH and IGFs
    Analysis of a large panel of genes in a cohort of patients with severe short stature: detection rate and genotype-phenotype correlations
    Padova, Italy
    Sat 23 10:00
    FC11.4
    Free Communications 11: GH and IGFs
    Long-term GH-treatment of children born small for gestational age (SGA) does not result in cerebrovascular abnormalities in adulthood compared to untreated controls
    Rotterdam, The Netherlands
    Sat 23 10:10
    FC11.5
    Free Communications 11: GH and IGFs
    Effective GH Replacement with Once-weekly Somapacitan in Japanese Children with GH Deficiency: 2-year Results from REAL4
    Suita, Japan
    Sat 23 10:20
    FC11.6
    Free Communications 11: GH and IGFs
    Longitudinal analysis of the risk of brain tumour recurrence or progression in relation to the timing of commencement of growth hormone replacement therapy.
    London, UK
    09:30 - 10:30 
    Free Communications 12: Thyroid
    Mississippi
    Chairs: Juliane Leger (Paris, France) & Joachim Pohlenz (Mainz, Germany)
    Sat 23 09:30
    FC12.1
    Free Communications 12: Thyroid
    Graves’ disease – are we just delaying the inevitable?
    Cambridge, UK
    Sat 23 09:40
    FC12.2
    Free Communications 12: Thyroid
    Thyroid function analysis in 48 patients affected by severe combined immunodeficiency caused by adenosine deaminase deficiency
    Milan, Italy
    Sat 23 09:50
    FC12.3
    Free Communications 12: Thyroid
    Hypothyroidism due to IYD bi-allelic pathogenic variants: clinical description of eight patients
    Brussels, Belgium
    Sat 23 10:00
    FC12.4
    Free Communications 12: Thyroid
    Thyroid hormone resistance due to THRB gene mutations : neonatal manifestations in two cases
    Paris, France
    Sat 23 10:10
    FC12.5
    Free Communications 12: Thyroid
    Teprotumumab in an adolescent with severe corticosteroid-resistant Graves ophthalmopathy: success but unexpected neurological manifestations.
    Paris, France
    Sat 23 10:20
    FC12.6
    Free Communications 12: Thyroid
    TSH screening in premature newborns: a critical appraisal of the value of a second sample.
    Brussels, Belgium
    09:30 - 10:30 
    Free Communications 13: Pituitary, neuroendocrinology and puberty 2
    Atlantic
    Chairs: Cynthia Andoniadou (London, UK) & Anne Rochtus (Leuven, Belgium)
    Sat 23 09:30
    FC13.1
    Free Communications 13: Pituitary, neuroendocrinology and puberty 2
    Genetic evaluation in children with self-limited pubertal delay discloses new candidate genes
    Sao Paulo, Brazil
    Sat 23 09:40
    FC13.2
    Free Communications 13: Pituitary, neuroendocrinology and puberty 2
    Targeted gene panel screening in 144 congenital hypopituitarism patients, incorporating 135 known and novel genes implicated in hypopituitarism and/or hypothalamo-pituitary development.
    London, UK
    Sat 23 09:50
    FC13.3
    Free Communications 13: Pituitary, neuroendocrinology and puberty 2
    Variants in Methyl-CpG-binding protein 2 (MECP2) are associated with X-Linked Central Precocious Puberty
    London, UK
    Sat 23 10:00
    FC13.4
    Free Communications 13: Pituitary, neuroendocrinology and puberty 2
    Clinical and molecular genetic characteristics of 98 patients with congenital hypopituitarism: A single-center experience
    Istanbul, Turkey
    Sat 23 10:10
    FC13.5
    Free Communications 13: Pituitary, neuroendocrinology and puberty 2
    Systematic review and meta-analysis of spermatogenesis rates after pubertal induction with gonadotropins in males with hypogonadotropic hypogonadism
    London, UK
    Sat 23 10:20
    FC13.6
    Free Communications 13: Pituitary, neuroendocrinology and puberty 2
    Effects of Blue Light Exposure and Exposure Duration on Male Rats Puberty Process
    Ankara, Turkey
    09:30 - 10:30 
    Free Communications 14 - Late Breaking
    Yangtze 1&2
    Chairs: Annemarie Verrijn-Stuart (Utrecht, The Netherlands) & Tommaso Aversa (Messina, Italy)
    Sat 23 09:30
    FC14.1
    Free Communications 14 - Late Breaking
    Sleep health characteristics in children with congenital adrenal hyperplasia
    Minneapolis, USA
    Sat 23 09:40
    FC14.2
    Free Communications 14 - Late Breaking
    New Reference Values for Thyroid Volume by Ultrasound in German Children and Adolescents Under Iodine-Sufficient Conditions From a Nationwide Study
    Essen, Germany
    Sat 23 09:50
    FC14.3
    Free Communications 14 - Late Breaking
    Deconvolution Analysis: GH secretagogue (LUM-201) enhances growth in individuals with moderate idiopathic Pediatric Growth Hormone Deficiency (iPGHD) by enhancing endogenous GH secretion and increasing IGF-1
    Santiago, Chile
    Sat 23 10:00
    FC14.4
    Free Communications 14 - Late Breaking
    Improvement in insulin sensitivity and glucose metabolism in adolescents with obesity treated with once-weekly semaglutide 2.4 mg: a secondary analysis of the STEP TEENS trial
    Pittsburgh, USA
    Sat 23 10:10
    FC14.5
    Free Communications 14 - Late Breaking
    Predicting Average IGF-I Concentration for Once-Weekly Somapacitan in Children with Growth Hormone Deficiency
    Cincinnati, USA
    Sat 23 10:20
    FC14.6
    Free Communications 14 - Late Breaking
    Understanding the genetic complexity of puberty timing across the allele frequency spectrum
    Cambridge, UK
    10:30 - 11:00 
    Refreshment Break, Posters and Exhibition
    Exhibition Hall
    11:00 - 11:30 
    Plenary 6
    King Willem Alexander Auditorium
    Chairs: Michel Polak (Paris, France) & Paul van Trotsenburg (Amsterdam, The Netherlands)
    Sat 23 11:00
    PL6
    Plenary 6
    How the genome predicts human disease
    Geneva, Switzerland
    11:30 - 12:15 
    Awards 4
    King Willem Alexander Auditorium
    Chair: Anita Hokken-Koelega (Rotterdam, The Netherlands)
    Sat 23 11:30
    Awards 4
    Andrea Prader Prize (30 mins) + ESPE International Award (15 mins)
    12:15 - 12:45 
    Plenary 7
    King Willem Alexander Auditorium
    Chairs: Nils Krone (Sheffield, UK) & Malgorzata Wasniewska (Messina, Italy)
    Sat 23 12:15
    PL7
    Plenary 7
    Novel approaches in autoimmune endocrine disorders
    Stockholm, Sweden
    12:45 - 14:15 
    Lunch, posters and exhibition
    Exhibition Hall
    14:00 - 14:45 
    Meet the Expert 2.2
    Pacific
    Sat 23 14:00
    Meet the Expert 2.2
    Informing children about their DSD - when and how?
    Oklahoma, USA
    14:00 - 14:45 
    Meet the Expert 6.2
    Mississippi
    Sat 23 14:00
    Meet the Expert 6.2
    Approach to Thyroid cancer in Children
    Poznan, Poland
    14:00 - 14:45 
    Meet the Expert 7.2
    Yangtze 1&2
    Sat 23 14:00
    Meet the Expert 7.2
    Management of hyperinsulism beyond the acute phase
    Texas, USA
    14:15 - 15:00 
    Novel Advances 2
    Atlantic
    Chairs: Daniëlle van der Kaay (Rotterdam, The Netherlands) & Agnes Linglart (Paris, France)
    Sat 23 14:15
    Novel Advances 2
    DNA Methylation Episignatures: Defining Biomarkers of Rare Disorders
    London, Canada
    14:15 - 15:15 
    Awards - Young Investigators
    Amazon
    Chair: Martine Cools (Ghent, Belgium)
    Sat 23 14:15
    Awards - Young Investigators
    ESPE Young Investigator Awards
    Sat 23 14:15
    Awards - Young Investigators
    Research Unit Lecture
    Sat 23 14:15
    Awards - Young Investigators
    Research Fellowship Lecture
    15:10 - 15:30 
    Refreshment Break, Posters and Exhibition
    Exhibition Hall
    15:30 - 17:00 
    Symposium 9 - Thyroid
    Mississippi
    Chairs: Athanasia Stoupa (Paris, France) & Christiaan Mooij (Amsterdam, The Netherlands)
    Sat 23 15:30
    S9.1
    Symposium 9 - Thyroid
    Central hypothyroidism due to mutations in IGSF1 - latest insights into its pathogenesis
    Montreal, Canada
    Sat 23 16:00
    S9.2
    Symposium 9 - Thyroid
    Is there role for combined T4 and T3 therapy in hypothyroidism
    University of Chicago, Chicago, USA
    Sat 23 16:30
    S9.3
    Symposium 9 - Thyroid
    The role of thyroid hormone transporters in brain development and function
    Essen, Germany
    15:30 - 17:00 
    Symposium 10 - Bone
    Yangtze 1&2
    Chairs: Ola Nilsson (Stockholm, Sweden) & Gabriele Hartmann (Vienna, Austria)
    Sat 23 15:30
    S10.1
    Symposium 10 - Bone
    Management of Fibrous dysplasia
    Bethesda, USA
    Sat 23 16:00
    S10.2
    Symposium 10 - Bone
    Inherited ectopic calcification disorders
    Münster, Germany
    Sat 23 16:30
    S10.3
    Symposium 10 - Bone
    Life-time disease burden of achondroplasia
    Baltimore, USA
    15:30 - 17:00 
    Symposium 11 - Diet, nutrients and the environment
    Pacific
    Chairs: Yael Lebenthal (Tel Aviv, Israel) & Edgar van Mil (Venlo, The Netherlands)
    Sat 23 15:30
    S11.1
    Symposium 11 - Diet, nutrients and the environment
    Timing of eating and exercise to improve metabolic health in humans
    Maastricht, The Netherlands
    Sat 23 16:00
    S11.2
    Symposium 11 - Diet, nutrients and the environment
    Sugar and ultra-processed food
    San Francisco, USA
    Sat 23 16:30
    S11.3
    Symposium 11 - Diet, nutrients and the environment
    Weight loss and mechanisms of weight regain
    University of Ulm, Germany
    15:30 - 17:00 
    Symposium 12: What's new for the HPG Axis
    Atlantic
    Chairs: Sasha Howard (London, UK) & Anne Simone Parent (Liege, Belgium)
    Sat 23 15:30
    S12.1
    Symposium 12: What's new for the HPG Axis
    Minipuberty - Looking into the future
    Copenhagen, Denmark
    Sat 23 16:00
    S12.2
    Symposium 12: What's new for the HPG Axis
    SEMA6A drives GnRH neuron-dependent puberty onset by tuning median eminence vascular permeability.
    Milan, Italy
    Sat 23 16:30
    S12.3
    Symposium 12: What's new for the HPG Axis
    Recent advances in our understanding of the regulation of GnRH secretion
    Córdoba, Spain
    17:05 - 17:35 
    Plenary 8
    King Willem Alexander Auditorium
    Chairs: Indi Banerjee (Manchester, UK) & Tadej Battelino (Ljubljana, Slovenia)
    Sat 23 17:05
    PL8
    Plenary 8
    Real world use of closed loop insulin delivery
    Amsterdam, The Netherlands
    17:35 - 17:50 
    Awards 5 - ESPE Meeting Host Poster Awards
    King Willem Alexander Auditorium
    Chair: Paul van Trotsenburg (Amsterdam, The Netherlands)
    17:55 - 18:10 
    Closing Ceremony
    King Willem Alexander Auditorium
Obesity working group steering committee
Thu 21 08:00
ESPE Working Group on Obesity
The ESPE Obesity Working Group
Rotterdam, The Netherlands
Moshe	Phillip
Petah Tikva, Israel
Thu 21 08:00
ESPE Working Group on Diabetes Technology
Introduction
Petah Tikva, Israel
Thu 21 08:05
ESPE Working Group on Diabetes Technology
Stage 1/Stage 2 T1DM – how do we monitor outside of clinical studies?
Petah Tikva, Israel
Rod	Mitchell
Edinburgh, UK
Thu 21 12:25
S3.3
Symposium 3 - Endocrine effects of cancer treatment
Fertility preservation in children with cancer
Edinburgh, UK
Rodolfo	Rey
Buenos Aires, Argentina
Thu 21 14:55
HDI1.2
How do I…? 1
How do I use AMH in paediatric practice?
Buenos Aires, Argentina
Gudrun	Rappold
Heidelberg, Germany
Thu 21 14:25
RFC2.1
Rapid Free Communications 2: Bone, growth plate and mineral metabolism
Identification of novel genes including NAV2 associated with isolated tall stature
Heidelberg, Germany
Alberto	Pereira
Amsterdam, The Netherlands
Fri 22 10:35
Endo-ERN Symposium
ERNs and clinical trials; the ERICA and Rare Disease Partnership perspective
Amsterdam, The Netherlands
Loredana	Marcovecchio
Cambridge, UK
Fri 22 15:06
YB2.4
Yearbook 2
Diabetes Type 1
Cambridge, UK
Ken	Ong
Cambridge, UK
Fri 22 15:18
YB2.5
Yearbook 2
Editors' Choice
Cambridge, UK
Sat 23 08:45
YB3.4
Yearbook 3
A tribute to Ze’ev Hochberg’s work
Bern, Switzerland
Cambridge, UK
Sat 23 10:20
FC14.6
Free Communications 14 - Late Breaking
Understanding the genetic complexity of puberty timing across the allele frequency spectrum
Cambridge, UK
The ESPEn Board
Fri 22 15:30
ESPE Nursing and Allied Health Working Group (PENS)
Q&A in Endocrine Nursing
Ola	Nilsson
Stockholm, Sweden
Sat 23 08:30
YB3.3
Yearbook 3
Bone, Growth Plate and Mineral Metabolism
Stockholm, Sweden
Ken	Ong
Cambridge, UK
Fri 22 15:18
YB2.5
Yearbook 2
Editors' Choice
Cambridge, UK
Sat 23 08:45
YB3.4
Yearbook 3
A tribute to Ze’ev Hochberg’s work
Bern, Switzerland
Cambridge, UK
Sat 23 10:20
FC14.6
Free Communications 14 - Late Breaking
Understanding the genetic complexity of puberty timing across the allele frequency spectrum
Cambridge, UK
Gerhard	Binder
Tubingen, Germany
Sat 23 09:05
RFC13.2
Rapid Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Arginine-stimulated copeptin is independent of GH secretion status
Tubingen, Germany
Ken	Ong
Cambridge, UK
Fri 22 15:18
YB2.5
Yearbook 2
Editors' Choice
Cambridge, UK
Sat 23 08:45
YB3.4
Yearbook 3
A tribute to Ze’ev Hochberg’s work
Bern, Switzerland
Cambridge, UK
Sat 23 10:20
FC14.6
Free Communications 14 - Late Breaking
Understanding the genetic complexity of puberty timing across the allele frequency spectrum
Cambridge, UK
Lasse  Fuchs
Leipzig, Germany
Fri 22 09:50
RFC8.5
Rapid Free Communications 8: Fat, metabolism and obesity 2
Effects of leptin knockdown on a human preadipocyte model
Leipzig, Germany
Veronica  Groendahl
Copenhagen, Denmark
Fri 22 10:30
FC7.4
Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
The effect of common genetic variants in CYP19A1 on serum Estradiol to Testosterone Ratio in healthy Danish children and adolescents
Copenhagen, Denmark
Wafaa  Laymoun
Mansoura, Egypt
Thu 21 14:40
RFC5.4
Rapid Free Communications 5: Diabetes and insulin 1
Effect of probiotic on glycemic control in children with type 1 diabetes : A randomized controlled trial
Mansoura, Egypt
Anand  Ramakrishnan
London, UK
Fri 22 09:30
RFC10.1
Rapid Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
A novel maternally inherited GNAS variant in a family with hyperphagia and obesity.
London, UK
London, UK
Ghislaine  van Thiel
Utrecht, The Netherlands
Thu 21 16:55
EE1.1
Ethics in Endocrinology
Ethics of expensive treatments
Utrecht, The Netherlands
Abdulsalam  Abu-Libdeh
Jerusalem, Israel
Fri 22 09:55
RFC10.6
Rapid Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
Two novel mutations in the DCAF17 gene in two Palestinian families with primary amenorrhea revealing molecular genetics in Woodhouse-Sakati syndrome & unique presentation
Jerusalem, Israel
Kübra Yüksek  Acinikli
Izmir, Turkey
Fri 22 09:35
RFC6.2
Rapid Free Communications 6: Pituitary, neuroendocrinology and puberty 1
Psychosocial Evaluation of Girls with Rapidly Progressive Puberty Presenting with Early Menarche
Izmir, Turkey
Maria  Adriana Rangel
Vila Nova de Gaia, Portugal
Sat 23 09:10
RFC14.3
Rapid Free Communications 14 - Late Breaking
Body composition in a pediatric population with type 1 diabetes mellitus - The importance of planned physical activity
Vila Nova de Gaia, Portugal
Emma  Alexander
London, UK
Sat 23 10:10
FC13.5
Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Systematic review and meta-analysis of spermatogenesis rates after pubertal induction with gonadotropins in males with hypogonadotropic hypogonadism
London, UK
Sarah  Allaert
Leuven, Belgium
Sat 23 09:10
RFC12.3
Rapid Free Communications 12: Thyroid
Thyroid disorders in childhood cancer survivors treated with 131 I-MIBG, TKIs or immune checkpoint inhibitors: incidence, mechanisms and clinical management – systematic review
Leuven, Belgium
Leuven, Belgium
Prof. Kristian  Almstrup
Copenhagen, Denmark
Thu 21 12:25
S1.3
Symposium 1 - Disorders of Sex Development
Pathogenesis of testicular dysfunction in Klinefelter syndrome
Copenhagen, Denmark
Nadia Amin
Leeds Teaching Hospital, Leeds, UK
Fri 22 10:20
FC9.3
Free Communications 9: Diabetes and insulin 2
A novel case of hypoglycaemia secondary to a pro-insulin processing disorder
Leeds Teaching Hospital, Leeds, UK
Konstantinos Anastasiou
Thu 21 09:00
ESPE Working Group on Obesity
Overweight and obesity in European Young Children: ToyBox-study lessons
Kirstine  Andersen
Odense, Denmark
Fri 22 09:35
RFC9.2
Rapid Free Communications 9: Diabetes and insulin 2
Two new candidate genes,OGDH and FGFR1 discovered in an insulinoma from a fifteen-year-old male
Odense, Denmark
Dr Cynthia Andoniadou
London, UK
Thu 21 11:55
S2.2
Symposium 2 - Hypothalamo-pituitary disorders
Stem cells in the pituitary
London, UK
Eleni  Angelopoulou
Athens, Greece
Thu 21 14:25
RFC5.1
Rapid Free Communications 5: Diabetes and insulin 1
Tear proteomics profile in children and adolescents with type 1 diabetes mellitus
Athens, Greece
Prof.  Stylianos Antonarakis
Geneva, Switzerland
Sat 23 11:00
PL6
Plenary 6
How the genome predicts human disease
Geneva, Switzerland
Jesús Argente
Madrid, Spain
Thu 21 15:15
FC3.3
Free Communications 3: Fat, metabolism and obesity 1
Frequency of Obesity-Related Gene Variants in a European Population With Early-Onset, Severe Obesity
Madrid, Spain
Thu 21 15:45
FC3.6
Free Communications 3: Fat, metabolism and obesity 1
Impact of Setmelanotide on Future Metabolic Syndrome Risk in Pediatric Patients With Bardet-Biedl Syndrome
Madrid, Spain
Fri 22
Awards 3
ESPE International Outstanding Clinician Award
Madrid, Spain
Fri 22
Awards 3
Outstanding Clinician Award
Madrid, Spain
Emrullah  Arslan
Izmir, Turkey
Thu 21 14:30
RFC4.2
Rapid Free Communications 4: Growth and syndromes (to include Turner syndrome)
Molecular genetic diagnosis in children with Idiopathic Short Stature: Single Center Experience
Izmir, Turkey
Silva Arslanian
Pittsburgh, USA
Sat 23 10:00
FC14.4
Free Communications 14 - Late Breaking
Improvement in insulin sensitivity and glucose metabolism in adolescents with obesity treated with once-weekly semaglutide 2.4 mg: a secondary analysis of the STEP TEENS trial
Pittsburgh, USA
Laura  Atger-Lallier
Paris, France
Sat 23 10:10
FC12.5
Free Communications 12: Thyroid
Teprotumumab in an adolescent with severe corticosteroid-resistant Graves ophthalmopathy: success but unexpected neurological manifestations.
Paris, France
Irina A Bacila
Sheffield, UK
Thu 21 15:05
FC1.2
Free Communications 1: Adrenals and HPA Axis
The pathophysiologic response of central nervous system due to differently impaired steroidogenesis
Sheffield, UK
Philippe Backeljauw
Cincinnati, USA
Sat 23 10:10
FC14.5
Free Communications 14 - Late Breaking
Predicting Average IGF-I Concentration for Once-Weekly Somapacitan in Children with Growth Hormone Deficiency
Cincinnati, USA
Patricia Bartaire
France
Thu 21 08:50
ESPE Working Group on Paediatric and Adolescent Gynaecology
Management of early puberty : adaptation or overmedicalization?
Paris, France
France
Judit Bassols
Salt, Spain
Fri 22 10:30
FC8.4
Free Communications 8: Fat, metabolism and obesity 2
Irs1 expression in peripheral blood associates with obesity and cardiovascular risk parameters in school-age girls
Salt, Spain
Tadej Battelino
Ljubljana, Slovenia
Thu 21 08:25
ESPE Working Group on Diabetes Technology
CGM use in Stage 2 T1DM
Ljubljana, Slovenia
Marianne Becker
Luxembourg, Luxembourg
Fri 22 10:10
FC9.2
Free Communications 9: Diabetes and insulin 2
Characterization of pediatric patients with type 2 diabetes and trends in their pharmaceutical management 2000-2022 in German-speaking countries: Analysis based on the DPV registry
Luxembourg, Luxembourg
Berlin, Germany
Ameya  Bendre
Stockholm, Sweden
Thu 21 15:25
Free Communications 4: Growth and syndromes (to include Turner syndrome)
Growth failure in aggrecan haploinsufficiency is due to a decrease in growth plate matrix volume and hypertrophic cell size
Stockholm, Sweden
Jugurtha Berkenou
Le Kremlin-Bicêtre, France
Thu 21 14:55
FC2.1
Free Communications 2: Bone, growth plate and mineral metabolism
Hearing loss in pseudohypoparathyroidism (inactivating PTH/PTHRP Signaling Disorder): a prospective study to assess prevalence and predictive factors of hearing loss in 44 patients affected with iPPSD/PHP
Le Kremlin-Bicêtre, France
Professor Daniel Bernard
Montreal, Canada
Sat 23 15:30
S9.1
Symposium 9 - Thyroid
Central hypothyroidism due to mutations in IGSF1 - latest insights into its pathogenesis
Montreal, Canada
Madalin  Berra
Orange, USA
Fri 22 10:30
FC10.4
Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
A Novel Mutation in RAI1 Gene in a Patient with Clinical Diagnosis of Rapid-Onset Obesity with Hypothalamic Dysregulation, Hypoventilation, and Autonomic Dysregulation (ROHHAD) Syndrome with Overlapping Symptoms of Smith Magenis Syndrome (SMS).
Orange, USA
Antonio Bianco
University of Chicago, Chicago, USA
Sat 23 16:00
S9.2
Symposium 9 - Thyroid
Is there role for combined T4 and T3 therapy in hypothyroidism
University of Chicago, Chicago, USA
Margit Bistrup Fischer
Copenhagen, Denmark
Fri 22 09:55
RFC7.6
Rapid Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
Prenatal AnoGenital Distance (AGD) by ultrasonography in 571 fetuses and correlation to postnatal AGD: A longitudinal cohort study of healthy males and females
Copenhagen, Denmark
Professor Carla Bizzarri
Rome, Italy
Thu 21 08:25
ESPE Working Group on Paediatric and Adolescent Gynaecology
Environmental programming of early pubertal onset
Rome, Italy
Fri 22 14:54
YB2.3
Yearbook 2
Oncology and Chronic Disease
Rome, Italy
Ineke  Böckmann
Hannover, Germany
Thu 21 15:25
FC2.4
Free Communications 2: Bone, growth plate and mineral metabolism
A real-world study in Germany and Switzerland regarding renal health in children with X-linked hypophosphatemia
Hannover, Germany
Claudia Boettcher
Bern, Switzerland
Thu 21 14:55
FC5.1
Free Communications 5: Diabetes and insulin 1
Diabetes mellitus and gender incongruence: Worse metabolic control in type 1 and higher mental health issue rates in type 1 and 2 diabetes – a DPV registry study
Bern, Switzerland
Emese Boros
Brussels, Belgium
Sat 23 09:50
FC12.3
Free Communications 12: Thyroid
Hypothyroidism due to IYD bi-allelic pathogenic variants: clinical description of eight patients
Brussels, Belgium
Sat 23 10:20
FC12.6
Free Communications 12: Thyroid
TSH screening in premature newborns: a critical appraisal of the value of a second sample.
Brussels, Belgium
Hanna  Borysewicz-Sańczyk
Białystok, Poland
Sat 23 09:20
RFC12.5
Rapid Free Communications 12: Thyroid
Application of Shear Wave Elastography (SWE) in the ultrasound evaluation of thyroid nodules in children and adolescents
Białystok, Poland
Artur Bossowski
Białystok, Poland
Thu 21 14:35
RFC5.3
Rapid Free Communications 5: Diabetes and insulin 1
3 Screen ICA ELISA–A new tool to identify pre-clinical diabetes in first-degree relatives of patients with type 1 diabetes (pre-d1abetes study)
Białystok, Poland
Stefanie Boutsen
Hoeselt, Belgium
Thu 21 08:00
ESPE Working Group on Turner Syndrome
Challenges and opportunities in prenatal and postnatal diagnosis of Turner Syndrome & Parents’ Testimony
Nijmegen, Netherlands
Hoeselt, Belgium
Alison Boyce
Bethesda, USA
Sat 23 15:30
S10.1
Symposium 10 - Bone
Management of Fibrous dysplasia
Bethesda, USA
Roisin  Boyle
Glasgow, UK
Fri 22 15:00
ESPE Nursing and Allied Health Working Group (PENS)
The role of a nurse in managing and supporting children and their families with a craniopharyngioma - Roisin Boyle
Glasgow, UK
Avivit Brener
Tel Aviv, Israel
Sat 23 09:15
RFC12.4
Rapid Free Communications 12: Thyroid
Polyethylene glycol thyroid stimulating hormone (PEG-TSH) in real-life: a practical tool for solving a biochemical dilemma
Tel Aviv, Israel
Tel Aviv, Israel
Federica Buonocore
London, UK
Fri 22 09:50
RFC7.5
Rapid Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
Sex differences in endocrine mechanisms during early human fetal brain development
London, UK
Alexander Busch
Copenhagen, Denmark
Fri 22 09:45
RFC7.4
Rapid Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
Serum steroid metabolome dynamics during infancy: a prospective, longitudinal cohort of healthy boys
Copenhagen, Denmark
Fri 22 10:00
FC7.1
Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
Polygenic scores for testosterone and SHBG are associated with hormone levels in male infants
Copenhagen, Denmark
Alistair Calder
London, UK
Thu 21 08:00
ESPE Bone and Growth Plate Working Group
Radiology of rare and less rare skeletal dysplasia
London, UK
Jean-Claude Carel
Paris, France
Thu 21 08:50
ESPE Working Group on Paediatric and Adolescent Gynaecology
Management of early puberty : adaptation or overmedicalization?
Paris, France
France
Anna Cariboni
Milan, Italy
Sat 23 16:00
S12.2
Symposium 12: What's new for the HPG Axis
SEMA6A drives GnRH neuron-dependent puberty onset by tuning median eminence vascular permeability.
Milan, Italy
Fernando  Cassorla
Santiago, Chile
Sat 23 09:50
FC14.3
Free Communications 14 - Late Breaking
Deconvolution Analysis: GH secretagogue (LUM-201) enhances growth in individuals with moderate idiopathic Pediatric Growth Hormone Deficiency (iPGHD) by enhancing endogenous GH secretion and increasing IGF-1
Santiago, Chile
Pascaline  Cattrysse
Montréal, Canada
Fri 22 09:30
RFC9.1
Rapid Free Communications 9: Diabetes and insulin 2
The association of dietary glycemic index and load with insulin sensitivity and secretion from early childhood to late adolescence: the QUALITY cohort
Montréal, Canada
Atilla  Çayır
Erzurum, Turkey
Sat 23 09:00
RFC14.1
Rapid Free Communications 14 - Late Breaking
Clinical characteristics of patients presented with primary adrenal insufficiency due to a p.R451W mutation in the CYP11A1 gene
Erzurum, Turkey
Ankara, Turkey
Manuela Cerbone
London, UK
Sat 23 09:25
RFC13.6
Rapid Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Pituitary size on volumetric MRI predicts the severity of the neuroendocrine phenotype in populations at risk
London, UK
Jean-Pierre Chanoine
Vancouver, Canada
Thu 21 11:25
YB1.1
Yearbook 1
Global Health for the Paediatric Endocrinologist
Vancouver, Canada
Professor Evangelia Charmandari
Athens, Greece
Thu 21 12:01
YB1.4
Yearbook 1
Adrenal
Athens, Greece
Wassim Chemaitilly
Pittsburgh, USA
Thu 21 11:55
S3.2
Symposium 3 - Endocrine effects of cancer treatment
Surveillance for endocrine disease in Childhood Cancer Survivors
Pittsburgh, USA
Ruimin  Chen
Thu 21 15:35
FC2.5
Free Communications 2: Bone, growth plate and mineral metabolism
Generation of novel genetic zebrafish models and using RNA-seq analysis to explore the role of ankrd11 gene on bone growth
Ting Chen
Suzhou, China
Thu 21 14:55
FC4.1
Free Communications 4: Growth and syndromes (to include Turner syndrome)
Heterozygous Null Mutations in FLNB as a Cause of apparent isolated Short Stature in Chinese Children
Suzhou, China
Ruoqian  Cheng
Shanghai, China
Sat 23 09:15
RFC14.4
Rapid Free Communications 14 - Late Breaking
Evaluating the Effect of Recombinant Human Growth Hormone Treatment on Sleep-related Breathing Disorders in Toddlers with Prader–Willi Syndrome: a one-year retrospective cohort study.
Shanghai, China
Benedetta  Ciacchini
Novara, Italy
Fri 22 10:20
FC8.3
Free Communications 8: Fat, metabolism and obesity 2
Impact of growth hormone therapy on body mass index in childhood-onset craniopharyngioma: a multicenter Italian study in 117 patients.
Novara, Italy
Professor  Stefano Cianfarani
University of Rome Tor Vergata, Rome, Italy
Fri 22
Awards 3
ESPE Hormone Research in Paediatrics Prizes
University of Rome Tor Vergata, Rome, Italy
Martine Cools
Ghent, Belgium
Fri 22
Awards 3
IFCAH-ESPE Award
Ghent, Belgium
Domenico Corica
Messina, Italy
Thu 21 14:30
RFC3.2
Rapid Free Communications 3: Fat, metabolism and obesity 1
Reduced central sensitivity to thyroid hormones in children and adolescents with overweight or obesity and impaired glucose tolerance.
Messina, Italy
Valérie Cormier-Daire
Paris, France
Thu 21 14:45
RFC4.5
Rapid Free Communications 4: Growth and syndromes (to include Turner syndrome)
Real-world safety and effectiveness of vosoritide: Results from an early access program in France
Paris, France
Fernanda de Azevedo Correa Correa
Lausanne, Switzerland
Sat 23 09:15
RFC13.4
Rapid Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Trio analyses of patients with congenital hypopituitarism reveals novel candidate genes
Lausanne, Switzerland
Prof Eveline Crone
Leiden, Netherlands
Fri 22 08:00
PL3
Plenary 3
Structural and functional development of the adolescent brain
Leiden, Netherlands
Olivia  Cunningham
Birmingham, UK
Fri 22 10:50
FC9.6
Free Communications 9: Diabetes and insulin 2
Puberty and Gonadal function in Wolfram Syndrome: A retrospective single centre study
Birmingham, UK
Johan de Graaf
Nijkerk, The Netherlands
Fri 22 09:40
Endo-ERN Symposium
European medicine shortages: How can we avoid a disaster for patients with rare conditions?
Nijkerk, The Netherlands
And  Demir
Helsinki, Finland
Fri 22 10:30
FC6.4
Free Communications 6: Pituitary, neuroendocrinology and puberty 1
Sleeptime-excreted total urinary luteinizing hormone concentrations reveal that the onset of central puberty occurs at around the same time in boys and girls: a longitudinal study
Helsinki, Finland
Huseyin Demirbilek
Ankara, Turkey
Sat 23 09:00
RFC14.1
Rapid Free Communications 14 - Late Breaking
Clinical characteristics of patients presented with primary adrenal insufficiency due to a p.R451W mutation in the CYP11A1 gene
Erzurum, Turkey
Ankara, Turkey
Annalisa Deodati
Rome, Italy
Sat 23 09:15
RFC11.4
Rapid Free Communications 11: GH and IGFs
Functional analysis of a novel mutation of IGF1R gene in two twins with growth failure. An example of genotype-phenotype heterogeneity.
Rome, Italy
Hans DeVries
Amsterdam, The Netherlands
Sat 23 17:05
PL8
Plenary 8
Real world use of closed loop insulin delivery
Amsterdam, The Netherlands
Yu  Ding
Shanghai, China
Fri 22 10:30
FC9.4
Free Communications 9: Diabetes and insulin 2
The high proportion of INS-MODY in Chinese children with MODY
Shanghai, China
Shanghai, China
Malcolm Donaldson
Glasgow, UK
Thu 21 09:15
ESPE Working Group on Turner Syndrome
I-TS & pubertal induction study
Glasgow, UK
Demi Dorrepaal
Rotterdam, The Netherlands
Sat 23 09:10
RFC11.3
Rapid Free Communications 11: GH and IGFs
Longitudinal assessment of health-related quality of life (HRQoL) & behavior in adults born small for gestational age (SGA) who were treated with growth hormone during childhood
Rotterdam, The Netherlands
Sat 23 10:00
FC11.4
Free Communications 11: GH and IGFs
Long-term GH-treatment of children born small for gestational age (SGA) does not result in cerebrovascular abnormalities in adulthood compared to untreated controls
Rotterdam, The Netherlands
Jacques Drouin
Montreal, Canada
Thu 21 12:25
S2.3
Symposium 2 - Hypothalamo-pituitary disorders
Pioneer transcription factors
Montreal, Canada
Katja  Dumic-Kubat
Zagreb, Croatia
Thu 21 08:15
ESPE Working Group on Disorders of Sex Development
Case presentation
Zagreb, Croatia
Petra  Dusatkova
Prague, Czech Republic
Fri 22 09:45
RFC9.4
Rapid Free Communications 9: Diabetes and insulin 2
Clinical and genetic characteristics of patients suspected to have Maturity-Onset Diabetes of the Young in the Czech Republic
Prague, Czech Republic
Maria Elfving
Malmö, Sweden
Fri 22 14:30
ESPE Nursing and Allied Health Working Group (PENS)
Childhood craniopharyngioma - challenges for the pediatric endocrinologist
Malmö, Sweden
Helena  Enders-Seidlitz
Berlin, Germany
Fri 22 09:50
RFC9.5
Rapid Free Communications 9: Diabetes and insulin 2
Insulin secretion defect in children and adolescents with obesity: Clinical and molecular genetic characterization
Berlin, Germany
Simge  Eren
Istanbul, Turkey
Thu 21 15:45
FC2.6
Free Communications 2: Bone, growth plate and mineral metabolism
Human breast milk-derived exosomes promote growth plate cell lines in vitro
Istanbul, Turkey
Fri 22 09:55
RFC9.6
Rapid Free Communications 9: Diabetes and insulin 2
Wharton jelly derived mesenchymal stem cells exosomes protect pancreatic beta cells from inflamation
Istanbul, Turkey
Diana-Alexandra Ertl
Le Kremlin-Bicêtre, France
Thu 21 14:40
RFC2.4
Rapid Free Communications 2: Bone, growth plate and mineral metabolism
Documentation of inactivating PTH/PTHrP Signaling Disorders (Pseudohypoparathyroidism) cases in EuRRECa / EuRR-Bone: a challenging, but worthwhile journey
Le Kremlin-Bicêtre, France
Thu 21 14:45
RFC2.5
Rapid Free Communications 2: Bone, growth plate and mineral metabolism
Growth in young children with X-linked hypophosphatemia treated with burosumab
Le Kremlin-Bicêtre, France
Thu 21 15:15
FC2.3
Free Communications 2: Bone, growth plate and mineral metabolism
Hyperparathyroidism after three years of burosumab in children affected with x-linked hypophosphatemia
Le Kremlin-Bicêtre, France
Elif  Eviz
Istanbul, Turkey
Thu 21 15:15
FC5.3
Free Communications 5: Diabetes and insulin 1
How feasible is it to meet the Time in Tight Range (TITR) target with Automatic Insulin Delivery (AID)?: 2128-day real-world data from a single center
Istanbul, Turkey
Ghassan  Faisal Mohamadsalih
Doha, Qatar
Thu 21 15:25
FC3.4
Free Communications 3: Fat, metabolism and obesity 1
A Novel Mutation in DYRK1B Associated With Abdominal Obesity Metabolic Syndrome 3 (AOMS3)
Doha, Qatar
Pavlos Fanis
Nicosia, Cyprus
Thu 21 14:30
RFC1.3
Rapid Free Communications 1: Adrenals and HPA Axis
The chimeric CYP21A1P/CYP21A2 and TNXA/TNXB gene deficiencies in patients with Congenital Adrenal Hyperplasia
Nicosia, Cyprus
Mariam Farman
Linz, Austria
Thu 21 15:05
FC2.2
Free Communications 2: Bone, growth plate and mineral metabolism
First Results of the Global ALPL Gene Variant Classification Project
Linz, Austria
Anna  Fedorczak
Lodz, Poland
Fri 22 10:40
FC10.5
Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
MCM4 deficiency causing Natural Killer and Glucocorticoid Deficiency with DNA repair defect (AR-NKGCD) - a large cases series from the Irish Traveller Community
Lodz, Poland
Sat 23 09:20
RFC11.5
Rapid Free Communications 11: GH and IGFs
Influence of sirtuin 1 and fibroblast growth factor 21 levels on IGF-1 concentration in children with short stature of different etiology
Lodz, Poland
Dr Martijn Finken
Amsterdam, The Netherlands
Fri 22 15:30
S6.3
Symposium 6 - Neonatal endocrinology
The development of the HPA axis of the newborn
Amsterdam, The Netherlands
Benjamin Fisher
Cambridge, UK
Thu 21 14:55
FC1.1
Free Communications 1: Adrenals and HPA Axis
Investigating intergenerational effects of glucocorticoids
Cambridge, UK
Professor Christa Flück
Bern, Switzerland
Thu 21 12:13
YB1.5
Yearbook 1
The Year in Science & Medicine
Bern, Switzerland
Sat 23 08:45
YB3.4
Yearbook 3
A tribute to Ze’ev Hochberg’s work
Bern, Switzerland
Cambridge, UK
Ingvild Halsør  Forthun
Norway
Fri 22 09:40
RFC6.3
Rapid Free Communications 6: Pituitary, neuroendocrinology and puberty 1
Exposure to Per- and Polyfluoroalkyl Substances and Pubertal Assessment by Ultrasound in Norwegian Boys and Girls: Data from the Bergen Growth Study 2
Norway
Hoda  Gad
Doha, Qatar
Thu 21 14:35
RFC3.3
Rapid Free Communications 3: Fat, metabolism and obesity 1
Early Corneal Nerve Loss in Children with Melanocortin 4 Receptor (MC4R) Gene Mutation Related Obesity
Doha, Qatar
Thu 21 15:35
FC3.5
Free Communications 3: Fat, metabolism and obesity 1
Early corneal nerve loss in children with obesity and type 2 diabetes
Doha, Qatar
Evelien Gevers
London, UK
Sat 23 09:05
RFC12.2
Rapid Free Communications 12: Thyroid
A novel frameshift mutation in Immunoglobulin Superfamily, Member 1 (IGSF1) causing central hypothyroidism, delayed puberty and GH deficiency
London, UK
Anthony  Goldstone
London, UK
Fri 22 10:10
FC8.2
Free Communications 8: Fat, metabolism and obesity 2
Frequency of MC4R Pathway Variants in a European Cohort of Individuals With Early-Onset Severe Obesity
London, UK
Laura  Golob
Minneapolis, USA
Sat 23 09:30
FC14.1
Free Communications 14 - Late Breaking
Sleep health characteristics in children with congenital adrenal hyperplasia
Minneapolis, USA
Ana Paula  Gonzalez-Mereles
London, UK
Sat 23 10:20
FC11.6
Free Communications 11: GH and IGFs
Longitudinal analysis of the risk of brain tumour recurrence or progression in relation to the timing of commencement of growth hormone replacement therapy.
London, UK
Corinna  Grasemann
Bochum, Germany
Thu 21 15:25
HDI1.3
How do I…? 1
How do I manage a child with hypercalcemia?
Bochum, Germany
Katerina Gregorova
Prague, Czech Republic
Thu 21 15:05
FC4.2
Free Communications 4: Growth and syndromes (to include Turner syndrome)
Genetic and phenotypic features of children with familial tall stature
Prague, Czech Republic
Louise Gregory
London, UK
Sat 23 09:40
FC13.2
Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Targeted gene panel screening in 144 congenital hypopituitarism patients, incorporating 135 known and novel genes implicated in hypopituitarism and/or hypothalamo-pituitary development.
London, UK
Giedre  Grigelioniene
Stockholm, Sweden
Thu 21 08:30
ESPE Bone and Growth Plate Working Group
Genetics of rare skeletal dysplasia
Stockholm, Sweden
Fay Guarraci
Georgetown, USA
Thu 21 08:30
ESPE Working Group on Gender Incongruence
Animal models of transgender care, advantages and drawbacks
Georgetown, USA
Laura  Guazzarotti
Padova, Italy
Sat 23 09:50
FC11.3
Free Communications 11: GH and IGFs
Analysis of a large panel of genes in a cohort of patients with severe short stature: detection rate and genotype-phenotype correlations
Padova, Italy
Maria Güemes
Madrid, Spain
Sat 23 09:05
RFC11.2
Rapid Free Communications 11: GH and IGFs
Are pappalysins and stanniocalcins involved in modifying the bioavailability of IGF-I in children with onset of type 1 diabetes mellitus?
Madrid, Spain
Tulay Guran
Istanbul, Turkey
Thu 21 14:40
RFC1.1
Rapid Free Communications 1: Adrenals and HPA Axis
Lack of NAD(P)+ transhydrogenase activity in patients with primary adrenal insufficiency due to NNT mutations
Istanbul, Turkey
Tülay Güran
Turkey, Istanbul
Thu 21 08:00
ESPE Working Group on Disorders of Sex Development
Introduction
Turkey, Istanbul
Thu 21 09:25
ESPE Working Group on Disorders of Sex Development
Concluding Remarks
Belgrade, Serbia
Turkey, Istanbul
Fri 22 14:42
YB2.2
Yearbook 2
DSD and gender incongruence
Turkey, Istanbul
Mark Gurnell
University of Cambridge, Cambridge, UK
Thu 21 11:25
S2.1
Symposium 2 - Hypothalamo-pituitary disorders
Novel imaging techniques in pituitary tumours
University of Cambridge, Cambridge, UK
Faruk Hadziselimovic
Liestal, Switzerland
Fri 22 09:40
RFC7.3
Rapid Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
Histone code, cryptorchidism,infertility
Liestal, Switzerland
Fri 22 10:50
FC7.6
Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
GnRHa response patterns of testis expressed genes in cryptorchid boys
Liestal, Switzerland
Rachel  Hamblin
Bristol, UK
Thu 21 08:25
ESPE Working Group on Turner Syndrome
Psychological aspects
Bristol, UK
Hui Hang
Nanchang, China
Thu 21 14:45
RFC3.5
Rapid Free Communications 3: Fat, metabolism and obesity 1
Multi-omics Reveals molecule target Underlying Adolescent obesity with metabolic syndrome
Nanchang, China
Thu 21 15:25
FC5.4
Free Communications 5: Diabetes and insulin 1
Changes of intestinal flora in children with type 1 diabetes mellitus and its related immune mechanism
Nanchang, China
Antoine  Harvengt
Bruxelles, Belgium
Thu 21 15:45
FC5.6
Free Communications 5: Diabetes and insulin 1
Post-Hypoglycemic Hyperglycemia Are Highly Relevant Markers For Stratification Of Glycemic Variability and Remission Status Of Pediatric Patients With New-Onset Type 1 Diabetes.
Bruxelles, Belgium
Katherine Hawton
Bristol, UK
Fri 22 10:10
FC10.2
Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
Immune profile response to rituximab in ROHHAD syndrome
Bristol, UK
Sat 23 09:00
RFC13.1
Rapid Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Are Glucagon-like peptide-1 (GLP-1) receptor agonists a new treatment option for hypothalamic obesity in the paediatric population: Preliminary experience from a tertiary paediatric endocrine centre
Bristol, UK
Karen Heath
Madrid, Spain
Sat 23 09:20
RFC14.5
Rapid Free Communications 14 - Late Breaking
Functional demonstration that variants in the C-terminal of IHH cause short stature and/brachdactyly
Madrid, Spain
Matti Hero
Helsinki, Finland
Fri 22 08:30
Controversy 1
Pharmacological manipulation of bone maturation should NOT be used to preserve final height in short children (AGAINST)."
Helsinki, Finland
Kevan  Herold
New Haven, USA
Thu 21 11:55
S4.2
Symposium 4 - Novel insights and innovations in diabetes
Delaying the development of T1DM
New Haven, USA
Dr Heike Heuer
Essen, Germany
Sat 23 16:30
S9.3
Symposium 9 - Thyroid
The role of thyroid hormone transporters in brain development and function
Essen, Germany
Shinji  Higuchi
Osaka, Japan
Fri 22 10:40
FC9.5
Free Communications 9: Diabetes and insulin 2
A case of NARS1 deficiency resulting in diabetes mellitus with liver cirrhosis and pancreatic atrophy
Osaka, Japan
Olaf Hiort
Lübeck, Germany
Thu 21 11:25
S1.1
Symposium 1 - Disorders of Sex Development
Life-long care for people with 46,XY DSD
Lübeck, Germany
Olaf Hiort
Lübeck, Germany
Fri 22 09:30
Endo-ERN Symposium
Perspective of Endo-ERN for the next five years
Lübeck, Germany
Raphael Hirtz
Essen, Germany
Sat 23 09:05
RFC14.2
Rapid Free Communications 14 - Late Breaking
No Relationship Between Thyroid Function and ADHD – Results From a Nationwide Prospective Epidemiological Study and Mendelian Randomization
Essen, Germany
Sat 23 09:40
FC14.2
Free Communications 14 - Late Breaking
New Reference Values for Thyroid Volume by Ultrasound in German Children and Adolescents Under Iodine-Sufficient Conditions From a Nationwide Study
Essen, Germany
Dr Julie Hoover Fong
Baltimore, USA
Sat 23 16:30
S10.3
Symposium 10 - Bone
Life-time disease burden of achondroplasia
Baltimore, USA
PD Nadine Hornig, PhD
Kiel, Germany
Thu 21 08:50
ESPE Working Group on Disorders of Sex Development
Androgen insensitivity syndrome Type 2
Kiel, Germany
Sasha Howard
London, UK
Sat 23 09:50
FC13.3
Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Variants in Methyl-CpG-binding protein 2 (MECP2) are associated with X-Linked Central Precocious Puberty
London, UK
Frank Hu
Boston, USA
Thu 21 16:15
PL2
Plenary 2
The food environment and the global childhood obesity epidemic: The role of ultra-processed food
Boston, USA
Angela Huebner
Dresden, Germany
Thu 21 15:25
FC1.3
Free Communications 1: Adrenals and HPA Axis
Generation and Characterization of a novel Humanized CYP21A2 Knock-in Mouse Model for Congenital Adrenal Hyperplasia
Dresden, Germany
Ieuan Hughes
Cambridge, UK
Thu 21 08:25
ESPE Working Group on Disorders of Sex Development
Androgen insensitivity syndrome Type 1
Cambridge, UK
Alessia  Ippolito
Milan, Italy
Sat 23 09:00
RFC12.1
Rapid Free Communications 12: Thyroid
Macro-TSH IgG complex in a case of Congenital Hypothyroidism (CH).
Milan, Italy
Melita Irving
London, UK
Thu 21 15:45
Free Communications 4: Growth and syndromes (to include Turner syndrome)
Persistence of Growth Promoting Effects in Infants and Toddlers with Achondroplasia: Results in Children Aged Over 2 Years Old from a Phase II Extension Study with Vosoritide
London, UK
Lorenzo Iughetti
Modena, Italy
Sat 23 10:00
HDI2.3
How do I…? 2
Diagnosis and management of hypercholesterolemia
Modena, Italy
Clément  Janot
Lyon, France
Fri 22 10:20
FC6.3
Free Communications 6: Pituitary, neuroendocrinology and puberty 1
Is the 24-hour urinary gonadotropin assay an effective diagnostic tool in central precocious puberty? A retrospective study of threshold setting and validation in two cohorts.
Lyon, France
Sjoerd Joustra
Leiden, The Netherlands
Thu 21 14:40
RFC4.4
Rapid Free Communications 4: Growth and syndromes (to include Turner syndrome)
Genetic findings in short Turkish children born to consanguineous parents
Leiden, The Netherlands
Thu 21 15:15
Free Communications 4: Growth and syndromes (to include Turner syndrome)
Pathogenic variants in GHSR cause short stature and growth hormone neurosecretory dysfunction; results from a large case series
Leiden, The Netherlands
Masayo Kagami
Tokyo, Japan
Thu 21 14:30
RFC2.2
Rapid Free Communications 2: Bone, growth plate and mineral metabolism
Familial pseudohypoparathyroidism type IB associated with an SVA retrotransposon insertion in the GNAS locus.
Tokyo, Japan
Gözde Akın  Kağızmanlı
Izmir, Turkey
Thu 21 14:35
RFC4.3
Rapid Free Communications 4: Growth and syndromes (to include Turner syndrome)
Aromatase inhibitors: an effective and safe option for height increment in boys with growth hormone deficiency?
Izmir, Turkey
Olle Kämpe
Stockholm, Sweden
Sat 23 12:15
PL7
Plenary 7
Novel approaches in autoimmune endocrine disorders
Stockholm, Sweden
Maria  Karantza
Athens, Greece
Fri 22 09:30
RFC8.1
Rapid Free Communications 8: Fat, metabolism and obesity 2
A novel heterozygous likely pathogenic variant in GNB1 causing hyperphagia, severe early onset obesity and neurodevelopmental disorder
Athens, Greece
Aylin  Kilinç Uğurlu
Ankara, Turkey
Sat 23 10:20
FC13.6
Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Effects of Blue Light Exposure and Exposure Duration on Male Rats Puberty Process
Ankara, Turkey
Aneta Kodytková
Prague, Czech Republic
Thu 21 15:35
Free Communications 4: Growth and syndromes (to include Turner syndrome)
From thalidomide embryopathy to genetic defects of the upper limb, internal organs, cerebral midline, and pituitary: The phenotypic spectrum of SALL4
Prague, Czech Republic
Hüseyin Anıl  Korkmaz
Izmir, Turkey
Thu 21 14:30
RFC5.2
Rapid Free Communications 5: Diabetes and insulin 1
Comparison of Optical Coherence Tomography Angiography Findings in Children with Type 1 Diabetes Mellitus and Autoimmune Thyroiditis with Healthy Children
Izmir, Turkey
Antje Körner
Leipzig, Germany
Fri 22 10:00
FC8.1
Free Communications 8: Fat, metabolism and obesity 2
Aberrant expression of agouti signaling protein (ASIP) as a new cause of monogenic severe childhood obesity
Leipzig, Germany
Dr Peter Kühnen
Berlin, Germany
Fri 22 10:05
Endo-ERN Symposium
It matters - set up of clinical trials in rare diseases
Berlin, Germany
Alexandra Kulle
Kiel, Germany
Thu 21 14:50
RFC1.2
Rapid Free Communications 1: Adrenals and HPA Axis
Interlaboratory comparison of LC-MS/MS measurements of 11 relevant steroid hormones in 27 DSD patients
Kiel, Germany
Ruth Ming Wai Kwong
London, UK
Fri 22 10:40
FC7.5
Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
SGPL1 deficiency, a cause of 46XY DSD and adrenal insufficiency, impairs lipid metabolism and steroidogenesis in Leydig cells
London, UK
Séverine  Labey
Paris, France
Sat 23 10:00
FC12.4
Free Communications 12: Thyroid
Thyroid hormone resistance due to THRB gene mutations : neonatal manifestations in two cases
Paris, France
Svetlana Lajic
Stockholm, Sweden
Fri 22 15:30
S8.3
Symposium 8 - Adrenals
Central nervous consequences of CAH and other adrenal disorders
Stockholm, Sweden
Lili Liang
Shanghai, China
Thu 21 14:45
Rapid Free Communications 1: Adrenals and HPA Axis
Clinical and genetic characteristics of 42 Chinese paediatric patients with X-Linked Adrenal Hypoplasia Congenita
Shanghai, China
David Lim
Southampton, UK
Thu 21 15:35
FC1.5
Free Communications 1: Adrenals and HPA Axis
Management of congenital adrenal hyperplasia in the first 90 days of life: a multi-centre I-CAH analysis of contemporary practice
Southampton, UK
Ruth  Loos
Copenhagen, Denmark
Fri 22 15:30
S7.3
Symposium 7 - Theories of obesity development and their implications on dietary interventions
Polygenic risk score
Copenhagen, Denmark
Abel López-Bermejo
Girona, Spain
Fri 22 10:50
FC10.6
Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
PLACENTAL MEST GENE EXPRESSION IS ASSOCIATED WITH POSTNATAL GROWTH AND OBESITY
Girona, Spain
Angela Lucas-Herald
Glasgow, UK
Fri 22 10:20
FC7.3
Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
ROS scavengers may improve genital skin healing in boys with hypospadias
Glasgow, UK
David  Ludwig
Boston, USA
Fri 22 14:30
S7.1
Symposium 7 - Theories of obesity development and their implications on dietary interventions
Competing Paradigms of Obesity Pathogenesis
Boston, USA
Professor Robert  Lustig
San Francisco, USA
Sat 23 16:00
S11.2
Symposium 11 - Diet, nutrients and the environment
Sugar and ultra-processed food
San Francisco, USA
Katharina Main
Copenhagen, Denmark
Sat 23 15:30
S12.1
Symposium 12: What's new for the HPG Axis
Minipuberty - Looking into the future
Copenhagen, Denmark
Dominique Maiter
Brussels, Belgium
Fri 22 08:35
Meet the Expert 5.1
Management of Pituitary adenomas in Children
Brussels, Belgium
Sat 23 08:00
Meet the Expert 5.2
Management of Pituitary adenomas in Children
Brussels, Belgium
= Henk Marquering
Amsterdam, The Netherlands
Fri 22 12:00
Plenary 4
How AI will change medicine
Amsterdam, The Netherlands
Concetta  Mastromauro
Chieti, Italy
Fri 22 09:55
RFC8.6
Rapid Free Communications 8: Fat, metabolism and obesity 2
Leukocytes and Neutrophil–Lymphocyte Ratio as Indicators of decreased insulin sensitivity in NGT Overweight and Obese Children with high 1-hour post-load plasma glucose levels
Chieti, Italy
Dr Debbie Matthews
The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom
Thu 21 08:10
ESPE Working Group on Turner Syndrome
Medical aspects
The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom
Prof. Margaret  McCarthy
Baltimore, USA
Thu 21 10:15
PL1
Plenary 1: Sex Differences in the Brain: Intersection of the Endocrine, Immune and Nervous Systems
Sex Differences in the Brain: Intersection of the Endocrine, Immune and Nervous Systems
Baltimore, USA
Sinead McGlacken-Byrne
London, United Kingdom
Fri 22 10:10
FC7.2
Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
Mapping the transcriptomic landscape of early human fetal ovary development through a clinically-focused lens
London, United Kingdom
Thomas  Meissner
Düsseldorf, Germany
Fri 22 10:00
FC10.1
Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
Dasiglucagon safety in paediatric participants with CHI
Düsseldorf, Germany
Dr Philippa  Melamed
Haifa, Israel
Fri 22 14:30
S6.1
Symposium 6 - Neonatal endocrinology
Unravelling the role of epigenetics in reproductive adaptations to early-life environment
Haifa, Israel
Maria  Melikyan
Moscow, Russian Federation
Fri 22 09:50
RFC10.5
Rapid Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
Insulinoma in childhood: A multicenter retrospective study of 28 patients
Moscow, Russian Federation
Veronica Mericq
Santiago, Chile
Fri 22 08:30
Controversy 1
Pharmacological manipulation of bone maturation should be used to preserve final height in short children (FOR)
Santiago, Chile
Bradley Miller
Minneapolis, USA
Sat 23 09:30
FC11.1
Free Communications 11: GH and IGFs
GH replacement therapy with once-weekly somapacitan in children with GH deficiency is effective and well-tolerated: 2-year results from REAL4
Minneapolis, USA
Idris  Mohammed
Doha, Qatar
Fri 22 09:45
RFC8.4
Rapid Free Communications 8: Fat, metabolism and obesity 2
Understanding the genetics of early onset obesity in a cohort of children from Qatar
Doha, Qatar
Gylli  Mola
Copenhagen, Denmark
Fri 22 09:30
RFC7.1
Rapid Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
Penile width increases more clearly than penile length during minipuberty: a longitudinal study of 136 healthy infant boys
Copenhagen, Denmark
Flavia Napoli
Genoa, Italy
Fri 22 09:45
RFC10.4
Rapid Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
Clinical phenotypes of a multicentric cohort of ROHHAD patients
Genoa, Italy
Fri 22 10:20
FC10.3
Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
ROHHAD syndrome, thrombotic risk and endothelial damage: a single center experience.
Genoa, Italy
Serge  Nef
Geneva, Switzerland
Thu 21 11:55
S1.2
Symposium 1 - Disorders of Sex Development
Regulation of germ cell fate during sex determination
Geneva, Switzerland
Marek Niedziela
Poznan, Poland
Fri 22 08:35
Meet the Expert 6.1
Approach to Thyroid cancer in Children
Poznan, Poland
Sat 23 14:00
Meet the Expert 6.2
Approach to Thyroid cancer in Children
Poznan, Poland
Revital Nimri
Petah Tikva, Israel
Sat 23 09:30
HDI2.2
How do I…? 2
How Do I initiate and follow patients on a closed-loop system?
Petah Tikva, Israel
Mitra Nourbakhsh
Tehran, Iran
Sat 23 09:25
RFC14.6
Rapid Free Communications 14 - Late Breaking
Enhanced histones acetylation in children with obesity: relationship with insulin resistance and inflammation
Tehran, Iran
Nattakarn Numsriskulrat
Bangkok, Thailand
Fri 22 10:50
FC6.6
Free Communications 6: Pituitary, neuroendocrinology and puberty 1
Serum Kisspeptin and DLK1 levels as a tool for diagnosis and monitoring of central precocious puberty treatment in Thai girls
Bangkok, Thailand
Barbora Obermannova
Prague, Czech Republic
Thu 21 14:45
RFC5.5
Rapid Free Communications 5: Diabetes and insulin 1
Syndrome of hypoglycemia unawareness in children with type 1 diabetes: clinical contribution of Clark and Gold questionnaire
Prague, Czech Republic
Yasuhisa  Ohata
Suita, Japan
Sat 23 10:10
FC11.5
Free Communications 11: GH and IGFs
Effective GH Replacement with Once-weekly Somapacitan in Japanese Children with GH Deficiency: 2-year Results from REAL4
Suita, Japan
Anouk  Olthof
Amsterdam, The Netherlands
Thu 21 14:35
RFC1.5
Rapid Free Communications 1: Adrenals and HPA Axis
The effect of storage and temperature on the stability of steroid hormones in dried blood spots
Amsterdam, The Netherlands
Susan Ozanne
Cambridge, UK
Fri 22 15:00
S6.2
Symposium 6 - Neonatal endocrinology
The role of insulin in prenatal programming of future metabolic disease
Cambridge, UK
Esin Karakilic  Ozturan
Turkey
Fri 22 09:55
RFC6.6
Rapid Free Communications 6: Pituitary, neuroendocrinology and puberty 1
Evaluation of Serum MKRN3 and DLK1 Concentrations for Predicting Variant Detection in MKRN3 and DLK1Genes in Patients with Central Precocious Puberty
Turkey
Stefania Palumbo
Fri 22 10:00
FC6.1
Free Communications 6: Pituitary, neuroendocrinology and puberty 1
Methylome analysis in idiopathic central precocious puberty girls
Valentina Pampanini
Rome, Italy
Sat 23 08:15
YB3.2
Yearbook 3
Growth and Growth Factors
Rome, Italy
Professor Anne-Simone Parent
Liège, Belgium
Fri 22 14:30
YB2.1
Yearbook 2
Puberty
Liège, Belgium
Andrea Cordero  Pearson
Cáceres, Spain
Thu 21 14:50
RFC5.6
Rapid Free Communications 5: Diabetes and insulin 1
Do females with Type 1 Diabetes have puberty earlier?
Cáceres, Spain
Giorgia Pepe
Messina, Italy
Thu 21 14:25
RFC3.1
Rapid Free Communications 3: Fat, metabolism and obesity 1
Fasting and meal-related zonulin serum levels in a large cohort of obese children and adolescents: a cross sectional study
Messina, Italy
Reena Perchard
Manchester, UK
Thu 21 14:25
RFC4.1
Rapid Free Communications 4: Growth and syndromes (to include Turner syndrome)
Functional networks reveal pathways linking early growth to childhood blood pressure in the Manchester BabyGRO Study
Manchester, UK
Catherine Peters
London, UK
Thu 21 14:25
HDI1.1
How do I…? 1
How do I manage abnormal thyroid function tests in the newborn?
London, UK
Orit Pinhas-Hamiel
Tel Aviv, Israel
Thu 21 11:37
YB1.2
Yearbook 1
Type 2 Diabetes, Metabolic Syndrome and Lipids
Tel Aviv, Israel
Orit Pinhas-Hamiel
Tel-Aviv, Israel
Sat 23 09:00
HDI2.1
How do I…? 2
How to manage long term complications in T2DM in adolescents?
Tel-Aviv, Israel
Lukas Plachy
Prague, Czech Republic
Sat 23 09:00
RFC11.1
Rapid Free Communications 11: GH and IGFs
The genetic aetiology of primary multiple pituitary hormone deficiency: a next-generation sequencing analysis of a single-centre cohort.
Prague, Czech Republic
Marysia Placzek
Sheffield, UK
Fri 22 15:00
S5.2
Symposium 5 - Hypothalamic syndromes
The evolution of the hypothalamus
Sheffield, UK
Ornpisa  Promsod
Bangkok, Thailand
Thu 21 15:35
FC5.5
Free Communications 5: Diabetes and insulin 1
Sleep Characteristics, Glycemic Control, and Endothelial Function in Adolescents and Young Adults with Type 1 Diabetes
Bangkok, Thailand
Elsa  Puerto-Carranza
Utrecht, The Netherlands
Fri 22 09:35
RFC8.2
Rapid Free Communications 8: Fat, metabolism and obesity 2
Acute rise of leptin after five days of dexamethasone and its association with hunger, fat mass, sleep and fatigue, in children with acute lymphoblastic leukemia
Utrecht, The Netherlands
Fri 22 09:40
RFC8.3
Rapid Free Communications 8: Fat, metabolism and obesity 2
Higher levels of serum α-Klotho are longitudinally associated with less visceral fat accumulation in apparently healthy girls experiencing weight gain
Utrecht, The Netherlands
Preetha Purushothaman
London, UK
Fri 22 09:30
RFC10.1
Rapid Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
A novel maternally inherited GNAS variant in a family with hyperphagia and obesity.
London, UK
London, UK
Richard Quinton
Imperial College London, London, UK
Fri 22 08:35
Meet the Expert 8.1
Puberty induction in hypogonadism
Imperial College London, London, UK
Sat 23 08:00
Meet the Expert 8.2
Puberty induction in hypogonadism
Imperial College London, London, UK
Adalbert Raimann
Vienna, Austria
Thu 21 14:50
RFC2.6
Rapid Free Communications 2: Bone, growth plate and mineral metabolism
Short term side effects of first bisphosphonate infusion in children with different underlying bone pathologies.
Vienna, Austria
Professor Nicole Reisch
Munich, Germany
Fri 22 14:30
S8.1
Symposium 8 - Adrenals
Understanding the role of 11-oxygenated androgens
Munich, Germany
Judith  Renes
Rotterdam, The Netherlands
Sat 23 09:40
FC11.2
Free Communications 11: GH and IGFs
Clinical characteristics of heterozygous ACAN gene variants and longer-term response to growth hormone treatment: real-world data
Rotterdam, The Netherlands
Felix  Reschke
Germany
Fri 22 09:45
RFC6.4
Rapid Free Communications 6: Pituitary, neuroendocrinology and puberty 1
Earlier Occurrence of Puberty and Pubertal Hair Development in Boys and Girls - Insights from the DPV Initiative Data
Germany
Raissa  Rezende
Sao Paulo, Brazil
Sat 23 09:30
FC13.1
Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Genetic evaluation in children with self-limited pubertal delay discloses new candidate genes
Sao Paulo, Brazil
Anne  Rochtus
Leuven, Belgium
Sat 23 09:10
RFC12.3
Rapid Free Communications 12: Thyroid
Thyroid disorders in childhood cancer survivors treated with 131 I-MIBG, TKIs or immune checkpoint inhibitors: incidence, mechanisms and clinical management – systematic review
Leuven, Belgium
Leuven, Belgium
Patrik Rorsman
Oxford, UK
Thu 21 12:25
S4.3
Symposium 4 - Novel insights and innovations in diabetes
Physical interaction between beta and delta cells
Oxford, UK
Elizabeth  Rosenfeld
Philadelphia, USA
Fri 22 09:40
RFC10.3
Rapid Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
Non-coding Variants in HK1 Account for 5% of Cases of Congenital Hyperinsulinism Without an Identified Genetic Cause
Philadelphia, USA
Dr Dr. Anya Rothenbuhler
Paris, France
Thu 21 14:35
RFC2.3
Rapid Free Communications 2: Bone, growth plate and mineral metabolism
High incidence of Chiari type I anomalies on MRI in young patients with X-linked hypophosphatemic rickets (XLHR)
Paris, France
Lisa  Ruck
Berlin, Germany
Thu 21 15:05
FC3.2
Free Communications 3: Fat, metabolism and obesity 1
Analysis of ligand- and mutation-dependent signaling of the melanocortin 4 receptor (MC4R): an example of the relevance of differential signaling (bias signaling)
Berlin, Germany
Frank Rutsch
Münster, Germany
Sat 23 16:00
S10.2
Symposium 10 - Bone
Inherited ectopic calcification disorders
Münster, Germany
Bekim  Sadikovic
London, Canada
Sat 23 14:15
Novel Advances 2
DNA Methylation Episignatures: Defining Biomarkers of Rare Disorders
London, Canada
Kyriakie Sarafoglou
Minneapolis, USA
Thu 21 15:15
FC1.4
Free Communications 1: Adrenals and HPA Axis
Response to Crinecerfont Treatment in Adolescents with Classic Congenital Adrenal Hyperplasia Is Correlated with Elevated Baseline Hormone Concentrations but Not Glucocorticoid Dose
Minneapolis, USA
Professor Ravi Savarirayan
Melbourne, Australia
Thu 21 14:50
RFC4.6
Rapid Free Communications 4: Growth and syndromes (to include Turner syndrome)
Results from the PROPEL 2 dose-finding study: oral infigratinib leads to significant increases in height velocity with good tolerability in children with achondroplasia
Melbourne, Australia
Lars Sävendahl
Stockholm, Sweden
Thu 21 11:25
S3.1
Symposium 3 - Endocrine effects of cancer treatment
Safety of GH treatment in cancer survivors
Stockholm, Sweden
Laura  Sayol-Torres
Spain
Fri 22 09:50
RFC6.5
Rapid Free Communications 6: Pituitary, neuroendocrinology and puberty 1
EFFICACY AND SECURITY OF GONADOTROPIN TREATMENT IN ADOLESCENTS WITH CONGENITAL HYPOGONADOTROPIC HYPOGONADISM
Spain
Jiska van  Schaik
Utrecht, The Netherlands
Sat 23 09:10
RFC13.3
Rapid Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Treatment and outcome of the Dutch Childhood Craniopharyngioma Cohort study; first results after centralization of care
Utrecht, The Netherlands
Andreas Schedl
Nice, France
Fri 22 15:00
S8.2
Symposium 8 - Adrenals
Adrenal cortex renewal in health and disease
Nice, France
Melanie Schirmer
Ulm, Germany
Fri 22 10:50
FC8.6
Free Communications 8: Fat, metabolism and obesity 2
Liraglutide treatment in adolescents with extreme obesity - Effects on weight loss in the first 9 months under real-life conditions
Ulm, Germany
Patrick Schrauwen
Maastricht, The Netherlands
Sat 23 15:30
S11.1
Symposium 11 - Diet, nutrients and the environment
Timing of eating and exercise to improve metabolic health in humans
Maastricht, The Netherlands
Asaf Ben  Simon
Tel Aviv, Israel
Thu 21 14:25
RFC1.4
Rapid Free Communications 1: Adrenals and HPA Axis
Unfavorable Body Composition in Children with Premature Adrenarche: Implications for Metabolic Health
Tel Aviv, Israel
Tel Aviv, Israel
Thorkild  Sørensen
Copenhagen, Denmark
Thu 21 08:20
ESPE Working Group on Obesity
Environmental contributions to obesity development
Copenhagen, Denmark
Fri 22 15:00
S7.2
Symposium 7 - Theories of obesity development and their implications on dietary interventions
From the social life through the psyche and the brain to the epidemic expansion of the adipose mass
Copenhagen, Denmark
All speakers
Thu 21 09:05
ESPE Working Group on Diabetes Technology
Discussion - Round Table
Robert  Stein
Leipzig, Germany
Fri 22 10:00
FC9.1
Free Communications 9: Diabetes and insulin 2
Reference values for the insulin response to glucose challenge enable the early detection of emerging (pre)diabetes in children and young adults with obesity
Leipzig, Germany
Chloe Stevens
Cambridge, UK
Sat 23 09:30
FC12.1
Free Communications 12: Thyroid
Graves’ disease – are we just delaying the inevitable?
Cambridge, UK
Maria Elisabeth Street
Parma, Italy
Thu 21 14:40
RFC3.4
Rapid Free Communications 3: Fat, metabolism and obesity 1
Effect of maternal diet and breastfeeding on growth and distribution of adiposity from birth up to 12 months: data from the European LIFE-MILCH project
Parma, Italy
Warittha  Supho
Bangkok, Thailand
Fri 22 09:40
RFC9.3
Rapid Free Communications 9: Diabetes and insulin 2
Impaired Insulin Secretion as a Pathophysiology Underlying Abnormal Glucose Metabolism in Pediatric Acute Lymphoblastic Leukemia (ALL) Survivors: A Study Comparing Glucose Metabolism between ALL Survivors and Simple Obese Children
Bangkok, Thailand
Dr Gabor Szinnai
Basel, Switzerland
Sat 23 08:00
YB3.1
Yearbook 3
Thyroid
Basel, Switzerland
Giulia  Tarantola
Milan, Italy
Sat 23 09:40
FC12.2
Free Communications 12: Thyroid
Thyroid function analysis in 48 patients affected by severe combined immunodeficiency caused by adenosine deaminase deficiency
Milan, Italy
Gürkan  Tarçın
Istanbul, Turkey
Fri 22 10:10
FC6.2
Free Communications 6: Pituitary, neuroendocrinology and puberty 1
The role of body composition and appetite-regulating hormones in idiopathic central precocious puberty and their changes during GnRH analogue therapy.
Istanbul, Turkey
Maithé Tauber
Toulouse, France
Thu 21 16:55
Meet the Expert 4.1
Clinical Management of Prader-Willi Syndrome in infants, children and adolescents
Toulouse, France
Sat 23 08:00
Meet the Expert 4.2
Clinical Management of Prader-Willi Syndrome in infants, children and adolescents
Toulouse, France
Manuel Tena-Sempere
Córdoba, Spain
Thu 21 08:00
ESPE Working Group on Paediatric and Adolescent Gynaecology
Early puberty: connecting nutritional status and pubertal activation
Córdoba, Spain
Sat 23 16:30
S12.3
Symposium 12: What's new for the HPG Axis
Recent advances in our understanding of the regulation of GnRH secretion
Córdoba, Spain
Anders  Tengholm
Uppsala, Sweden
Thu 21 11:25
S4.1
Symposium 4 - Novel insights and innovations in diabetes
Role of alpha cells in islet function
Uppsala, Sweden
Daniel Tews
Ulm, Germany
Thu 21 14:50
RFC3.6
Rapid Free Communications 3: Fat, metabolism and obesity 1
Glucocorticoid-mediated leptin secretion from human adipocytes is dependent on glucose availability
Ulm, Germany
Dr Paul Thornton
Texas, USA
Fri 22 08:35
Meet the Expert 7.1
Management of hyperinsulism beyond the acute phase
Texas, USA
Sat 23 14:00
Meet the Expert 7.2
Management of hyperinsulism beyond the acute phase
Texas, USA
Ahmet  Uçar
Istanbul, Turkey
Sat 23 09:25
RFC11.6
Rapid Free Communications 11: GH and IGFs
Evaluation Of The Growth Hormone-Insulin like Growth Factor1 Axis And Serum Fibroblast Growth Factor 21 Levels As Related To Stature In Children And Adolescents With Coeliac Disease Adherent To Gluten Free Diet
Istanbul, Turkey
Adi  Uretzky
Tel Aviv, Israel
Thu 21 14:25
RFC1.4
Rapid Free Communications 1: Adrenals and HPA Axis
Unfavorable Body Composition in Children with Premature Adrenarche: Implications for Metabolic Health
Tel Aviv, Israel
Tel Aviv, Israel
Erica van den Akker
Rotterdam, The Netherlands
Thu 21 08:00
ESPE Working Group on Obesity
The ESPE Obesity Working Group
Rotterdam, The Netherlands
Janielle van der Velden
Nijmegen, Netherlands
Thu 21 08:00
ESPE Working Group on Turner Syndrome
Challenges and opportunities in prenatal and postnatal diagnosis of Turner Syndrome & Parents’ Testimony
Nijmegen, Netherlands
Hoeselt, Belgium
Thu 21 09:25
ESPE Working Group on Turner Syndrome
Update form TSWG and Disclosure
Nijmegen, Netherlands
Yvonne van der Zwan
Nijmegen, The Netherlands
Thu 21 15:45
FC1.6
Free Communications 1: Adrenals and HPA Axis
Cardiovascular risk profile in adult patients with congenital adrenal hyperplasia: a cross-sectional study
Nijmegen, The Netherlands
Hanneke Van Santen
Utrecht, The Netherlands
Fri 22 14:30
S5.1
Symposium 5 - Hypothalamic syndromes
Hypothalamic syndrome in Cancer survivors
Utrecht, The Netherlands
Hugo Vankelecom
Leuven, Belgium
Fri 22 16:10
PL5
Plenary 5
Cracking the pituitary stem cell code across life using single-cell transcriptomics and organoid models
Leuven, Belgium
Riitta Veijola
Oulu, Finland
Thu 21 08:45
ESPE Working Group on Diabetes Technology
Immune intervention of newly diagnosed of T1DM – where are we today?
Oulu, Finland
Annemarie Verrijn Stuart
Utrecht, The Netherlands
Thu 21 16:55
Meet the Expert 1.1
Management of MEN1 in children and adolescents
Utrecht, The Netherlands
Fri 22 08:35
Meet the Expert 1.2
Management of MEN1 in children and adolescents
Utrecht, The Netherlands
Annelou Vries
Amsterdam, The Netherlands
Thu 21 08:00
ESPE Working Group on Gender Incongruence
Gender dysphoria and autism, implications for diagnosis and decision making
Amsterdam, The Netherlands
Martine Vries
Leiden, The Netherlands
Thu 21 08:35
ESPE Working Group on Turner Syndrome
Ethical considerations
Leiden, The Netherlands
Thu 21 17:25
EE1.2
Ethics in Endocrinology
Should we strive for normality?
Leiden, The Netherlands
Lieke Vrouenraets
Leiden, The Netherlands
Thu 21 09:00
ESPE Working Group on Gender Incongruence
Moral dilemmas surrounding puberty suppression in transgender adolescents’
Leiden, The Netherlands
Rade Vukovic
Belgrade, Serbia
Thu 21 09:25
ESPE Working Group on Disorders of Sex Development
Concluding Remarks
Belgrade, Serbia
Turkey, Istanbul
Professor Martin Wabitsch
University of Ulm, Germany
Thu 21 11:49
YB1.3
Yearbook 1
Obesity and Weight Regulation
University of Ulm, Germany
Fri 22 10:40
FC8.5
Free Communications 8: Fat, metabolism and obesity 2
Impact of Setmelanotide on Metabolic Syndrome Risk in Pediatric Patients With POMC and LEPR Deficiency
University of Ulm, Germany
Sat 23 16:30
S11.3
Symposium 11 - Diet, nutrients and the environment
Weight loss and mechanisms of weight regain
University of Ulm, Germany
Prof. Debra Weese-Mayer
Chicago, USA
Fri 22 15:30
S5.3
Symposium 5 - Hypothalamic syndromes
ROHHAD/ROHHADNET syndrome
Chicago, USA
Professor Daniel  Weghuber
Paracelsus Medical School, Salzburg, Austria
Thu 21 08:40
ESPE Working Group on Obesity
New treatment in children and adolescents with obesity
Paracelsus Medical School, Salzburg, Austria
Haiyan  Wei
Zhengzhou, China
Fri 22 09:30
RFC6.1
Rapid Free Communications 6: Pituitary, neuroendocrinology and puberty 1
Clinical application of LH cut-off value in the diagnosis of CPP according to the international consensus
Zhengzhou, China
Karen van  Wessel
Utrecht, The Netherlands
Sat 23 09:20
RFC13.5
Rapid Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Growth hormone and TSH deficiency after [177Lu]Lu-DOTATATE therapy for pediatric neuroblastoma; description of a first case.
Utrecht, The Netherlands
Susanna Wiegand
Berlin, Germany
Fri 22 10:10
FC9.2
Free Communications 9: Diabetes and insulin 2
Characterization of pediatric patients with type 2 diabetes and trends in their pharmaceutical management 2000-2022 in German-speaking countries: Analysis based on the DPV registry
Luxembourg, Luxembourg
Berlin, Germany
Amy Wisniewski
Oklahoma, USA
Thu 21 16:55
Meet the Expert 2.1
Informing children about their DSD – when and how?
Oklahoma, USA
Sat 23 14:00
Meet the Expert 2.2
Informing children about their DSD - when and how?
Oklahoma, USA
Jan Maarten  Wit
Leiden, The Netherlands
Thu 21 16:55
Meet the Expert 3.1
Uncertainties around diagnosing growth hormone deficiency
Leiden, The Netherlands
Sat 23 08:00
Meet the Expert 3.2
Uncertainties around diagnosing growth hormone deficiency
Leiden, The Netherlands
Selma Witchel
Pittsburgh, USA
Fri 22 09:35
RFC7.2
Rapid Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
International Evidence-Based Guidelines for PCOS 2023: Recommendations in Adolescent Girls
Pittsburgh, USA
Chris Worth
Manchester, UK
Fri 22 09:35
RFC10.2
Rapid Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
Utility of Continuous Glucose Monitoring (CGM) during pancreatic surgery in patients with Congenital Hyperinsulinism
Manchester, UK
Manchester, UK
Sarah  Worthington
Manchester, UK
Fri 22 09:35
RFC10.2
Rapid Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
Utility of Continuous Glucose Monitoring (CGM) during pancreatic surgery in patients with Congenital Hyperinsulinism
Manchester, UK
Manchester, UK
Zehra  Yavas Abali
Istanbul, Turkey
Thu 21 08:05
ESPE Working Group on Disorders of Sex Development
Case Presentation
Istanbul, Turkey
Sat 23 10:00
FC13.4
Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Clinical and molecular genetic characteristics of 98 patients with congenital hypopituitarism: A single-center experience
Istanbul, Turkey
Melek  Yildiz
Istanbul, Turkey
Thu 21 15:05
FC5.2
Free Communications 5: Diabetes and insulin 1
Nailfold capillaroscopy: An alternative non-invasive tool for evaluating microvascular involvement in children with type 1 diabetes
Istanbul, Turkey
Shuxian  Yuan
Zhengzhou, China
Fri 22 10:40
FC6.5
Free Communications 6: Pituitary, neuroendocrinology and puberty 1
Clinical characteristics of 213 children with early pubertal development complicated with pineal cyst
Zhengzhou, China
Hussein  Zaitoon
Tel Aviv, Israel
Sat 23 09:15
RFC12.4
Rapid Free Communications 12: Thyroid
Polyethylene glycol thyroid stimulating hormone (PEG-TSH) in real-life: a practical tool for solving a biochemical dilemma
Tel Aviv, Israel
Tel Aviv, Israel
Qianwen Zhang
Shanghai, China
Fri 22 10:30
FC9.4
Free Communications 9: Diabetes and insulin 2
The high proportion of INS-MODY in Chinese children with MODY
Shanghai, China
Shanghai, China
Stefanie Zorn
Ulm, Germany
Thu 21 14:55
FC3.1
Free Communications 3: Fat, metabolism and obesity 1
Early childhood height and weight development in children with monogenic obesity: A European multicenter cohort study
Ulm, Germany
Amnon  Zung
Rehovot, Israel
Sat 23 09:25
RFC12.6
Rapid Free Communications 12: Thyroid
Phenylbutyrate treatment of three patients with Monocarboxylate Transporter 8 deficiency
Rehovot, Israel
Workshop 1
Thu 21 14:25
Rapid Free Communications 1: Adrenals and HPA Axis
Pacific
Chairs: Christa Flück (Bern, Switzerland) & Li Chan (London, UK)
Thu 21 14:25
RFC1.4
Rapid Free Communications 1: Adrenals and HPA Axis
Unfavorable Body Composition in Children with Premature Adrenarche: Implications for Metabolic Health
Tel Aviv, Israel
Tel Aviv, Israel
Thu 21 14:30
RFC1.3
Rapid Free Communications 1: Adrenals and HPA Axis
The chimeric CYP21A1P/CYP21A2 and TNXA/TNXB gene deficiencies in patients with Congenital Adrenal Hyperplasia
Nicosia, Cyprus
Thu 21 14:35
RFC1.5
Rapid Free Communications 1: Adrenals and HPA Axis
The effect of storage and temperature on the stability of steroid hormones in dried blood spots
Amsterdam, The Netherlands
Thu 21 14:40
RFC1.1
Rapid Free Communications 1: Adrenals and HPA Axis
Lack of NAD(P)+ transhydrogenase activity in patients with primary adrenal insufficiency due to NNT mutations
Istanbul, Turkey
Thu 21 14:45
Rapid Free Communications 1: Adrenals and HPA Axis
Clinical and genetic characteristics of 42 Chinese paediatric patients with X-Linked Adrenal Hypoplasia Congenita
Shanghai, China
Thu 21 14:50
RFC1.2
Rapid Free Communications 1: Adrenals and HPA Axis
Interlaboratory comparison of LC-MS/MS measurements of 11 relevant steroid hormones in 27 DSD patients
Kiel, Germany
Oral 0
Expert 15
Thu 21 16:55
Meet the Expert 1.1
Mississippi
Thu 21 16:55
Meet the Expert 1.1
Management of MEN1 in children and adolescents
Utrecht, The Netherlands
Thu 21 16:55
Meet the Expert 2.1
Atlantic
Thu 21 16:55
Meet the Expert 2.1
Informing children about their DSD – when and how?
Oklahoma, USA
Thu 21 16:55
Meet the Expert 3.1
Yangtze 1&2
Thu 21 16:55
Meet the Expert 3.1
Uncertainties around diagnosing growth hormone deficiency
Leiden, The Netherlands
Thu 21 16:55
Meet the Expert 4.1
Amazon
Thu 21 16:55
Meet the Expert 4.1
Clinical Management of Prader-Willi Syndrome in infants, children and adolescents
Toulouse, France
Fri 22 08:35
Meet the Expert 5.1
Yangtze 1&2
Fri 22 08:35
Meet the Expert 5.1
Management of Pituitary adenomas in Children
Brussels, Belgium
Fri 22 08:35
Meet the Expert 6.1
Atlantic
Fri 22 08:35
Meet the Expert 6.1
Approach to Thyroid cancer in Children
Poznan, Poland
Fri 22 08:35
Meet the Expert 7.1
Amazon
Fri 22 08:35
Meet the Expert 7.1
Management of hyperinsulism beyond the acute phase
Texas, USA
Fri 22 08:35
Meet the Expert 1.2
Pacific
Fri 22 08:35
Meet the Expert 1.2
Management of MEN1 in children and adolescents
Utrecht, The Netherlands
Sat 23 08:00
Meet the Expert 3.2
Yangtze 1&2
Sat 23 08:00
Meet the Expert 3.2
Uncertainties around diagnosing growth hormone deficiency
Leiden, The Netherlands
Sat 23 08:00
Meet the Expert 4.2
Pacific
Sat 23 08:00
Meet the Expert 4.2
Clinical Management of Prader-Willi Syndrome in infants, children and adolescents
Toulouse, France
Sat 23 08:00
Meet the Expert 5.2
Everest 1&2
Sat 23 08:00
Meet the Expert 5.2
Management of Pituitary adenomas in Children
Brussels, Belgium
Sat 23 08:00
Meet the Expert 8.2
Atlantic
Sat 23 08:00
Meet the Expert 8.2
Puberty induction in hypogonadism
Imperial College London, London, UK
Sat 23 14:00
Meet the Expert 2.2
Pacific
Sat 23 14:00
Meet the Expert 2.2
Informing children about their DSD - when and how?
Oklahoma, USA
Sat 23 14:00
Meet the Expert 6.2
Mississippi
Sat 23 14:00
Meet the Expert 6.2
Approach to Thyroid cancer in Children
Poznan, Poland
Sat 23 14:00
Meet the Expert 7.2
Yangtze 1&2
Sat 23 14:00
Meet the Expert 7.2
Management of hyperinsulism beyond the acute phase
Texas, USA
Plenary 7
Thu 21 10:15
Plenary 1: Sex Differences in the Brain: Intersection of the Endocrine, Immune and Nervous Systems
King Willem Alexander Auditorium
Chairs: Anita Hokken-Koelega (Rotterdam, The Netherlands) & Sabine Hannema (Amsterdam, The Netherlands)
Thu 21 10:15
PL1
Plenary 1: Sex Differences in the Brain: Intersection of the Endocrine, Immune and Nervous Systems
Sex Differences in the Brain: Intersection of the Endocrine, Immune and Nervous Systems
Baltimore, USA
Fri 22 08:00
Plenary 3
King Willem Alexander Auditorium
Chairs: Agnès Linglart (Paris, France) & Paul van Trotsenburg (Amsterdam, The Netherlands)
Fri 22 08:00
PL3
Plenary 3
Structural and functional development of the adolescent brain
Leiden, Netherlands
Fri 22 12:00
Plenary 4
King Willem Alexander Auditorium
Chairs: Martine Cools (Ghent, Belgium) & Faisal Ahmed (Glasgow, UK)
Fri 22 12:00
Plenary 4
How AI will change medicine
Amsterdam, The Netherlands
Fri 22 16:10
Plenary 5
King Willem Alexander Auditorium
Chairs: Rasha Hamza (Cairo, Egypt) & Mehul Dattani (London, UK)
Fri 22 16:10
PL5
Plenary 5
Cracking the pituitary stem cell code across life using single-cell transcriptomics and organoid models
Leuven, Belgium
Sat 23 11:00
Plenary 6
King Willem Alexander Auditorium
Chairs: Michel Polak (Paris, France) & Paul van Trotsenburg (Amsterdam, The Netherlands)
Sat 23 11:00
PL6
Plenary 6
How the genome predicts human disease
Geneva, Switzerland
Sat 23 12:15
Plenary 7
King Willem Alexander Auditorium
Chairs: Nils Krone (Sheffield, UK) & Malgorzata Wasniewska (Messina, Italy)
Sat 23 12:15
PL7
Plenary 7
Novel approaches in autoimmune endocrine disorders
Stockholm, Sweden
Sat 23 17:05
Plenary 8
King Willem Alexander Auditorium
Chairs: Indi Banerjee (Manchester, UK) & Tadej Battelino (Ljubljana, Slovenia)
Sat 23 17:05
PL8
Plenary 8
Real world use of closed loop insulin delivery
Amsterdam, The Netherlands
Catering and Social 0
Nurse 0
Other 12
Thu 21 10:45
Awards 1 - Henning Andersen Prizes
King Willem Alexander Auditorium
Chair: Nils Krone (Sheffield, UK)
Thu 21 10:45
Awards 1 - Henning Andersen Prizes
Awards 1 - Henning Andersen Prizes
Thu 21 14:25
How do I…? 1
King Willem Alexander Auditorium
Chairs: Naomi Weintrob (Tel Aviv, Israel) & Johnny Deladoëy (Montréal, Canada)
Thu 21 14:25
HDI1.1
How do I…? 1
How do I manage abnormal thyroid function tests in the newborn?
London, UK
Thu 21 14:55
HDI1.2
How do I…? 1
How do I use AMH in paediatric practice?
Buenos Aires, Argentina
Thu 21 15:25
HDI1.3
How do I…? 1
How do I manage a child with hypercalcemia?
Bochum, Germany
Thu 21 16:15
Plenary 2
King Willem Alexander Auditorium
Chairs: Stefano Cianfarani (Rome, Italy) & Erica van den Akker (Rotterdam, The Netherlands)
Thu 21 16:15
PL2
Plenary 2
The food environment and the global childhood obesity epidemic: The role of ultra-processed food
Boston, USA
Thu 21 16:55
Ethics in Endocrinology
King Willem Alexander Auditorium
Chairs: Theo Sas (Rotterdam, The Netherlands) & Marek Niedziela (Poznan, Poland)
Thu 21 16:55
EE1.1
Ethics in Endocrinology
Ethics of expensive treatments
Utrecht, The Netherlands
Thu 21 17:25
EE1.2
Ethics in Endocrinology
Should we strive for normality?
Leiden, The Netherlands
Fri 22 09:30
Endo-ERN Symposium
Oceania
Chairs: Olaf Hiort (Lübeck, Germany) & Luca Persani (Milan, Italy)
Fri 22 09:30
Endo-ERN Symposium
Perspective of Endo-ERN for the next five years
Lübeck, Germany
Fri 22 09:40
Endo-ERN Symposium
European medicine shortages: How can we avoid a disaster for patients with rare conditions?
Nijkerk, The Netherlands
Fri 22 10:05
Endo-ERN Symposium
It matters - set up of clinical trials in rare diseases
Berlin, Germany
Fri 22 10:35
Endo-ERN Symposium
ERNs and clinical trials; the ERICA and Rare Disease Partnership perspective
Amsterdam, The Netherlands
Fri 22 11:30
Awards 2
ESPE Research Award
King Willem Alexander Auditorium
Chair: Agnès Linglart (Paris, France)
Fri 22 11:30
Awards 2
ESPE Research Award
Fri 22 12:30
Awards 3
King Willem Alexander Auditorium
Fri 22
Awards 3
ESPE International Outstanding Clinician Award
Madrid, Spain
Fri 22
Awards 3
Outstanding Clinician Award
Madrid, Spain
Fri 22
Awards 3
ESPE Hormone Research in Paediatrics Prizes
University of Rome Tor Vergata, Rome, Italy
Fri 22
Awards 3
IFCAH-ESPE Award
Ghent, Belgium
Sat 23 09:00
How do I…? 2
King Willem Alexander Auditorium
Chairs: Zdenek Sumnik (Prague, Czech Republic) & Saartje Straetemans (Maastricht, The Netherlands)
Sat 23 09:00
HDI2.1
How do I…? 2
How to manage long term complications in T2DM in adolescents?
Tel-Aviv, Israel
Sat 23 09:30
HDI2.2
How do I…? 2
How Do I initiate and follow patients on a closed-loop system?
Petah Tikva, Israel
Sat 23 10:00
HDI2.3
How do I…? 2
Diagnosis and management of hypercholesterolemia
Modena, Italy
Sat 23 11:30
Awards 4
King Willem Alexander Auditorium
Chair: Anita Hokken-Koelega (Rotterdam, The Netherlands)
Sat 23 11:30
Awards 4
Andrea Prader Prize (30 mins) + ESPE International Award (15 mins)
Sat 23 14:15
Novel Advances 2
Atlantic
Chairs: Daniëlle van der Kaay (Rotterdam, The Netherlands) & Agnes Linglart (Paris, France)
Sat 23 14:15
Novel Advances 2
DNA Methylation Episignatures: Defining Biomarkers of Rare Disorders
London, Canada
Sat 23 14:15
Awards - Young Investigators
Amazon
Chair: Martine Cools (Ghent, Belgium)
Sat 23 14:15
Awards - Young Investigators
ESPE Young Investigator Awards
Sat 23 14:15
Awards - Young Investigators
Research Unit Lecture
Sat 23 14:15
Awards - Young Investigators
Research Fellowship Lecture
Sat 23 17:35
Awards 5 - ESPE Meeting Host Poster Awards
King Willem Alexander Auditorium
Chair: Paul van Trotsenburg (Amsterdam, The Netherlands)
Symposium 19
Thu 21 11:25
Symposium 1 - Disorders of Sex Development
Atlantic
Chairs: Angela Lucas Herald (Glasgow, UK) & David Zangen (Jerusalem, Israel)
Thu 21 11:25
S1.1
Symposium 1 - Disorders of Sex Development
Life-long care for people with 46,XY DSD
Lübeck, Germany
Thu 21 11:55
S1.2
Symposium 1 - Disorders of Sex Development
Regulation of germ cell fate during sex determination
Geneva, Switzerland
Thu 21 12:25
S1.3
Symposium 1 - Disorders of Sex Development
Pathogenesis of testicular dysfunction in Klinefelter syndrome
Copenhagen, Denmark
Thu 21 11:25
Symposium 2 - Hypothalamo-pituitary disorders
Pacific
Chairs: Mariacarolina Salerno (Naples, Italy) & Roland Pfaffle (Leipzig, Germany)
Thu 21 11:25
S2.1
Symposium 2 - Hypothalamo-pituitary disorders
Novel imaging techniques in pituitary tumours
University of Cambridge, Cambridge, UK
Thu 21 11:55
S2.2
Symposium 2 - Hypothalamo-pituitary disorders
Stem cells in the pituitary
London, UK
Thu 21 12:25
S2.3
Symposium 2 - Hypothalamo-pituitary disorders
Pioneer transcription factors
Montreal, Canada
Thu 21 11:25
Symposium 3 - Endocrine effects of cancer treatment
Mississippi
Chairs: Hoong-wei Gan (London, UK) & Hanneke van Santen (Utrecht, The Netherlands)
Thu 21 11:25
S3.1
Symposium 3 - Endocrine effects of cancer treatment
Safety of GH treatment in cancer survivors
Stockholm, Sweden
Thu 21 11:55
S3.2
Symposium 3 - Endocrine effects of cancer treatment
Surveillance for endocrine disease in Childhood Cancer Survivors
Pittsburgh, USA
Thu 21 12:25
S3.3
Symposium 3 - Endocrine effects of cancer treatment
Fertility preservation in children with cancer
Edinburgh, UK
Thu 21 11:25
Symposium 4 - Novel insights and innovations in diabetes
Yangtze 1&2
Chairs: Jacques Beltrand (Paris, France) & May Ng (Liverpool, UK)
Thu 21 11:25
S4.1
Symposium 4 - Novel insights and innovations in diabetes
Role of alpha cells in islet function
Uppsala, Sweden
Thu 21 11:55
S4.2
Symposium 4 - Novel insights and innovations in diabetes
Delaying the development of T1DM
New Haven, USA
Thu 21 12:25
S4.3
Symposium 4 - Novel insights and innovations in diabetes
Physical interaction between beta and delta cells
Oxford, UK
Thu 21 13:15
Satellite Symposium 1
For more information please see satellite programme
Thu 21 13:15
Satellite Symposium 2
For more information please see satellite programme
Thu 21 17:50
Satellite Symposium 3
For more information please see satellite programme
Thu 21 17:50
Satellite Symposium 4
For more information please see satellite programme
Thu 21 17:50
Satellite Symposium 5
For more information please see satellite programme
Fri 22 14:30
Symposium 5 - Hypothalamic syndromes
Mississippi
Chairs: Herman Müller (Berlin, Germany) & Maithé Tauber (Toulouse, France)
Fri 22 14:30
S5.1
Symposium 5 - Hypothalamic syndromes
Hypothalamic syndrome in Cancer survivors
Utrecht, The Netherlands
Fri 22 15:00
S5.2
Symposium 5 - Hypothalamic syndromes
The evolution of the hypothalamus
Sheffield, UK
Fri 22 15:30
S5.3
Symposium 5 - Hypothalamic syndromes
ROHHAD/ROHHADNET syndrome
Chicago, USA
Fri 22 13:20
Satellite Symposium 6
For more information please see satellite programme
Fri 22 13:20
Satellite Symposium 7
For more information please see satellite programme
Fri 22 14:30
Symposium 6 - Neonatal endocrinology
Yangtze 1&2
Chairs: Khalid Hussain (Doha, Qatar) & Maria Güemes (Madrid, Spain)
Fri 22 14:30
S6.1
Symposium 6 - Neonatal endocrinology
Unravelling the role of epigenetics in reproductive adaptations to early-life environment
Haifa, Israel
Fri 22 15:00
S6.2
Symposium 6 - Neonatal endocrinology
The role of insulin in prenatal programming of future metabolic disease
Cambridge, UK
Fri 22 15:30
S6.3
Symposium 6 - Neonatal endocrinology
The development of the HPA axis of the newborn
Amsterdam, The Netherlands
Fri 22 14:30
Symposium 7 - Theories of obesity development and their implications on dietary interventions
Pacific
Chairs: Violeta Iotova (Varna, Bulgaria) & Ram Weiss (Jerusalem, Israel)
Fri 22 14:30
S7.1
Symposium 7 - Theories of obesity development and their implications on dietary interventions
Competing Paradigms of Obesity Pathogenesis
Boston, USA
Fri 22 15:00
S7.2
Symposium 7 - Theories of obesity development and their implications on dietary interventions
From the social life through the psyche and the brain to the epidemic expansion of the adipose mass
Copenhagen, Denmark
Fri 22 15:30
S7.3
Symposium 7 - Theories of obesity development and their implications on dietary interventions
Polygenic risk score
Copenhagen, Denmark
Fri 22 14:30
Symposium 8 - Adrenals
Atlantic
Chairs: Evangelia Charmandari (Athens, Greece) & Uta Neumann (Berlin, Germany)
Fri 22 14:30
S8.1
Symposium 8 - Adrenals
Understanding the role of 11-oxygenated androgens
Munich, Germany
Fri 22 15:00
S8.2
Symposium 8 - Adrenals
Adrenal cortex renewal in health and disease
Nice, France
Fri 22 15:30
S8.3
Symposium 8 - Adrenals
Central nervous consequences of CAH and other adrenal disorders
Stockholm, Sweden
Fri 22 17:00
Satellite Symposium 8
For more information please see satellite programme
Sat 23 15:30
Symposium 9 - Thyroid
Mississippi
Chairs: Athanasia Stoupa (Paris, France) & Christiaan Mooij (Amsterdam, The Netherlands)
Sat 23 15:30
S9.1
Symposium 9 - Thyroid
Central hypothyroidism due to mutations in IGSF1 - latest insights into its pathogenesis
Montreal, Canada
Sat 23 16:00
S9.2
Symposium 9 - Thyroid
Is there role for combined T4 and T3 therapy in hypothyroidism
University of Chicago, Chicago, USA
Sat 23 16:30
S9.3
Symposium 9 - Thyroid
The role of thyroid hormone transporters in brain development and function
Essen, Germany
Sat 23 15:30
Symposium 10 - Bone
Yangtze 1&2
Chairs: Ola Nilsson (Stockholm, Sweden) & Gabriele Hartmann (Vienna, Austria)
Sat 23 15:30
S10.1
Symposium 10 - Bone
Management of Fibrous dysplasia
Bethesda, USA
Sat 23 16:00
S10.2
Symposium 10 - Bone
Inherited ectopic calcification disorders
Münster, Germany
Sat 23 16:30
S10.3
Symposium 10 - Bone
Life-time disease burden of achondroplasia
Baltimore, USA
Sat 23 15:30
Symposium 11 - Diet, nutrients and the environment
Pacific
Chairs: Yael Lebenthal (Tel Aviv, Israel) & Edgar van Mil (Venlo, The Netherlands)
Sat 23 15:30
S11.1
Symposium 11 - Diet, nutrients and the environment
Timing of eating and exercise to improve metabolic health in humans
Maastricht, The Netherlands
Sat 23 16:00
S11.2
Symposium 11 - Diet, nutrients and the environment
Sugar and ultra-processed food
San Francisco, USA
Sat 23 16:30
S11.3
Symposium 11 - Diet, nutrients and the environment
Weight loss and mechanisms of weight regain
University of Ulm, Germany
No Session Type 61
Thu 21 07:00
Registration
Thu 21 07:30
Breakfast for Working Group Attendees
Pacific Foyer, King Willem Alexander on 1st Floor, First Floor Lobby, Amazon Foyeer
Thu 21 08:00
ESPE Working Group on Disorders of Sex Development
Atlantic
Chair: Tülay Güran (Istanbul, Turkey)
Thu 21 08:00
ESPE Working Group on Disorders of Sex Development
Introduction
Turkey, Istanbul
Thu 21 08:05
ESPE Working Group on Disorders of Sex Development
Case Presentation
Istanbul, Turkey
Thu 21 08:15
ESPE Working Group on Disorders of Sex Development
Case presentation
Zagreb, Croatia
Thu 21 08:25
ESPE Working Group on Disorders of Sex Development
Androgen insensitivity syndrome Type 1
Cambridge, UK
Thu 21 08:50
ESPE Working Group on Disorders of Sex Development
Androgen insensitivity syndrome Type 2
Kiel, Germany
Thu 21 09:15
ESPE Working Group on Disorders of Sex Development
Discussion with attendees
Thu 21 09:25
ESPE Working Group on Disorders of Sex Development
Concluding Remarks
Belgrade, Serbia
Turkey, Istanbul
Thu 21 08:00
ESPE Working Group on Obesity
Pacific
Chair: Erica van den Akker (Rotterdam, The Netherlands)
Thu 21 08:00
ESPE Working Group on Obesity
The ESPE Obesity Working Group
Rotterdam, The Netherlands
Thu 21 08:20
ESPE Working Group on Obesity
Environmental contributions to obesity development
Copenhagen, Denmark
Thu 21 08:40
ESPE Working Group on Obesity
New treatment in children and adolescents with obesity
Paracelsus Medical School, Salzburg, Austria
Thu 21 09:00
ESPE Working Group on Obesity
Overweight and obesity in European Young Children: ToyBox-study lessons
Thu 21 09:20
ESPE Working Group on Obesity
Q&A
Thu 21 08:00
ESPE Bone and Growth Plate Working Group
Yangtze 1&2
Chair: Evelien Gevers (London, UK)
Thu 21 08:00
ESPE Bone and Growth Plate Working Group
Radiology of rare and less rare skeletal dysplasia
London, UK
Thu 21 08:30
ESPE Bone and Growth Plate Working Group
Genetics of rare skeletal dysplasia
Stockholm, Sweden
Thu 21 09:00
ESPE Bone and Growth Plate Working Group
2x clinical case from working group members
Thu 21 08:00
ESPE Working Group on Diabetes Technology
Mississippi
Chair: Moshe Phillip (Petah Tikva, Israel)
Thu 21 08:00
ESPE Working Group on Diabetes Technology
Introduction
Petah Tikva, Israel
Thu 21 08:05
ESPE Working Group on Diabetes Technology
Stage 1/Stage 2 T1DM – how do we monitor outside of clinical studies?
Petah Tikva, Israel
Thu 21 08:25
ESPE Working Group on Diabetes Technology
CGM use in Stage 2 T1DM
Ljubljana, Slovenia
Thu 21 08:45
ESPE Working Group on Diabetes Technology
Immune intervention of newly diagnosed of T1DM – where are we today?
Oulu, Finland
Thu 21 09:05
ESPE Working Group on Diabetes Technology
Discussion - Round Table
Thu 21 08:00
ESPE Working Group on Paediatric and Adolescent Gynaecology
King Willem Alexander Auditorium
Chair: Lourdes Ibanez Toda (Barcelona, Spain)
Thu 21 08:00
ESPE Working Group on Paediatric and Adolescent Gynaecology
Early puberty: connecting nutritional status and pubertal activation
Córdoba, Spain
Thu 21 08:25
ESPE Working Group on Paediatric and Adolescent Gynaecology
Environmental programming of early pubertal onset
Rome, Italy
Thu 21 08:50
ESPE Working Group on Paediatric and Adolescent Gynaecology
Management of early puberty : adaptation or overmedicalization?
Paris, France
France
Thu 21 08:00
ESPE Working Group on Gender Incongruence
Amazon
Chair: Sabine Hannema (Amsterdam, The Netherlands)
Thu 21 08:00
ESPE Working Group on Gender Incongruence
Gender dysphoria and autism, implications for diagnosis and decision making
Amsterdam, The Netherlands
Thu 21 08:30
ESPE Working Group on Gender Incongruence
Animal models of transgender care, advantages and drawbacks
Georgetown, USA
Thu 21 09:00
ESPE Working Group on Gender Incongruence
Moral dilemmas surrounding puberty suppression in transgender adolescents’
Leiden, The Netherlands
Thu 21 08:00
ESPE Working Group on Turner Syndrome
Everest 1&2
Chair: Janielle van der Velden (Nijmegen, The Netherlands)
Thu 21 08:00
ESPE Working Group on Turner Syndrome
Challenges and opportunities in prenatal and postnatal diagnosis of Turner Syndrome & Parents’ Testimony
Nijmegen, Netherlands
Hoeselt, Belgium
Thu 21 08:10
ESPE Working Group on Turner Syndrome
Medical aspects
The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle, United Kingdom
Thu 21 08:25
ESPE Working Group on Turner Syndrome
Psychological aspects
Bristol, UK
Thu 21 08:35
ESPE Working Group on Turner Syndrome
Ethical considerations
Leiden, The Netherlands
Thu 21 08:45
ESPE Working Group on Turner Syndrome
Panel discussion (interactive)
Thu 21 09:15
ESPE Working Group on Turner Syndrome
I-TS & pubertal induction study
Glasgow, UK
Thu 21 09:25
ESPE Working Group on Turner Syndrome
Update form TSWG and Disclosure
Nijmegen, Netherlands
Thu 21 09:30
Refreshment Break, Posters and Exhibition
Exhibition Hall
Thu 21 10:00
Opening Ceremony
King Willem Alexander Auditorium
Thu 21 11:25
Yearbook 1
Amazon
Chair: Christa Flück (Bern, Switzerland)
Thu 21 11:25
YB1.1
Yearbook 1
Global Health for the Paediatric Endocrinologist
Vancouver, Canada
Thu 21 11:37
YB1.2
Yearbook 1
Type 2 Diabetes, Metabolic Syndrome and Lipids
Tel Aviv, Israel
Thu 21 11:49
YB1.3
Yearbook 1
Obesity and Weight Regulation
University of Ulm, Germany
Thu 21 12:01
YB1.4
Yearbook 1
Adrenal
Athens, Greece
Thu 21 12:13
YB1.5
Yearbook 1
The Year in Science & Medicine
Bern, Switzerland
Thu 21 12:55
Lunch, posters and exhibition
Exhibition Hall
Thu 21 14:25
Rapid Free Communications 2: Bone, growth plate and mineral metabolism
Mississippi
Chairs: Evelien Gevers (London, UK) & Wolfgang Högler (Linz, Austria)
Thu 21 14:25
RFC2.1
Rapid Free Communications 2: Bone, growth plate and mineral metabolism
Identification of novel genes including NAV2 associated with isolated tall stature
Heidelberg, Germany
Thu 21 14:30
RFC2.2
Rapid Free Communications 2: Bone, growth plate and mineral metabolism
Familial pseudohypoparathyroidism type IB associated with an SVA retrotransposon insertion in the GNAS locus.
Tokyo, Japan
Thu 21 14:35
RFC2.3
Rapid Free Communications 2: Bone, growth plate and mineral metabolism
High incidence of Chiari type I anomalies on MRI in young patients with X-linked hypophosphatemic rickets (XLHR)
Paris, France
Thu 21 14:40
RFC2.4
Rapid Free Communications 2: Bone, growth plate and mineral metabolism
Documentation of inactivating PTH/PTHrP Signaling Disorders (Pseudohypoparathyroidism) cases in EuRRECa / EuRR-Bone: a challenging, but worthwhile journey
Le Kremlin-Bicêtre, France
Thu 21 14:45
RFC2.5
Rapid Free Communications 2: Bone, growth plate and mineral metabolism
Growth in young children with X-linked hypophosphatemia treated with burosumab
Le Kremlin-Bicêtre, France
Thu 21 14:50
RFC2.6
Rapid Free Communications 2: Bone, growth plate and mineral metabolism
Short term side effects of first bisphosphonate infusion in children with different underlying bone pathologies.
Vienna, Austria
Thu 21 14:25
Rapid Free Communications 3: Fat, metabolism and obesity 1
Yangtze 1&2
Chairs: Francesco Chiarelli (Chieti, Italy) & Senthil Senniappan (Liverpool, UK)
Thu 21 14:25
RFC3.1
Rapid Free Communications 3: Fat, metabolism and obesity 1
Fasting and meal-related zonulin serum levels in a large cohort of obese children and adolescents: a cross sectional study
Messina, Italy
Thu 21 14:30
RFC3.2
Rapid Free Communications 3: Fat, metabolism and obesity 1
Reduced central sensitivity to thyroid hormones in children and adolescents with overweight or obesity and impaired glucose tolerance.
Messina, Italy
Thu 21 14:35
RFC3.3
Rapid Free Communications 3: Fat, metabolism and obesity 1
Early Corneal Nerve Loss in Children with Melanocortin 4 Receptor (MC4R) Gene Mutation Related Obesity
Doha, Qatar
Thu 21 14:40
RFC3.4
Rapid Free Communications 3: Fat, metabolism and obesity 1
Effect of maternal diet and breastfeeding on growth and distribution of adiposity from birth up to 12 months: data from the European LIFE-MILCH project
Parma, Italy
Thu 21 14:45
RFC3.5
Rapid Free Communications 3: Fat, metabolism and obesity 1
Multi-omics Reveals molecule target Underlying Adolescent obesity with metabolic syndrome
Nanchang, China
Thu 21 14:50
RFC3.6
Rapid Free Communications 3: Fat, metabolism and obesity 1
Glucocorticoid-mediated leptin secretion from human adipocytes is dependent on glucose availability
Ulm, Germany
Thu 21 14:25
Rapid Free Communications 4: Growth and syndromes (to include Turner syndrome)
Atlantic
Chairs: Cheri Deal (Montréal, Canada) & Janielle van der velden (Nijmegen, The Netherlands)
Thu 21 14:25
RFC4.1
Rapid Free Communications 4: Growth and syndromes (to include Turner syndrome)
Functional networks reveal pathways linking early growth to childhood blood pressure in the Manchester BabyGRO Study
Manchester, UK
Thu 21 14:30
RFC4.2
Rapid Free Communications 4: Growth and syndromes (to include Turner syndrome)
Molecular genetic diagnosis in children with Idiopathic Short Stature: Single Center Experience
Izmir, Turkey
Thu 21 14:35
RFC4.3
Rapid Free Communications 4: Growth and syndromes (to include Turner syndrome)
Aromatase inhibitors: an effective and safe option for height increment in boys with growth hormone deficiency?
Izmir, Turkey
Thu 21 14:40
RFC4.4
Rapid Free Communications 4: Growth and syndromes (to include Turner syndrome)
Genetic findings in short Turkish children born to consanguineous parents
Leiden, The Netherlands
Thu 21 14:45
RFC4.5
Rapid Free Communications 4: Growth and syndromes (to include Turner syndrome)
Real-world safety and effectiveness of vosoritide: Results from an early access program in France
Paris, France
Thu 21 14:50
RFC4.6
Rapid Free Communications 4: Growth and syndromes (to include Turner syndrome)
Results from the PROPEL 2 dose-finding study: oral infigratinib leads to significant increases in height velocity with good tolerability in children with achondroplasia
Melbourne, Australia
Thu 21 14:25
Rapid Free Communications 5: Diabetes and insulin 1
Amazon
Chairs: Paul Voorhoeve (Nijmegen, The Netherlands) & Marianna Rachmiel (Zerifin, Israel)
Thu 21 14:25
RFC5.1
Rapid Free Communications 5: Diabetes and insulin 1
Tear proteomics profile in children and adolescents with type 1 diabetes mellitus
Athens, Greece
Thu 21 14:30
RFC5.2
Rapid Free Communications 5: Diabetes and insulin 1
Comparison of Optical Coherence Tomography Angiography Findings in Children with Type 1 Diabetes Mellitus and Autoimmune Thyroiditis with Healthy Children
Izmir, Turkey
Thu 21 14:35
RFC5.3
Rapid Free Communications 5: Diabetes and insulin 1
3 Screen ICA ELISA–A new tool to identify pre-clinical diabetes in first-degree relatives of patients with type 1 diabetes (pre-d1abetes study)
Białystok, Poland
Thu 21 14:40
RFC5.4
Rapid Free Communications 5: Diabetes and insulin 1
Effect of probiotic on glycemic control in children with type 1 diabetes : A randomized controlled trial
Mansoura, Egypt
Thu 21 14:45
RFC5.5
Rapid Free Communications 5: Diabetes and insulin 1
Syndrome of hypoglycemia unawareness in children with type 1 diabetes: clinical contribution of Clark and Gold questionnaire
Prague, Czech Republic
Thu 21 14:50
RFC5.6
Rapid Free Communications 5: Diabetes and insulin 1
Do females with Type 1 Diabetes have puberty earlier?
Cáceres, Spain
Thu 21 14:55
Free Communications 1: Adrenals and HPA Axis
Pacific
Chairs: Christa Flück (Bern, Switzerland) & Li Chan (London, UK)
Thu 21 14:55
FC1.1
Free Communications 1: Adrenals and HPA Axis
Investigating intergenerational effects of glucocorticoids
Cambridge, UK
Thu 21 15:05
FC1.2
Free Communications 1: Adrenals and HPA Axis
The pathophysiologic response of central nervous system due to differently impaired steroidogenesis
Sheffield, UK
Thu 21 15:15
FC1.4
Free Communications 1: Adrenals and HPA Axis
Response to Crinecerfont Treatment in Adolescents with Classic Congenital Adrenal Hyperplasia Is Correlated with Elevated Baseline Hormone Concentrations but Not Glucocorticoid Dose
Minneapolis, USA
Thu 21 15:25
FC1.3
Free Communications 1: Adrenals and HPA Axis
Generation and Characterization of a novel Humanized CYP21A2 Knock-in Mouse Model for Congenital Adrenal Hyperplasia
Dresden, Germany
Thu 21 15:35
FC1.5
Free Communications 1: Adrenals and HPA Axis
Management of congenital adrenal hyperplasia in the first 90 days of life: a multi-centre I-CAH analysis of contemporary practice
Southampton, UK
Thu 21 15:45
FC1.6
Free Communications 1: Adrenals and HPA Axis
Cardiovascular risk profile in adult patients with congenital adrenal hyperplasia: a cross-sectional study
Nijmegen, The Netherlands
Thu 21 14:55
Free Communications 2: Bone, growth plate and mineral metabolism
Mississippi
Chairs: Evelien Gevers (London, UK) & Wolfgang Högler (Linz, Austria)
Thu 21 14:55
FC2.1
Free Communications 2: Bone, growth plate and mineral metabolism
Hearing loss in pseudohypoparathyroidism (inactivating PTH/PTHRP Signaling Disorder): a prospective study to assess prevalence and predictive factors of hearing loss in 44 patients affected with iPPSD/PHP
Le Kremlin-Bicêtre, France
Thu 21 15:05
FC2.2
Free Communications 2: Bone, growth plate and mineral metabolism
First Results of the Global ALPL Gene Variant Classification Project
Linz, Austria
Thu 21 15:15
FC2.3
Free Communications 2: Bone, growth plate and mineral metabolism
Hyperparathyroidism after three years of burosumab in children affected with x-linked hypophosphatemia
Le Kremlin-Bicêtre, France
Thu 21 15:25
FC2.4
Free Communications 2: Bone, growth plate and mineral metabolism
A real-world study in Germany and Switzerland regarding renal health in children with X-linked hypophosphatemia
Hannover, Germany
Thu 21 15:35
FC2.5
Free Communications 2: Bone, growth plate and mineral metabolism
Generation of novel genetic zebrafish models and using RNA-seq analysis to explore the role of ankrd11 gene on bone growth
Thu 21 15:45
FC2.6
Free Communications 2: Bone, growth plate and mineral metabolism
Human breast milk-derived exosomes promote growth plate cell lines in vitro
Istanbul, Turkey
Thu 21 14:55
Free Communications 3: Fat, metabolism and obesity 1
Yangtze 1&2
Chairs: Francesco Chiarelli (Chieti, Italy) & Senthil Senniappan (Liverpool, UK)
Thu 21 14:55
FC3.1
Free Communications 3: Fat, metabolism and obesity 1
Early childhood height and weight development in children with monogenic obesity: A European multicenter cohort study
Ulm, Germany
Thu 21 15:05
FC3.2
Free Communications 3: Fat, metabolism and obesity 1
Analysis of ligand- and mutation-dependent signaling of the melanocortin 4 receptor (MC4R): an example of the relevance of differential signaling (bias signaling)
Berlin, Germany
Thu 21 15:15
FC3.3
Free Communications 3: Fat, metabolism and obesity 1
Frequency of Obesity-Related Gene Variants in a European Population With Early-Onset, Severe Obesity
Madrid, Spain
Thu 21 15:25
FC3.4
Free Communications 3: Fat, metabolism and obesity 1
A Novel Mutation in DYRK1B Associated With Abdominal Obesity Metabolic Syndrome 3 (AOMS3)
Doha, Qatar
Thu 21 15:35
FC3.5
Free Communications 3: Fat, metabolism and obesity 1
Early corneal nerve loss in children with obesity and type 2 diabetes
Doha, Qatar
Thu 21 15:45
FC3.6
Free Communications 3: Fat, metabolism and obesity 1
Impact of Setmelanotide on Future Metabolic Syndrome Risk in Pediatric Patients With Bardet-Biedl Syndrome
Madrid, Spain
Thu 21 14:55
Free Communications 4: Growth and syndromes (to include Turner syndrome)
Atlantic
Chairs: Cheri Deal (Montréal, Canada) & Janielle van der velden (Nijmegen, The Netherlands)
Thu 21 14:55
FC4.1
Free Communications 4: Growth and syndromes (to include Turner syndrome)
Heterozygous Null Mutations in FLNB as a Cause of apparent isolated Short Stature in Chinese Children
Suzhou, China
Thu 21 15:05
FC4.2
Free Communications 4: Growth and syndromes (to include Turner syndrome)
Genetic and phenotypic features of children with familial tall stature
Prague, Czech Republic
Thu 21 15:15
Free Communications 4: Growth and syndromes (to include Turner syndrome)
Pathogenic variants in GHSR cause short stature and growth hormone neurosecretory dysfunction; results from a large case series
Leiden, The Netherlands
Thu 21 15:25
Free Communications 4: Growth and syndromes (to include Turner syndrome)
Growth failure in aggrecan haploinsufficiency is due to a decrease in growth plate matrix volume and hypertrophic cell size
Stockholm, Sweden
Thu 21 15:35
Free Communications 4: Growth and syndromes (to include Turner syndrome)
From thalidomide embryopathy to genetic defects of the upper limb, internal organs, cerebral midline, and pituitary: The phenotypic spectrum of SALL4
Prague, Czech Republic
Thu 21 15:45
Free Communications 4: Growth and syndromes (to include Turner syndrome)
Persistence of Growth Promoting Effects in Infants and Toddlers with Achondroplasia: Results in Children Aged Over 2 Years Old from a Phase II Extension Study with Vosoritide
London, UK
Thu 21 14:55
Free Communications 5: Diabetes and insulin 1
Amazon
Chairs: Paul Voorhoeve (Nijmegen, The Netherlands) & Marianna Rachmiel (Zerifin, Israel)
Thu 21 14:55
FC5.1
Free Communications 5: Diabetes and insulin 1
Diabetes mellitus and gender incongruence: Worse metabolic control in type 1 and higher mental health issue rates in type 1 and 2 diabetes – a DPV registry study
Bern, Switzerland
Thu 21 15:05
FC5.2
Free Communications 5: Diabetes and insulin 1
Nailfold capillaroscopy: An alternative non-invasive tool for evaluating microvascular involvement in children with type 1 diabetes
Istanbul, Turkey
Thu 21 15:15
FC5.3
Free Communications 5: Diabetes and insulin 1
How feasible is it to meet the Time in Tight Range (TITR) target with Automatic Insulin Delivery (AID)?: 2128-day real-world data from a single center
Istanbul, Turkey
Thu 21 15:25
FC5.4
Free Communications 5: Diabetes and insulin 1
Changes of intestinal flora in children with type 1 diabetes mellitus and its related immune mechanism
Nanchang, China
Thu 21 15:35
FC5.5
Free Communications 5: Diabetes and insulin 1
Sleep Characteristics, Glycemic Control, and Endothelial Function in Adolescents and Young Adults with Type 1 Diabetes
Bangkok, Thailand
Thu 21 15:45
FC5.6
Free Communications 5: Diabetes and insulin 1
Post-Hypoglycemic Hyperglycemia Are Highly Relevant Markers For Stratification Of Glycemic Variability and Remission Status Of Pediatric Patients With New-Onset Type 1 Diabetes.
Bruxelles, Belgium
Thu 21 15:55
Refreshment Break, Posters and Exhibition
Exhibition Hall
Fri 22 07:15
Registration
Fri 22 08:15
Industry Expert Forum 1
For more information please see Industry Expert programme
Fri 22 08:30
Controversy 1
King Willem Alexander Auditorium
Chairs: Peter Clayton (Manchester, UK) & Philippe Backeljauw (Cincinnati, USA)
Fri 22 08:30
Controversy 1
Pharmacological manipulation of bone maturation should be used to preserve final height in short children (FOR)
Santiago, Chile
Fri 22 08:30
Controversy 1
Pharmacological manipulation of bone maturation should NOT be used to preserve final height in short children (AGAINST)."
Helsinki, Finland
Fri 22 09:00
Industry Expert Fora 2&3
For more information please see Industry Expert programme
Fri 22 09:30
Rapid Free Communications 6: Pituitary, neuroendocrinology and puberty 1
Pacific
Chairs: Nitash Zwaveling-Soonawala (Amsterdam, The Netherlands) & Paul Dimitri (Sheffield, UK)
Fri 22 09:30
RFC6.1
Rapid Free Communications 6: Pituitary, neuroendocrinology and puberty 1
Clinical application of LH cut-off value in the diagnosis of CPP according to the international consensus
Zhengzhou, China
Fri 22 09:35
RFC6.2
Rapid Free Communications 6: Pituitary, neuroendocrinology and puberty 1
Psychosocial Evaluation of Girls with Rapidly Progressive Puberty Presenting with Early Menarche
Izmir, Turkey
Fri 22 09:40
RFC6.3
Rapid Free Communications 6: Pituitary, neuroendocrinology and puberty 1
Exposure to Per- and Polyfluoroalkyl Substances and Pubertal Assessment by Ultrasound in Norwegian Boys and Girls: Data from the Bergen Growth Study 2
Norway
Fri 22 09:45
RFC6.4
Rapid Free Communications 6: Pituitary, neuroendocrinology and puberty 1
Earlier Occurrence of Puberty and Pubertal Hair Development in Boys and Girls - Insights from the DPV Initiative Data
Germany
Fri 22 09:50
RFC6.5
Rapid Free Communications 6: Pituitary, neuroendocrinology and puberty 1
EFFICACY AND SECURITY OF GONADOTROPIN TREATMENT IN ADOLESCENTS WITH CONGENITAL HYPOGONADOTROPIC HYPOGONADISM
Spain
Fri 22 09:55
RFC6.6
Rapid Free Communications 6: Pituitary, neuroendocrinology and puberty 1
Evaluation of Serum MKRN3 and DLK1 Concentrations for Predicting Variant Detection in MKRN3 and DLK1Genes in Patients with Central Precocious Puberty
Turkey
Fri 22 09:30
Rapid Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
Atlantic
Chairs: Hedi Claahsen (Nijmegen, The Netherlands) & Anna Nordenström (Stockholm, Sweden)
Fri 22 09:30
RFC7.1
Rapid Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
Penile width increases more clearly than penile length during minipuberty: a longitudinal study of 136 healthy infant boys
Copenhagen, Denmark
Fri 22 09:35
RFC7.2
Rapid Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
International Evidence-Based Guidelines for PCOS 2023: Recommendations in Adolescent Girls
Pittsburgh, USA
Fri 22 09:40
RFC7.3
Rapid Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
Histone code, cryptorchidism,infertility
Liestal, Switzerland
Fri 22 09:45
RFC7.4
Rapid Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
Serum steroid metabolome dynamics during infancy: a prospective, longitudinal cohort of healthy boys
Copenhagen, Denmark
Fri 22 09:50
RFC7.5
Rapid Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
Sex differences in endocrine mechanisms during early human fetal brain development
London, UK
Fri 22 09:55
RFC7.6
Rapid Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
Prenatal AnoGenital Distance (AGD) by ultrasonography in 571 fetuses and correlation to postnatal AGD: A longitudinal cohort study of healthy males and females
Copenhagen, Denmark
Fri 22 09:30
Rapid Free Communications 8: Fat, metabolism and obesity 2
Yangtze 1&2
Chairs: Cosimo Giannini (Chieti, Italy) & Thomas Reinehr (Datteln, Germany)
Fri 22 09:30
RFC8.1
Rapid Free Communications 8: Fat, metabolism and obesity 2
A novel heterozygous likely pathogenic variant in GNB1 causing hyperphagia, severe early onset obesity and neurodevelopmental disorder
Athens, Greece
Fri 22 09:35
RFC8.2
Rapid Free Communications 8: Fat, metabolism and obesity 2
Acute rise of leptin after five days of dexamethasone and its association with hunger, fat mass, sleep and fatigue, in children with acute lymphoblastic leukemia
Utrecht, The Netherlands
Fri 22 09:40
RFC8.3
Rapid Free Communications 8: Fat, metabolism and obesity 2
Higher levels of serum α-Klotho are longitudinally associated with less visceral fat accumulation in apparently healthy girls experiencing weight gain
Utrecht, The Netherlands
Fri 22 09:45
RFC8.4
Rapid Free Communications 8: Fat, metabolism and obesity 2
Understanding the genetics of early onset obesity in a cohort of children from Qatar
Doha, Qatar
Fri 22 09:50
RFC8.5
Rapid Free Communications 8: Fat, metabolism and obesity 2
Effects of leptin knockdown on a human preadipocyte model
Leipzig, Germany
Fri 22 09:55
RFC8.6
Rapid Free Communications 8: Fat, metabolism and obesity 2
Leukocytes and Neutrophil–Lymphocyte Ratio as Indicators of decreased insulin sensitivity in NGT Overweight and Obese Children with high 1-hour post-load plasma glucose levels
Chieti, Italy
Fri 22 09:30
Rapid Free Communications 9: Diabetes and insulin 2
Mississippi
Chairs: Kanetee Busiah (Vaud, Switzerland) & Mieke Houdijk (Leiden, The Netherlands)
Fri 22 09:30
RFC9.1
Rapid Free Communications 9: Diabetes and insulin 2
The association of dietary glycemic index and load with insulin sensitivity and secretion from early childhood to late adolescence: the QUALITY cohort
Montréal, Canada
Fri 22 09:35
RFC9.2
Rapid Free Communications 9: Diabetes and insulin 2
Two new candidate genes,OGDH and FGFR1 discovered in an insulinoma from a fifteen-year-old male
Odense, Denmark
Fri 22 09:40
RFC9.3
Rapid Free Communications 9: Diabetes and insulin 2
Impaired Insulin Secretion as a Pathophysiology Underlying Abnormal Glucose Metabolism in Pediatric Acute Lymphoblastic Leukemia (ALL) Survivors: A Study Comparing Glucose Metabolism between ALL Survivors and Simple Obese Children
Bangkok, Thailand
Fri 22 09:45
RFC9.4
Rapid Free Communications 9: Diabetes and insulin 2
Clinical and genetic characteristics of patients suspected to have Maturity-Onset Diabetes of the Young in the Czech Republic
Prague, Czech Republic
Fri 22 09:50
RFC9.5
Rapid Free Communications 9: Diabetes and insulin 2
Insulin secretion defect in children and adolescents with obesity: Clinical and molecular genetic characterization
Berlin, Germany
Fri 22 09:55
RFC9.6
Rapid Free Communications 9: Diabetes and insulin 2
Wharton jelly derived mesenchymal stem cells exosomes protect pancreatic beta cells from inflamation
Istanbul, Turkey
Fri 22 09:30
Rapid Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
Amazon
Chairs: Rasa Verkauskiene (Kaunas, Lithuania) & Martijn Finken (Amsterdam, The Netherlands)
Fri 22 09:30
RFC10.1
Rapid Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
A novel maternally inherited GNAS variant in a family with hyperphagia and obesity.
London, UK
London, UK
Fri 22 09:35
RFC10.2
Rapid Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
Utility of Continuous Glucose Monitoring (CGM) during pancreatic surgery in patients with Congenital Hyperinsulinism
Manchester, UK
Manchester, UK
Fri 22 09:40
RFC10.3
Rapid Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
Non-coding Variants in HK1 Account for 5% of Cases of Congenital Hyperinsulinism Without an Identified Genetic Cause
Philadelphia, USA
Fri 22 09:45
RFC10.4
Rapid Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
Clinical phenotypes of a multicentric cohort of ROHHAD patients
Genoa, Italy
Fri 22 09:50
RFC10.5
Rapid Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
Insulinoma in childhood: A multicenter retrospective study of 28 patients
Moscow, Russian Federation
Fri 22 09:55
RFC10.6
Rapid Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
Two novel mutations in the DCAF17 gene in two Palestinian families with primary amenorrhea revealing molecular genetics in Woodhouse-Sakati syndrome & unique presentation
Jerusalem, Israel
Fri 22 10:00
Free Communications 6: Pituitary, neuroendocrinology and puberty 1
Pacific
Chairs: Nitash Zwaveling-Soonawala (Amsterdam, The Netherlands) & Paul Dimitri (Sheffield, UK)
Fri 22 10:00
FC6.1
Free Communications 6: Pituitary, neuroendocrinology and puberty 1
Methylome analysis in idiopathic central precocious puberty girls
Fri 22 10:10
FC6.2
Free Communications 6: Pituitary, neuroendocrinology and puberty 1
The role of body composition and appetite-regulating hormones in idiopathic central precocious puberty and their changes during GnRH analogue therapy.
Istanbul, Turkey
Fri 22 10:20
FC6.3
Free Communications 6: Pituitary, neuroendocrinology and puberty 1
Is the 24-hour urinary gonadotropin assay an effective diagnostic tool in central precocious puberty? A retrospective study of threshold setting and validation in two cohorts.
Lyon, France
Fri 22 10:30
FC6.4
Free Communications 6: Pituitary, neuroendocrinology and puberty 1
Sleeptime-excreted total urinary luteinizing hormone concentrations reveal that the onset of central puberty occurs at around the same time in boys and girls: a longitudinal study
Helsinki, Finland
Fri 22 10:40
FC6.5
Free Communications 6: Pituitary, neuroendocrinology and puberty 1
Clinical characteristics of 213 children with early pubertal development complicated with pineal cyst
Zhengzhou, China
Fri 22 10:50
FC6.6
Free Communications 6: Pituitary, neuroendocrinology and puberty 1
Serum Kisspeptin and DLK1 levels as a tool for diagnosis and monitoring of central precocious puberty treatment in Thai girls
Bangkok, Thailand
Fri 22 10:00
Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
Atlantic
Chairs: Hedi Claahsen (Nijmegen, The Netherlands) & Anna Nordenström (Stockholm, Sweden)
Fri 22 10:00
FC7.1
Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
Polygenic scores for testosterone and SHBG are associated with hormone levels in male infants
Copenhagen, Denmark
Fri 22 10:10
FC7.2
Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
Mapping the transcriptomic landscape of early human fetal ovary development through a clinically-focused lens
London, United Kingdom
Fri 22 10:20
FC7.3
Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
ROS scavengers may improve genital skin healing in boys with hypospadias
Glasgow, UK
Fri 22 10:30
FC7.4
Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
The effect of common genetic variants in CYP19A1 on serum Estradiol to Testosterone Ratio in healthy Danish children and adolescents
Copenhagen, Denmark
Fri 22 10:40
FC7.5
Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
SGPL1 deficiency, a cause of 46XY DSD and adrenal insufficiency, impairs lipid metabolism and steroidogenesis in Leydig cells
London, UK
Fri 22 10:50
FC7.6
Free Communications 7: Sex differentiation, gonads and gynaecology or sex endocrinology
GnRHa response patterns of testis expressed genes in cryptorchid boys
Liestal, Switzerland
Fri 22 10:00
Free Communications 8: Fat, metabolism and obesity 2
Yangtze 1&2
Chairs: Cosimo Giannini (Chieti, Italy) & Thomas Reinehr (Datteln, Germany)
Fri 22 10:00
FC8.1
Free Communications 8: Fat, metabolism and obesity 2
Aberrant expression of agouti signaling protein (ASIP) as a new cause of monogenic severe childhood obesity
Leipzig, Germany
Fri 22 10:10
FC8.2
Free Communications 8: Fat, metabolism and obesity 2
Frequency of MC4R Pathway Variants in a European Cohort of Individuals With Early-Onset Severe Obesity
London, UK
Fri 22 10:20
FC8.3
Free Communications 8: Fat, metabolism and obesity 2
Impact of growth hormone therapy on body mass index in childhood-onset craniopharyngioma: a multicenter Italian study in 117 patients.
Novara, Italy
Fri 22 10:30
FC8.4
Free Communications 8: Fat, metabolism and obesity 2
Irs1 expression in peripheral blood associates with obesity and cardiovascular risk parameters in school-age girls
Salt, Spain
Fri 22 10:40
FC8.5
Free Communications 8: Fat, metabolism and obesity 2
Impact of Setmelanotide on Metabolic Syndrome Risk in Pediatric Patients With POMC and LEPR Deficiency
University of Ulm, Germany
Fri 22 10:50
FC8.6
Free Communications 8: Fat, metabolism and obesity 2
Liraglutide treatment in adolescents with extreme obesity - Effects on weight loss in the first 9 months under real-life conditions
Ulm, Germany
Fri 22 10:00
Free Communications 9: Diabetes and insulin 2
Mississippi
Chairs: Kanetee Busiah (Vaud, Switzerland) & Mieke Houdijk (Leiden, The Netherlands)
Fri 22 10:00
FC9.1
Free Communications 9: Diabetes and insulin 2
Reference values for the insulin response to glucose challenge enable the early detection of emerging (pre)diabetes in children and young adults with obesity
Leipzig, Germany
Fri 22 10:10
FC9.2
Free Communications 9: Diabetes and insulin 2
Characterization of pediatric patients with type 2 diabetes and trends in their pharmaceutical management 2000-2022 in German-speaking countries: Analysis based on the DPV registry
Luxembourg, Luxembourg
Berlin, Germany
Fri 22 10:20
FC9.3
Free Communications 9: Diabetes and insulin 2
A novel case of hypoglycaemia secondary to a pro-insulin processing disorder
Leeds Teaching Hospital, Leeds, UK
Fri 22 10:30
FC9.4
Free Communications 9: Diabetes and insulin 2
The high proportion of INS-MODY in Chinese children with MODY
Shanghai, China
Shanghai, China
Fri 22 10:40
FC9.5
Free Communications 9: Diabetes and insulin 2
A case of NARS1 deficiency resulting in diabetes mellitus with liver cirrhosis and pancreatic atrophy
Osaka, Japan
Fri 22 10:50
FC9.6
Free Communications 9: Diabetes and insulin 2
Puberty and Gonadal function in Wolfram Syndrome: A retrospective single centre study
Birmingham, UK
Fri 22 10:00
Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
Amazon
Chairs: Rasa Verkauskiene (Kaunas, Lithuania) & Martijn Finken (Amsterdam, The Netherlands)
Fri 22 10:00
FC10.1
Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
Dasiglucagon safety in paediatric participants with CHI
Düsseldorf, Germany
Fri 22 10:10
FC10.2
Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
Immune profile response to rituximab in ROHHAD syndrome
Bristol, UK
Fri 22 10:20
FC10.3
Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
ROHHAD syndrome, thrombotic risk and endothelial damage: a single center experience.
Genoa, Italy
Fri 22 10:30
FC10.4
Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
A Novel Mutation in RAI1 Gene in a Patient with Clinical Diagnosis of Rapid-Onset Obesity with Hypothalamic Dysregulation, Hypoventilation, and Autonomic Dysregulation (ROHHAD) Syndrome with Overlapping Symptoms of Smith Magenis Syndrome (SMS).
Orange, USA
Fri 22 10:40
FC10.5
Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
MCM4 deficiency causing Natural Killer and Glucocorticoid Deficiency with DNA repair defect (AR-NKGCD) - a large cases series from the Irish Traveller Community
Lodz, Poland
Fri 22 10:50
FC10.6
Free Communications 10: Fetal, neonatal endocrinology and metabolism (to include hypoglycaemia) & Multisystem endocrine disorders
PLACENTAL MEST GENE EXPRESSION IS ASSOCIATED WITH POSTNATAL GROWTH AND OBESITY
Girona, Spain
Fri 22 11:00
Refreshment Break, Posters and Exhibition
Exhibition Hall
Fri 22 13:00
Lunch, posters and exhibition
Exhibition Hall
Fri 22 13:20
Satellite Symposium 5
For more information please see satellite programme
Fri 22 14:30
Yearbook 2
Amazon
Chair: Ken Ong (Cambridge, UK)
Fri 22 14:30
YB2.1
Yearbook 2
Puberty
Liège, Belgium
Fri 22 14:42
YB2.2
Yearbook 2
DSD and gender incongruence
Turkey, Istanbul
Fri 22 14:54
YB2.3
Yearbook 2
Oncology and Chronic Disease
Rome, Italy
Fri 22 15:06
YB2.4
Yearbook 2
Diabetes Type 1
Cambridge, UK
Fri 22 15:18
YB2.5
Yearbook 2
Editors' Choice
Cambridge, UK
Fri 22 14:30
ESPE Nursing and Allied Health Working Group (PENS)
Everest 1&2
Chairs: Camilla Ernstsson (Umeå, Sweden), Clare Simpson (Leeds, UK) & Sandra Greetham (Hull, UK)
Fri 22 14:30
ESPE Nursing and Allied Health Working Group (PENS)
Childhood craniopharyngioma - challenges for the pediatric endocrinologist
Malmö, Sweden
Fri 22 15:00
ESPE Nursing and Allied Health Working Group (PENS)
The role of a nurse in managing and supporting children and their families with a craniopharyngioma - Roisin Boyle
Glasgow, UK
Fri 22 15:30
ESPE Nursing and Allied Health Working Group (PENS)
Q&A in Endocrine Nursing
Fri 22 16:40
Refreshment Break, Posters and Exhibition
Exhibition Hall
Fri 22 17:00
Satellite Symposium 9
For more information please see satellite programme
Fri 22 17:00
Satellite Symposium 10
For more information please see satellite programme
Fri 22 18:30
ESPE Annual Business Meeting
Pacific
Sat 23 07:15
Registration
Sat 23 08:00
Yearbook 3
Amazon
Chairs: Christa Flück (Bern, Switzerland) & Ken Ong (Cambridge, UK)
Sat 23 08:00
YB3.1
Yearbook 3
Thyroid
Basel, Switzerland
Sat 23 08:15
YB3.2
Yearbook 3
Growth and Growth Factors
Rome, Italy
Sat 23 08:30
YB3.3
Yearbook 3
Bone, Growth Plate and Mineral Metabolism
Stockholm, Sweden
Sat 23 08:45
YB3.4
Yearbook 3
A tribute to Ze’ev Hochberg’s work
Bern, Switzerland
Cambridge, UK
Sat 23 09:00
Rapid Free Communications 11: GH and IGFs
Pacific
Chairs: Helen Storr (London, UK) & Christiaan de Bruin (Leiden, The Netherlands)
Sat 23 09:00
RFC11.1
Rapid Free Communications 11: GH and IGFs
The genetic aetiology of primary multiple pituitary hormone deficiency: a next-generation sequencing analysis of a single-centre cohort.
Prague, Czech Republic
Sat 23 09:05
RFC11.2
Rapid Free Communications 11: GH and IGFs
Are pappalysins and stanniocalcins involved in modifying the bioavailability of IGF-I in children with onset of type 1 diabetes mellitus?
Madrid, Spain
Sat 23 09:10
RFC11.3
Rapid Free Communications 11: GH and IGFs
Longitudinal assessment of health-related quality of life (HRQoL) & behavior in adults born small for gestational age (SGA) who were treated with growth hormone during childhood
Rotterdam, The Netherlands
Sat 23 09:15
RFC11.4
Rapid Free Communications 11: GH and IGFs
Functional analysis of a novel mutation of IGF1R gene in two twins with growth failure. An example of genotype-phenotype heterogeneity.
Rome, Italy
Sat 23 09:20
RFC11.5
Rapid Free Communications 11: GH and IGFs
Influence of sirtuin 1 and fibroblast growth factor 21 levels on IGF-1 concentration in children with short stature of different etiology
Lodz, Poland
Sat 23 09:25
RFC11.6
Rapid Free Communications 11: GH and IGFs
Evaluation Of The Growth Hormone-Insulin like Growth Factor1 Axis And Serum Fibroblast Growth Factor 21 Levels As Related To Stature In Children And Adolescents With Coeliac Disease Adherent To Gluten Free Diet
Istanbul, Turkey
Sat 23 09:00
Rapid Free Communications 12: Thyroid
Mississippi
Chairs: Athanasia Stoupa (Paris, France) & Joachim Pohlenz (Mainz, Germany)
Sat 23 09:00
RFC12.1
Rapid Free Communications 12: Thyroid
Macro-TSH IgG complex in a case of Congenital Hypothyroidism (CH).
Milan, Italy
Sat 23 09:05
RFC12.2
Rapid Free Communications 12: Thyroid
A novel frameshift mutation in Immunoglobulin Superfamily, Member 1 (IGSF1) causing central hypothyroidism, delayed puberty and GH deficiency
London, UK
Sat 23 09:10
RFC12.3
Rapid Free Communications 12: Thyroid
Thyroid disorders in childhood cancer survivors treated with 131 I-MIBG, TKIs or immune checkpoint inhibitors: incidence, mechanisms and clinical management – systematic review
Leuven, Belgium
Leuven, Belgium
Sat 23 09:15
RFC12.4
Rapid Free Communications 12: Thyroid
Polyethylene glycol thyroid stimulating hormone (PEG-TSH) in real-life: a practical tool for solving a biochemical dilemma
Tel Aviv, Israel
Tel Aviv, Israel
Sat 23 09:20
RFC12.5
Rapid Free Communications 12: Thyroid
Application of Shear Wave Elastography (SWE) in the ultrasound evaluation of thyroid nodules in children and adolescents
Białystok, Poland
Sat 23 09:25
RFC12.6
Rapid Free Communications 12: Thyroid
Phenylbutyrate treatment of three patients with Monocarboxylate Transporter 8 deficiency
Rehovot, Israel
Sat 23 09:00
Rapid Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Atlantic
Chairs: Cynthia Andoniadou (London, UK) & Anne Rochtus (Leuven, Belgium)
Sat 23 09:00
RFC13.1
Rapid Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Are Glucagon-like peptide-1 (GLP-1) receptor agonists a new treatment option for hypothalamic obesity in the paediatric population: Preliminary experience from a tertiary paediatric endocrine centre
Bristol, UK
Sat 23 09:05
RFC13.2
Rapid Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Arginine-stimulated copeptin is independent of GH secretion status
Tubingen, Germany
Sat 23 09:10
RFC13.3
Rapid Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Treatment and outcome of the Dutch Childhood Craniopharyngioma Cohort study; first results after centralization of care
Utrecht, The Netherlands
Sat 23 09:15
RFC13.4
Rapid Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Trio analyses of patients with congenital hypopituitarism reveals novel candidate genes
Lausanne, Switzerland
Sat 23 09:20
RFC13.5
Rapid Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Growth hormone and TSH deficiency after [177Lu]Lu-DOTATATE therapy for pediatric neuroblastoma; description of a first case.
Utrecht, The Netherlands
Sat 23 09:25
RFC13.6
Rapid Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Pituitary size on volumetric MRI predicts the severity of the neuroendocrine phenotype in populations at risk
London, UK
Sat 23 09:00
Rapid Free Communications 14 - Late Breaking
Yangtze 1&2
Chairs: Annemarie Verrijn-Stuart (Utrecht, Netherlands) & Tommaso Aversa (Messina, Italy)
Sat 23 09:00
RFC14.1
Rapid Free Communications 14 - Late Breaking
Clinical characteristics of patients presented with primary adrenal insufficiency due to a p.R451W mutation in the CYP11A1 gene
Erzurum, Turkey
Ankara, Turkey
Sat 23 09:05
RFC14.2
Rapid Free Communications 14 - Late Breaking
No Relationship Between Thyroid Function and ADHD – Results From a Nationwide Prospective Epidemiological Study and Mendelian Randomization
Essen, Germany
Sat 23 09:10
RFC14.3
Rapid Free Communications 14 - Late Breaking
Body composition in a pediatric population with type 1 diabetes mellitus - The importance of planned physical activity
Vila Nova de Gaia, Portugal
Sat 23 09:15
RFC14.4
Rapid Free Communications 14 - Late Breaking
Evaluating the Effect of Recombinant Human Growth Hormone Treatment on Sleep-related Breathing Disorders in Toddlers with Prader–Willi Syndrome: a one-year retrospective cohort study.
Shanghai, China
Sat 23 09:20
RFC14.5
Rapid Free Communications 14 - Late Breaking
Functional demonstration that variants in the C-terminal of IHH cause short stature and/brachdactyly
Madrid, Spain
Sat 23 09:25
RFC14.6
Rapid Free Communications 14 - Late Breaking
Enhanced histones acetylation in children with obesity: relationship with insulin resistance and inflammation
Tehran, Iran
Sat 23 09:30
Free Communications 11: GH and IGFs
Pacific
Chairs: Helen Storr (London, UK) & Christiaan de Bruin (Leiden, The Netherlands)
Sat 23 09:30
FC11.1
Free Communications 11: GH and IGFs
GH replacement therapy with once-weekly somapacitan in children with GH deficiency is effective and well-tolerated: 2-year results from REAL4
Minneapolis, USA
Sat 23 09:40
FC11.2
Free Communications 11: GH and IGFs
Clinical characteristics of heterozygous ACAN gene variants and longer-term response to growth hormone treatment: real-world data
Rotterdam, The Netherlands
Sat 23 09:50
FC11.3
Free Communications 11: GH and IGFs
Analysis of a large panel of genes in a cohort of patients with severe short stature: detection rate and genotype-phenotype correlations
Padova, Italy
Sat 23 10:00
FC11.4
Free Communications 11: GH and IGFs
Long-term GH-treatment of children born small for gestational age (SGA) does not result in cerebrovascular abnormalities in adulthood compared to untreated controls
Rotterdam, The Netherlands
Sat 23 10:10
FC11.5
Free Communications 11: GH and IGFs
Effective GH Replacement with Once-weekly Somapacitan in Japanese Children with GH Deficiency: 2-year Results from REAL4
Suita, Japan
Sat 23 10:20
FC11.6
Free Communications 11: GH and IGFs
Longitudinal analysis of the risk of brain tumour recurrence or progression in relation to the timing of commencement of growth hormone replacement therapy.
London, UK
Sat 23 09:30
Free Communications 12: Thyroid
Mississippi
Chairs: Juliane Leger (Paris, France) & Joachim Pohlenz (Mainz, Germany)
Sat 23 09:30
FC12.1
Free Communications 12: Thyroid
Graves’ disease – are we just delaying the inevitable?
Cambridge, UK
Sat 23 09:40
FC12.2
Free Communications 12: Thyroid
Thyroid function analysis in 48 patients affected by severe combined immunodeficiency caused by adenosine deaminase deficiency
Milan, Italy
Sat 23 09:50
FC12.3
Free Communications 12: Thyroid
Hypothyroidism due to IYD bi-allelic pathogenic variants: clinical description of eight patients
Brussels, Belgium
Sat 23 10:00
FC12.4
Free Communications 12: Thyroid
Thyroid hormone resistance due to THRB gene mutations : neonatal manifestations in two cases
Paris, France
Sat 23 10:10
FC12.5
Free Communications 12: Thyroid
Teprotumumab in an adolescent with severe corticosteroid-resistant Graves ophthalmopathy: success but unexpected neurological manifestations.
Paris, France
Sat 23 10:20
FC12.6
Free Communications 12: Thyroid
TSH screening in premature newborns: a critical appraisal of the value of a second sample.
Brussels, Belgium
Sat 23 09:30
Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Atlantic
Chairs: Cynthia Andoniadou (London, UK) & Anne Rochtus (Leuven, Belgium)
Sat 23 09:30
FC13.1
Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Genetic evaluation in children with self-limited pubertal delay discloses new candidate genes
Sao Paulo, Brazil
Sat 23 09:40
FC13.2
Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Targeted gene panel screening in 144 congenital hypopituitarism patients, incorporating 135 known and novel genes implicated in hypopituitarism and/or hypothalamo-pituitary development.
London, UK
Sat 23 09:50
FC13.3
Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Variants in Methyl-CpG-binding protein 2 (MECP2) are associated with X-Linked Central Precocious Puberty
London, UK
Sat 23 10:00
FC13.4
Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Clinical and molecular genetic characteristics of 98 patients with congenital hypopituitarism: A single-center experience
Istanbul, Turkey
Sat 23 10:10
FC13.5
Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Systematic review and meta-analysis of spermatogenesis rates after pubertal induction with gonadotropins in males with hypogonadotropic hypogonadism
London, UK
Sat 23 10:20
FC13.6
Free Communications 13: Pituitary, neuroendocrinology and puberty 2
Effects of Blue Light Exposure and Exposure Duration on Male Rats Puberty Process
Ankara, Turkey
Sat 23 09:30
Free Communications 14 - Late Breaking
Yangtze 1&2
Chairs: Annemarie Verrijn-Stuart (Utrecht, The Netherlands) & Tommaso Aversa (Messina, Italy)
Sat 23 09:30
FC14.1
Free Communications 14 - Late Breaking
Sleep health characteristics in children with congenital adrenal hyperplasia
Minneapolis, USA
Sat 23 09:40
FC14.2
Free Communications 14 - Late Breaking
New Reference Values for Thyroid Volume by Ultrasound in German Children and Adolescents Under Iodine-Sufficient Conditions From a Nationwide Study
Essen, Germany
Sat 23 09:50
FC14.3
Free Communications 14 - Late Breaking
Deconvolution Analysis: GH secretagogue (LUM-201) enhances growth in individuals with moderate idiopathic Pediatric Growth Hormone Deficiency (iPGHD) by enhancing endogenous GH secretion and increasing IGF-1
Santiago, Chile
Sat 23 10:00
FC14.4
Free Communications 14 - Late Breaking
Improvement in insulin sensitivity and glucose metabolism in adolescents with obesity treated with once-weekly semaglutide 2.4 mg: a secondary analysis of the STEP TEENS trial
Pittsburgh, USA
Sat 23 10:10
FC14.5
Free Communications 14 - Late Breaking
Predicting Average IGF-I Concentration for Once-Weekly Somapacitan in Children with Growth Hormone Deficiency
Cincinnati, USA
Sat 23 10:20
FC14.6
Free Communications 14 - Late Breaking
Understanding the genetic complexity of puberty timing across the allele frequency spectrum
Cambridge, UK
Sat 23 10:30
Refreshment Break, Posters and Exhibition
Exhibition Hall
Sat 23 12:45
Lunch, posters and exhibition
Exhibition Hall
Sat 23 15:10
Refreshment Break, Posters and Exhibition
Exhibition Hall
Sat 23 15:30
Symposium 12: What's new for the HPG Axis
Atlantic
Chairs: Sasha Howard (London, UK) & Anne Simone Parent (Liege, Belgium)
Sat 23 15:30
S12.1
Symposium 12: What's new for the HPG Axis
Minipuberty - Looking into the future
Copenhagen, Denmark
Sat 23 16:00
S12.2
Symposium 12: What's new for the HPG Axis
SEMA6A drives GnRH neuron-dependent puberty onset by tuning median eminence vascular permeability.
Milan, Italy
Sat 23 16:30
S12.3
Symposium 12: What's new for the HPG Axis
Recent advances in our understanding of the regulation of GnRH secretion
Córdoba, Spain
Sat 23 17:55
Closing Ceremony
King Willem Alexander Auditorium

0 result(s) found.

Please wait...

     
      - 
     
     
     


    Abstracts from this event
      Abstracts from other events


          Session starts at:
          Abstract time:
        Event:


        Read full abstract